data_1irz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1irz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 mt -58.58 -19.99 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 72.7 t60 -80.41 -30.26 37.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.691 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.55 -33.27 66.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -73.83 -42.62 60.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.53 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 49.4 t80 -67.28 -22.57 65.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.873 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 43.6 mt -81.53 -44.88 16.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.672 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.74 -19.96 60.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.123 -0.986 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' O ' HD13 ' A' ' 25' ' ' LEU . . . -79.56 -38.87 33.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -0.953 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 18.7 t -71.26 -47.14 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.57 -43.14 97.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.585 0.707 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -58.92 -22.84 60.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.7 mt -112.54 -1.73 14.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.6 107.59 0.29 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.62 -19.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -1.091 . . . . 0.0 109.771 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.21 -43.34 70.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -116.8 14.24 15.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.027 . . . . 0.0 110.101 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -79.6 120.16 23.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.5 m -100.63 157.18 34.2 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 108.969 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.427 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 34.9 Cg_endo -77.23 -24.11 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.404 2.069 . . . . 0.0 110.144 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.12 -52.98 28.72 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.225 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 20.2 mmtp -67.99 -41.83 81.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.153 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.535 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.7 mt -64.53 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.608 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 43.2 tp -53.5 -35.72 60.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.49 -33.72 67.16 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.4 mt -57.31 -38.48 74.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.425 -0.797 . . . . 0.0 109.045 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mmt -73.55 -51.47 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 t30 56.39 26.4 10.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 21.7 t -94.0 154.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 16.6 p30 -80.3 146.82 31.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.316 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 77.19 -2.23 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.6 mt -102.35 119.24 38.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 109.485 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.86 -179.99 3.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.504 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.428 ' HB3' HD22 ' A' ' 36' ' ' LEU . 3.8 ptt-85 -77.07 -26.95 54.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 75.2 tt0 -72.53 -23.01 60.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.42 -36.46 58.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.45 -25.9 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 0.0 109.151 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HB1' ' CG ' ' A' ' 32' ' ' PRO . . . -77.02 -20.4 56.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -77.91 -46.15 22.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -63.66 -30.33 71.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.858 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.311 0.576 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.26 -19.16 62.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 109.811 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.56 ' CE1' HD13 ' A' ' 19' ' ' LEU . 13.7 t-160 -79.96 -23.83 41.39 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -71.7 -28.91 64.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -79.01 -47.95 15.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.133 -0.979 . . . . 0.0 109.139 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 49' ' ' VAL . 78.2 t80 -69.86 -22.21 63.28 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD13 ' CE1' ' A' ' 15' ' ' HIS . 12.4 mt -78.54 -39.45 37.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 109.74 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.88 -24.34 55.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.192 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.515 ' HB1' ' CD1' ' A' ' 38' ' ' LEU . . . -76.91 -43.66 34.71 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 108.737 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 21.7 t -65.38 -46.44 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 108.814 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.58 -44.79 95.81 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.522 0.677 . . . . 0.0 109.391 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -59.49 -23.09 62.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 0.0 109.918 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.518 ' CD1' HG12 ' A' ' 35' ' ' ILE . 4.7 mt -107.25 -7.03 16.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.02 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.78 108.94 0.55 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 2.8 p -53.1 -18.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 109.751 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.46 -46.58 79.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 13.66 15.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . . . -75.8 108.93 8.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 17.2 m -96.66 160.11 30.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 109.037 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.99 9.98 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.443 2.096 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.65 -48.81 58.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.347 -0.845 . . . . 0.0 109.302 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 66.8 mmtt -69.9 -42.89 72.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 109.18 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.6 mt -65.9 -24.68 34.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.031 -1.043 . . . . 0.0 108.433 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 19.0 tp -54.65 -32.6 59.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.21 -32.05 55.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.12 -36.45 77.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.592 -0.693 . . . . 0.0 109.598 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.413 ' HE3' ' HB2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -86.46 -46.73 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.97 . . . . 0.0 109.739 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 t30 51.28 24.87 2.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 108.885 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 76.8 t -78.95 157.82 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.556 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.3 p-10 -90.34 146.26 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 ttmt 77.03 -2.25 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.1 mt -95.36 107.26 19.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 109.364 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -88.97 175.97 7.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 4.6 mtm180 -78.75 -24.95 44.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.765 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -22.97 54.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.583 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.93 -43.68 64.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.697 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.572 HG12 ' CE1' ' A' ' 18' ' ' PHE . 76.6 t -83.45 -26.59 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 46' ' ' ARG . . . -76.19 -20.02 57.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 m -78.12 -45.61 22.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.73 -26.6 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 109.241 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.7 tp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.03 -23.1 66.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.442 -0.786 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.535 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 3.9 t60 -71.62 -26.5 62.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.01 -37.61 72.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -72.85 -47.51 45.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 62.9 t80 -68.93 -22.29 64.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.535 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 21.8 mt -82.15 -39.67 22.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.912 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.17 -22.57 44.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.112 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 38' ' ' LEU . . . -79.35 -41.24 28.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 108.834 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 28.3 t -70.59 -45.75 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.94 -43.72 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.15 -23.22 62.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.529 -0.732 . . . . 0.0 109.688 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 HD13 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mt -112.61 -0.57 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.817 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . 78.18 107.16 0.19 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HA ' HG11 ' A' ' 22' ' ' VAL . 9.5 p -52.28 -19.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -1.057 . . . . 0.0 109.921 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 -42.28 65.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -116.84 14.48 15.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' GLY . . . -89.22 133.45 34.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.8 m -115.89 160.24 36.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.397 -0.814 . . . . 0.0 109.069 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.6 Cg_endo -76.18 -17.27 17.17 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.47 2.113 . . . . 0.0 110.253 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -71.54 -54.79 9.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.171 -0.956 . . . . 0.0 109.31 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -38.47 80.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.218 -0.927 . . . . 0.0 108.838 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.7 mt -63.43 -25.34 38.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.575 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.1 tp -51.75 -36.2 46.38 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -73.34 -35.12 65.97 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' CD1' HD13 ' A' ' 25' ' ' LEU . 5.0 mt -58.01 -35.77 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.554 -0.716 . . . . 0.0 109.336 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.0 mmm -78.98 -51.28 9.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 57.94 25.75 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 44' ' ' LEU . 72.8 t -82.27 146.54 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.295 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.0 p30 -80.32 145.92 31.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.57 0.75 3.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.658 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' A' ' 41' ' ' VAL . 4.0 mm? -103.11 137.55 41.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.65 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -118.46 173.85 6.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.4 ptt180 -77.85 -19.72 54.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.18 -43.21 53.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.51 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -61.65 -36.42 80.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.31 -25.22 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -76.18 -20.7 57.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -77.96 -45.73 23.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -62.45 -26.22 68.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.4 tp . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.401 0.619 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.56 -19.64 63.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.106 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.576 ' CG ' HD13 ' A' ' 19' ' ' LEU . 15.8 t-160 -80.69 -25.38 38.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.93 -34.23 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -0.927 . . . . 0.0 109.476 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -78.54 -40.61 34.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.208 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.529 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 44.8 t80 -74.07 -22.61 59.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.576 HD13 ' CG ' ' A' ' 15' ' ' HIS . 11.6 mt -82.48 -37.44 25.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.27 -24.94 51.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.106 -0.996 . . . . 0.0 109.296 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . . . -75.93 -39.7 55.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 17.1 t -68.51 -47.37 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 108.879 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.57 -41.75 90.91 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.566 0.698 . . . . 0.0 109.187 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -56.09 -25.86 47.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 109.606 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.8 mt -109.32 -6.19 15.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 110.031 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 110.25 0.77 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.17 -19.0 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -1.073 . . . . 0.0 109.831 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.23 48.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -111.08 14.42 21.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 0.0 109.822 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.38 134.42 36.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.997 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -120.99 160.55 44.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 108.951 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.72 -24.7 11.47 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.371 2.048 . . . . 0.0 110.208 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.91 -53.82 18.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.362 -0.836 . . . . 0.0 109.062 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.59 -40.21 84.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.324 -0.86 . . . . 0.0 109.125 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.5 mt -65.1 -26.3 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.655 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 46' ' ' ARG . 47.9 tp -52.51 -36.3 55.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.11 -34.22 63.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.3 mt -58.99 -34.41 71.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 109.406 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 mmm -80.85 -51.49 8.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.17 23.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 108.936 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.519 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 20.5 t -80.65 156.83 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.485 -0.759 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 26.5 p30 -88.07 146.54 25.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 76.06 1.78 3.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 14.2 mt -106.16 117.71 34.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.516 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.39 167.97 9.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.532 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 38.6 ttp180 -76.24 -21.47 56.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.27 -29.43 48.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -68.59 -42.18 78.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.409 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 -25.09 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 46' ' ' ARG . . . -70.33 -20.51 62.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 m -80.79 -42.03 22.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.892 . . . . 0.0 109.507 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -75.4 -28.26 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.412 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.409 0.623 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.51 -20.26 64.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.022 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.543 ' CE1' HD12 ' A' ' 19' ' ' LEU . 17.3 t-160 -79.05 -22.39 45.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 109.921 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -77.34 -31.04 54.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -77.09 -42.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 32.3 t80 -73.36 -25.48 60.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD12 ' CE1' ' A' ' 15' ' ' HIS . 11.8 mt -82.2 -33.87 29.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.717 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 -22.96 45.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.134 -0.979 . . . . 0.0 109.359 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' O ' ' CD1' ' A' ' 25' ' ' LEU . . . -78.46 -41.23 33.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.234 -0.916 . . . . 0.0 108.644 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 15.5 t -65.69 -47.97 84.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.15 -44.81 95.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.666 -0.646 . . . . 0.0 109.332 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -61.43 -22.93 65.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.771 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -108.16 -3.92 18.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.768 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.53 108.52 0.81 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 22' ' ' VAL . 11.4 p -54.56 -18.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -1.094 . . . . 0.0 109.738 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.82 -46.79 77.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.83 13.75 15.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.85 97.47 4.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.657 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 33.1 m -90.48 159.88 40.45 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.279 -0.888 . . . . 0.0 108.923 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.99 -22.08 13.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.292 1.995 . . . . 0.0 109.936 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.11 -51.6 44.44 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.266 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -69.28 -44.39 71.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.154 -0.967 . . . . 0.0 108.951 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.9 mt -63.05 -23.49 33.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.08 -1.013 . . . . 0.0 108.606 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 29.4 tp -52.74 -39.37 62.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -36.49 68.86 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -57.37 -29.38 64.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.532 -0.73 . . . . 0.0 109.254 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.422 ' HB3' HG22 ' A' ' 41' ' ' VAL . 25.0 mtp -83.25 -49.58 9.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 53.84 24.98 4.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.213 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.524 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 58.7 t -84.5 144.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -81.33 147.82 29.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 9.8 ttpt 78.05 -3.16 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.583 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.2 mt -99.47 109.56 22.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 p -89.27 169.89 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.27 -23.57 54.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -32.08 62.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -68.07 -35.61 78.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.462 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 49' ' ' VAL . 95.7 t -83.25 -25.74 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.99 -24.13 48.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.253 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.8 m -76.36 -44.27 37.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.334 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -62.74 -30.46 71.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.19 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.4 tp . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.276 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.33 -55.39 4.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.605 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 81.6 t60 -45.65 -25.19 0.44 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.687 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -68.19 -48.81 64.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -68.25 -35.15 77.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CE1' HG23 ' A' ' 35' ' ' ILE . 52.7 t80 -69.95 -25.98 63.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 45.9 mt -77.7 -44.36 28.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -24.63 61.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 108.926 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 38' ' ' LEU . . . -74.27 -40.57 62.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 16.4 t -69.51 -46.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.0 108.906 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.33 -40.25 85.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.412 ' ND1' ' C ' ' A' ' 24' ' ' HIS . 8.4 t-80 -54.82 -27.54 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.518 -0.739 . . . . 0.0 109.354 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' CD1' ' A' ' 38' ' ' LEU . 3.5 mt -106.53 -9.03 16.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . 94.99 111.39 2.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.9 -18.33 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -1.098 . . . . 0.0 110.088 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.58 -43.19 39.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.216 -0.928 . . . . 0.0 110.648 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -116.72 14.87 15.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 110.257 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' CB ' HG11 ' A' ' 22' ' ' VAL . . . -69.22 124.06 22.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.984 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 23.2 m -106.17 160.4 26.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 108.994 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.8 Cg_endo -76.59 -23.57 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.347 2.031 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -69.36 -52.72 24.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.401 -0.812 . . . . 0.0 109.382 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 14.2 mtpp -67.13 -38.97 86.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -0.86 . . . . 0.0 109.354 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG23 ' CE1' ' A' ' 18' ' ' PHE . 1.7 mt -67.23 -24.72 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.999 -1.063 . . . . 0.0 108.863 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' A' ' 46' ' ' ARG . 58.0 tp -54.09 -38.97 65.9 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -74.37 -35.85 63.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.562 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.3 mt -57.21 -28.79 63.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.589 -0.694 . . . . 0.0 109.343 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.403 ' HE1' HD13 ' A' ' 44' ' ' LEU . 36.8 mmm -82.54 -43.94 16.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.408 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 50.85 23.77 1.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 93.7 t -87.48 155.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.559 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.6 p-10 -90.1 140.71 29.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER 80.22 -8.48 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.528 -0.732 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 10.5 mt -84.2 125.37 32.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.96 -1.088 . . . . 0.0 109.152 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 p -109.34 158.91 17.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB3' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -78.17 -17.79 56.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.412 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -74.13 -22.91 59.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -80.47 -37.7 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.619 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.485 HG11 ' CE1' ' A' ' 18' ' ' PHE . 69.0 t -83.02 -24.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.35 -39.39 59.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -72.12 -38.5 69.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.516 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.7 t60 -70.04 -25.98 63.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.126 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.353 0.596 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.79 -19.58 29.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.883 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.575 ' CD2' HD11 ' A' ' 19' ' ' LEU . 4.7 t60 -75.8 -32.94 60.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -67.42 -30.36 70.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -78.71 -38.12 39.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.517 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 60.7 t80 -75.19 -23.22 57.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.676 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.575 HD11 ' CD2' ' A' ' 15' ' ' HIS . 4.5 mt -82.48 -36.54 26.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.66 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.31 -24.5 50.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . . . -76.7 -43.32 38.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 108.768 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 27' ' ' VAL . 17.5 t -67.16 -45.7 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -59.54 -43.54 93.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -58.61 -23.22 58.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.534 -0.728 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.4 mt -112.83 -1.66 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.02 107.19 0.49 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.524 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 8.1 p -54.41 -18.58 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -1.146 . . . . 0.0 109.748 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -46.79 74.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.949 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -116.8 14.01 15.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.0 109.919 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.49 ' CB ' HG12 ' A' ' 22' ' ' VAL . . . -70.05 125.61 27.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.772 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 16.7 m -109.66 160.04 29.37 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.316 -0.865 . . . . 0.0 108.932 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.47 -19.25 15.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.41 2.074 . . . . 0.0 110.046 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.52 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -70.54 -55.13 9.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.397 -0.814 . . . . 0.0 109.03 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' CG2' ' A' ' 31' ' ' VAL . 16.7 mttp -67.92 -39.47 83.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.6 mt -68.0 -25.32 31.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.091 -1.043 . . . . 0.0 108.562 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.442 HD11 ' CA ' ' A' ' 46' ' ' ARG . 25.8 tp -53.63 -38.33 63.96 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.1 -35.64 66.64 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.4 mt -57.66 -31.39 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.627 -0.67 . . . . 0.0 109.419 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.3 mtt -79.96 -53.24 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 55.17 27.0 8.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.202 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 24.5 t -88.31 157.52 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -90.27 140.87 29.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 81.84 -7.44 1.39 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 110.033 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.53 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 16.9 mt -90.58 136.99 32.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -114.0 164.26 14.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.554 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 33' ' ' LYS . 32.7 ttp85 -78.73 -31.37 46.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.94 -22.87 63.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.429 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 3.9 m-20 -72.24 -36.52 69.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.12 -27.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.226 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.17 63.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.304 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.69 -50.26 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.378 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -54.39 -28.68 45.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 108.964 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.88 -19.26 59.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.581 ' CE1' ' CG ' ' A' ' 19' ' ' LEU . 4.0 t60 -77.33 -26.05 51.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.915 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.69 -43.69 53.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.75 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -78.39 -33.82 48.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 108.836 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.538 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 59.1 t80 -76.59 -23.19 53.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.35 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.581 ' CG ' ' CE1' ' A' ' 15' ' ' HIS . 13.7 mt -78.79 -37.77 40.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 109.628 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.81 50.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.142 -0.974 . . . . 0.0 108.902 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 38' ' ' LEU . . . -76.41 -43.43 40.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.312 -0.867 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 25.0 t -67.24 -45.76 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.733 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.96 -43.12 95.25 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.516 0.674 . . . . 0.0 109.262 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -58.28 -23.16 55.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.739 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -111.39 -4.49 14.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.152 -0.967 . . . . 0.0 110.067 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . 88.37 110.05 1.08 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 27' ' ' VAL . 13.7 p -54.07 -18.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -1.116 . . . . 0.0 109.909 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 29' ' ' ARG . 8.7 pt-20 -80.16 -37.41 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.75 14.5 15.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.176 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' CB ' HG12 ' A' ' 22' ' ' VAL . . . -79.32 135.27 36.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.163 -0.961 . . . . 0.0 110.091 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 35' ' ' ILE . 1.7 m -119.74 160.53 42.03 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.365 -0.835 . . . . 0.0 108.936 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HG3' HD22 ' A' ' 53' ' ' LEU . 33.9 Cg_endo -75.64 -24.21 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.409 2.073 . . . . 0.0 110.005 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.1 -52.42 28.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.371 -0.831 . . . . 0.0 109.298 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -69.18 -38.89 78.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.542 HG12 ' CD1' ' A' ' 25' ' ' LEU . 1.6 mt -67.8 -24.78 31.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.082 -1.011 . . . . 0.0 108.61 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 46' ' ' ARG . 20.3 tp -53.34 -37.92 62.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.99 -34.47 64.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -59.24 -31.64 69.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.442 -0.786 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 83.0 mmm -85.09 -50.26 7.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.7 t30 54.48 25.46 6.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.21 -0.932 . . . . 0.0 109.104 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 7.8 t -78.77 158.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.54 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 22.4 p30 -89.67 144.66 25.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 76.37 -0.5 3.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.4 mt -101.81 115.56 30.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 109.506 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -99.26 168.23 10.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.75 -18.23 60.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -32.94 61.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.481 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.24 -25.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.134 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -77.7 -20.85 52.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.281 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -76.63 -43.76 37.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 109.297 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.8 t60 -67.07 -30.75 70.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 32' ' ' PRO . 5.8 tp . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.432 HD22 ' HE3' ' A' ' 39' ' ' MET . 11.9 mt -58.51 -20.08 42.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.58 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -78.58 -32.82 47.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.41 -38.25 65.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.763 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -74.33 -35.31 63.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.526 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 50.7 t80 -72.41 -26.88 62.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.883 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.54 -39.85 27.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -23.68 51.34 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.127 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 25' ' ' LEU . . . -77.43 -41.8 38.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.867 . . . . 0.0 108.967 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 21.3 t -69.6 -45.11 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 108.658 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -59.57 -42.31 92.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.476 0.655 . . . . 0.0 109.236 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -57.49 -24.26 54.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -0.759 . . . . 0.0 109.676 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -110.47 -4.83 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.22 110.1 0.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.44 ' HA ' HG11 ' A' ' 22' ' ' VAL . 6.3 p -53.94 -18.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -41.51 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -116.74 14.74 15.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.32 24.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.073 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 19.1 m -104.24 160.11 27.12 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 108.81 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.42 -25.76 9.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.355 2.037 . . . . 0.0 110.066 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.27 -50.26 54.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HB2' HG23 ' A' ' 31' ' ' VAL . 12.6 mttm -68.16 -40.71 82.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.151 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.57 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.6 mt -63.88 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.07 . . . . 0.0 108.681 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.6 tp -54.2 -35.0 61.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 3.0 p30 -78.99 -28.93 43.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 6.2 mt -63.36 -31.83 73.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.495 -0.753 . . . . 0.0 109.129 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.441 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 1.8 mtt -89.12 -40.95 12.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 52.25 25.37 3.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 109.051 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 19.5 t -80.93 146.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 109.582 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 17.6 p-10 -89.82 149.92 22.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.344 -0.847 . . . . 0.0 109.516 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 79.07 -3.76 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -93.41 130.3 39.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.304 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -102.59 160.42 14.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 23.6 ptt85 -77.97 -21.97 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -29.97 62.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.41 -25.32 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -78.55 -21.73 48.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 m -78.95 -43.02 25.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -67.81 -27.39 66.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.33 0.586 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.4 mt -85.05 -58.28 2.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.987 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.467 ' CE1' ' HG ' ' A' ' 19' ' ' LEU . 52.9 t-80 -49.46 -22.08 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.4 -42.24 62.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.51 -36.63 84.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 109.352 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.539 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 47.1 t80 -69.62 -32.92 71.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.467 ' HG ' ' CE1' ' A' ' 15' ' ' HIS . 11.5 mt -70.38 -45.49 65.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.11 70.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . . . -70.79 -40.36 72.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.229 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 19.7 t -63.56 -48.16 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.28 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -59.18 -44.11 92.18 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 109.326 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.54 -22.89 65.55 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 110.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.6 mt -110.45 -1.69 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.03 108.45 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 22' ' ' VAL . 2.9 p -53.13 -19.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -1.107 . . . . 0.0 109.557 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.61 -44.06 83.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -116.94 13.16 14.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -0.999 . . . . 0.0 110.159 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.19 109.01 15.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.878 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 35' ' ' ILE . 2.9 m -99.67 160.49 27.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 108.949 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.13 -27.32 8.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.434 2.089 . . . . 0.0 110.022 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.48 -48.42 64.51 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.471 -0.768 . . . . 0.0 109.248 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -70.17 -42.72 72.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.565 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.8 mt -66.61 -24.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.014 -1.053 . . . . 0.0 108.634 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 46' ' ' ARG . 10.8 tp -56.16 -31.02 62.99 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.61 -32.14 57.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.565 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 52.1 mt -57.87 -37.91 74.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.113 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.431 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 2.2 mmm -84.37 -47.95 10.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.769 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 49.24 25.09 1.12 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 108.804 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.513 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 11.9 t -78.55 159.54 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.527 -0.733 . . . . 0.0 109.81 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.2 p-10 -86.18 147.72 25.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 109.223 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 78.9 -6.39 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 109.603 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.513 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.7 mt -102.86 102.64 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.447 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 p -91.73 169.25 10.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 14.2 ptm180 -69.96 -18.6 63.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.852 . . . . 0.0 109.669 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -76.76 -24.26 52.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.747 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.37 -33.47 37.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 4.3 t -83.33 -30.28 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.178 -0.951 . . . . 0.0 108.775 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.88 43.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.128 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -80.14 -42.12 24.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.278 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 15' ' ' HIS . 55.7 t-80 -69.85 -30.6 68.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.7 mt -64.57 -19.97 65.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.431 -0.793 . . . . 0.0 109.983 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.513 ' NE2' HD12 ' A' ' 19' ' ' LEU . 15.2 t60 -80.91 -22.19 39.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 110.03 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.46 -32.1 42.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.918 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -80.41 -35.86 34.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 18.3 t80 -76.96 -23.37 52.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.539 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.513 HD12 ' NE2' ' A' ' 15' ' ' HIS . 12.8 mt -83.01 -35.77 25.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.666 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.58 -26.86 55.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.004 . . . . 0.0 109.274 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 25' ' ' LEU . . . -75.03 -41.55 58.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.176 -0.953 . . . . 0.0 108.786 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 17.3 t -67.37 -47.9 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.847 . . . . 0.0 108.985 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -59.52 -41.88 90.99 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.502 0.667 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 24' ' ' HIS . 21.1 t-160 -58.91 -24.0 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.505 -0.747 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 38' ' ' LEU . 3.4 mt -108.5 -7.5 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.96 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 109.46 0.27 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.03 -20.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -1.07 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.17 -41.21 64.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.818 . . . . 0.0 110.24 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.27 14.73 15.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.003 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.25 132.0 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.4 m -110.36 160.25 29.13 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG3' HD21 ' A' ' 53' ' ' LEU . 35.0 Cg_endo -77.4 -25.52 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.367 2.045 . . . . 0.0 110.369 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 9.9 tmtt? -68.43 -52.93 27.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.301 -0.875 . . . . 0.0 109.309 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -66.21 -39.49 89.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.314 -0.866 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.543 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.5 mt -65.92 -26.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.995 -1.065 . . . . 0.0 108.691 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' A' ' 46' ' ' ARG . 17.3 tp -52.78 -36.1 57.6 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.31 -34.82 68.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.543 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.9 mt -57.09 -37.27 71.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.529 -0.732 . . . . 0.0 109.125 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.7 mmm -76.56 -52.73 9.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 51.24 24.63 2.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 108.951 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 66.4 t -79.91 153.31 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 5.6 p-10 -90.03 143.1 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.9 OUTLIER 82.46 -7.31 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 13.1 mt -91.38 143.46 26.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 109.53 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -118.31 163.74 16.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.511 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 59.7 ttp85 -73.76 -19.07 60.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -24.61 47.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.04 -44.77 65.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 49' ' ' VAL . 55.5 t -83.24 -25.81 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.25 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -19.99 58.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.309 -0.869 . . . . 0.0 109.09 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -74.48 -48.03 29.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.565 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -60.67 -37.41 81.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.975 . . . . 0.0 109.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.422 HD21 ' HG3' ' A' ' 32' ' ' PRO . 6.1 tp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 mt -60.44 -20.1 58.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.418 -0.801 . . . . 0.0 109.803 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -75.93 -28.65 58.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.836 . . . . 0.0 109.7 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -69.39 -42.74 74.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -72.22 -37.76 69.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.119 -0.988 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 76.9 t80 -73.66 -22.43 59.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.32 -0.863 . . . . 0.0 109.836 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.624 ' CD1' ' CE1' ' A' ' 15' ' ' HIS . 10.6 mt -83.2 -39.07 21.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.804 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.36 -23.78 50.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.053 -1.029 . . . . 0.0 109.189 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' HB1' ' CB ' ' A' ' 38' ' ' LEU . . . -76.85 -39.52 50.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.244 -0.91 . . . . 0.0 109.011 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.561 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 17.4 t -71.36 -47.35 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 108.605 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.29 -40.67 86.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -56.7 -27.74 59.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.532 -0.73 . . . . 0.0 109.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.2 mt -105.19 -7.78 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.4 110.7 1.1 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -48.55 -23.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -1.131 . . . . 0.0 109.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.52 -45.88 71.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.76 . . . . 0.0 110.023 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -111.49 14.53 21.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' CB ' HG11 ' A' ' 22' ' ' VAL . . . -76.72 117.24 18.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 110.008 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -110.44 160.84 27.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.38 -26.86 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.28 1.986 . . . . 0.0 110.26 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 7.3 tmtt? -68.53 -50.96 48.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HB2' HG22 ' A' ' 31' ' ' VAL . 2.1 mmtt -69.36 -42.58 75.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.561 ' CD1' ' CG2' ' A' ' 22' ' ' VAL . 1.5 mt -63.34 -25.28 38.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.75 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 17.1 tp -52.48 -36.76 55.65 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.45 -33.12 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.25 -35.15 74.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.536 -0.727 . . . . 0.0 109.597 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 mmt -79.0 -48.08 15.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.371 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t30 53.36 23.54 3.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.535 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 18.8 t -86.77 158.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.08 148.78 24.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.187 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.7 ttmt 77.0 -2.95 2.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.535 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 13.5 mt -101.57 95.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -90.89 176.95 6.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -72.75 -18.98 61.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -34.23 42.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -73.53 -38.49 65.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 109.574 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -82.97 -25.9 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.196 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 46' ' ' ARG . . . -69.78 -22.14 63.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.415 -0.803 . . . . 0.0 109.308 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 m -74.55 -49.34 22.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.425 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 6.5 t60 -55.45 -29.0 57.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.835 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.459 0.647 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.7 mt -64.98 -19.56 66.04 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.551 -0.718 . . . . 0.0 109.742 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.621 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 70.2 t60 -79.51 -22.33 44.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -0.922 . . . . 0.0 109.297 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -71.31 -28.39 64.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.563 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -80.43 -38.68 29.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.522 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 92.8 t80 -75.7 -24.13 56.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 11.8 mt -75.84 -41.69 51.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.536 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.09 -24.65 59.51 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.13 -0.982 . . . . 0.0 109.347 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -77.27 -41.86 39.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 19.7 t -66.61 -45.49 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.931 . . . . 0.0 108.889 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -61.62 -45.28 94.74 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.547 0.689 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -62.6 -23.4 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.462 -0.774 . . . . 0.0 110.205 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' CD1' ' CD1' ' A' ' 38' ' ' LEU . 2.2 mt -107.89 -3.45 18.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 109.847 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . 77.36 107.64 0.16 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 27' ' ' VAL . 8.0 p -51.5 -21.01 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -1.12 . . . . 0.0 109.52 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.8 -45.07 91.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -116.75 13.81 15.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 26' ' ' GLY . . . -83.21 118.53 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.083 -1.01 . . . . 0.0 109.714 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 35' ' ' ILE . 1.8 m -105.6 160.02 27.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 108.927 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.55 -26.21 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.406 2.07 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.85 -51.02 44.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 109.242 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -69.81 -41.42 75.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.085 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.53 HG12 ' CD1' ' A' ' 25' ' ' LEU . 1.5 mt -65.65 -24.76 35.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.54 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 27.2 tp -52.99 -38.84 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.22 -35.18 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 4.5 mt -58.09 -32.69 68.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 109.599 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.458 ' HE1' ' HB2' ' A' ' 18' ' ' PHE . 2.5 mmt -71.33 -43.37 67.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.469 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.84 26.98 8.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.951 . . . . 0.0 109.041 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 58.6 t -97.13 148.09 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.138 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.8 p-10 -84.33 148.35 26.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.87 -0.9 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.75 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -100.16 110.22 22.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.132 -0.98 . . . . 0.0 109.392 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -96.21 172.14 8.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 ptt180 -76.64 -17.89 58.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.923 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.78 -34.5 60.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -65.4 -38.76 90.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.14 -25.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.062 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 46' ' ' ARG . . . -71.33 -28.02 63.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.845 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -70.55 -50.51 36.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.853 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.34 -32.01 68.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.07 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.0 tp . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.25 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 14' ' ' LEU . 11.6 mt -54.59 -24.53 21.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.536 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 1.4 t60 -72.43 -36.83 68.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -71.37 -25.14 62.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.861 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -79.55 -41.68 26.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 63.0 t80 -70.06 -23.57 63.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 15' ' ' HIS . 23.2 mt -80.32 -43.84 20.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.962 . . . . 0.0 109.53 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -22.7 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.112 -0.993 . . . . 0.0 109.262 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 25' ' ' LEU . . . -76.34 -43.94 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 0.0 108.707 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 15.0 t -64.01 -47.9 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.88 . . . . 0.0 108.915 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -59.52 -44.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.608 0.718 . . . . 0.0 109.137 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -58.14 -23.34 54.78 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.535 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -110.16 -4.9 15.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.994 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.84 109.11 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 8.3 p -52.88 -19.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -1.068 . . . . 0.0 109.798 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 -45.45 75.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.51 14.03 15.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 109.897 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . . . -72.1 105.4 3.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 34' ' ' LYS . 5.9 m -93.17 160.46 33.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.009 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 35.0 Cg_endo -76.86 -29.2 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.426 2.084 . . . . 0.0 110.068 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 6.7 tmtt? -65.84 -49.6 67.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.208 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 2.0 mtpt -67.36 -45.01 77.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.56 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.8 mt -62.8 -23.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.698 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 55.3 tp -53.81 -36.93 63.01 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -74.79 -31.43 61.74 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.7 mt -59.74 -32.76 70.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.433 ' HB3' HG22 ' A' ' 41' ' ' VAL . 42.2 mmm -84.36 -49.99 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.817 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.55 23.65 1.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 108.932 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 8.7 t -82.05 151.93 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.708 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.78 150.03 23.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.569 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 77.17 -2.35 2.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.661 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 12.9 mt -99.04 104.09 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -82.73 162.67 21.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.6 -19.04 63.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.965 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -26.49 38.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -41.53 71.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.24 -30.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.35 -20.01 62.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -75.79 -50.06 16.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.862 . . . . 0.0 109.227 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -57.11 -31.23 65.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.209 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.3 tp . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 mt -62.76 -20.19 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 110.101 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.526 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 27.7 t60 -78.72 -22.57 46.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.778 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -75.29 -41.05 58.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.055 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 37.2 t80 -69.21 -22.2 63.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.439 -0.788 . . . . 0.0 109.723 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 20.0 mt -81.05 -44.38 18.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.98 59.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.954 -1.091 . . . . 0.0 109.165 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -77.29 -43.49 33.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 0.0 109.104 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 35' ' ' ILE . 21.3 t -64.64 -43.69 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 108.969 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -57.92 -43.31 86.14 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.644 0.735 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.491 ' CD2' ' O ' ' A' ' 24' ' ' HIS . 14.4 t60 -62.0 -23.11 66.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.316 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -111.04 -2.34 15.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.0 110.195 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 108.59 0.31 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 27' ' ' VAL . 11.9 p -53.27 -18.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -1.069 . . . . 0.0 109.892 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -65.87 -47.28 75.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.785 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 mtp85 -117.08 13.85 14.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.23 9.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' CG2' ' HG3' ' A' ' 34' ' ' LYS . 10.7 m -105.48 159.97 27.65 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.2 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.344 2.029 . . . . 0.0 110.036 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 1.4 tmtt? -70.16 -43.84 70.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -70.57 -46.32 63.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.328 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.553 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -64.69 -25.7 38.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.277 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 46' ' ' ARG . 24.5 tp -52.29 -34.57 47.31 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.1 -34.69 59.51 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.0 mt -57.92 -33.87 69.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.694 -0.629 . . . . 0.0 109.665 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.9 mtp -86.43 -47.4 9.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.85 23.89 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 45.2 t -77.98 157.82 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 0.0 109.543 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 p30 -84.14 143.44 29.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 75.9 4.47 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.541 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 12.5 mt -111.75 100.59 9.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 p -94.03 169.89 9.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.388 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -59.96 -23.27 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.269 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 44.3 tp10 -73.57 -32.62 64.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.339 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.25 -34.73 78.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.45 -30.35 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.888 . . . . 0.0 109.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.42 -20.12 60.16 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.361 -0.837 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -75.95 -48.48 21.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.119 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -58.6 -37.75 76.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.012 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.285 0.564 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' GLN . . . 176.81 167.06 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -50.06 -179.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 5.4 tttt -155.58 55.2 0.62 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HG3' HG22 ' A' ' 8' ' ' VAL . 9.7 ptpt -85.9 135.77 37.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 109.299 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' C ' ' CG ' ' A' ' 7' ' ' ARG . 36.2 Cg_endo -78.69 136.2 13.43 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.487 2.125 . . . . 0.0 110.541 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 38.6 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.707 . . . . 0.0 110.062 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 12.0 t -67.92 125.19 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.32 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -91.26 -53.54 4.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -160.86 79.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.454 ' OG1' ' CG1' ' A' ' 8' ' ' VAL . 33.1 p -113.34 175.45 5.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.482 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -56.93 -20.5 23.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.74 -59.71 2.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.537 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 10.5 mt -58.58 -19.99 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 72.7 t60 -80.41 -30.26 37.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.691 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.55 -33.27 66.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -73.83 -42.62 60.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.53 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 49.4 t80 -67.28 -22.57 65.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.873 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 43.6 mt -81.53 -44.88 16.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.672 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.74 -19.96 60.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.123 -0.986 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' O ' HD13 ' A' ' 25' ' ' LEU . . . -79.56 -38.87 33.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -0.953 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 18.7 t -71.26 -47.14 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.57 -43.14 97.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.585 0.707 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -58.92 -22.84 60.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.7 mt -112.54 -1.73 14.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.6 107.59 0.29 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.62 -19.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -1.091 . . . . 0.0 109.771 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.21 -43.34 70.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -116.8 14.24 15.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.027 . . . . 0.0 110.101 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -79.6 120.16 23.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.5 m -100.63 157.18 34.2 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 108.969 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.427 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 34.9 Cg_endo -77.23 -24.11 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.404 2.069 . . . . 0.0 110.144 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.12 -52.98 28.72 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.225 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 20.2 mmtp -67.99 -41.83 81.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.153 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.535 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.7 mt -64.53 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.608 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 43.2 tp -53.5 -35.72 60.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.49 -33.72 67.16 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.4 mt -57.31 -38.48 74.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.425 -0.797 . . . . 0.0 109.045 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mmt -73.55 -51.47 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 t30 56.39 26.4 10.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 21.7 t -94.0 154.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 16.6 p30 -80.3 146.82 31.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.316 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 77.19 -2.23 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.6 mt -102.35 119.24 38.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 109.485 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.86 -179.99 3.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.504 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.428 ' HB3' HD22 ' A' ' 36' ' ' LEU . 3.8 ptt-85 -77.07 -26.95 54.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 75.2 tt0 -72.53 -23.01 60.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.42 -36.46 58.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.45 -25.9 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 0.0 109.151 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HB1' ' CG ' ' A' ' 32' ' ' PRO . . . -77.02 -20.4 56.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -77.91 -46.15 22.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -63.66 -30.33 71.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -71.55 -48.39 48.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.56 -19.26 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -79.91 -28.07 39.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 60' ' ' LEU . 22.0 t80 -71.01 -46.41 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.44 -40.42 71.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.6 t -64.7 -38.7 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' O ' ' CG1' ' A' ' 63' ' ' VAL . . . -74.44 -12.22 60.44 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 56' ' ' PHE . 5.7 mt -91.07 -27.27 18.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -61.16 -81.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -87.29 103.91 15.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.583 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -128.93 106.73 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.441 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.419 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.18 -178.42 0.2 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 152.19 29.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 3.9 mmtt -120.62 76.02 1.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.497 ' HD2' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER 60.88 98.65 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' ARG . 36.6 Cg_endo -80.83 120.47 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.666 2.244 . . . . 0.0 110.262 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 6' ' ' PRO . 4.4 mtt180 43.58 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 11' ' ' THR . 58.3 t -51.53 117.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.963 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 7.0 tp -91.48 -38.55 12.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 108.809 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 7.4 m95 -169.85 76.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.074 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.524 ' CG2' HG13 ' A' ' 8' ' ' VAL . 51.6 p -111.06 176.09 5.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 109.588 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -57.97 -20.28 36.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.688 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -59.46 2.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.754 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.523 HD12 ' CG1' ' A' ' 8' ' ' VAL . 9.7 mt -62.26 -19.16 62.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 109.811 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.56 ' CE1' HD13 ' A' ' 19' ' ' LEU . 13.7 t-160 -79.96 -23.83 41.39 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -71.7 -28.91 64.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -79.01 -47.95 15.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.133 -0.979 . . . . 0.0 109.139 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 49' ' ' VAL . 78.2 t80 -69.86 -22.21 63.28 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD13 ' CE1' ' A' ' 15' ' ' HIS . 12.4 mt -78.54 -39.45 37.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 109.74 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.88 -24.34 55.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.192 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.515 ' HB1' ' CD1' ' A' ' 38' ' ' LEU . . . -76.91 -43.66 34.71 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 108.737 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 21.7 t -65.38 -46.44 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 108.814 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.58 -44.79 95.81 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.522 0.677 . . . . 0.0 109.391 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -59.49 -23.09 62.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 0.0 109.918 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.518 ' CD1' HG12 ' A' ' 35' ' ' ILE . 4.7 mt -107.25 -7.03 16.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.02 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.78 108.94 0.55 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 2.8 p -53.1 -18.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 109.751 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.46 -46.58 79.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 13.66 15.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . . . -75.8 108.93 8.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 17.2 m -96.66 160.11 30.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 109.037 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.99 9.98 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.443 2.096 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -69.65 -48.81 58.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.347 -0.845 . . . . 0.0 109.302 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 66.8 mmtt -69.9 -42.89 72.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 109.18 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.6 mt -65.9 -24.68 34.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.031 -1.043 . . . . 0.0 108.433 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 19.0 tp -54.65 -32.6 59.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.21 -32.05 55.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.12 -36.45 77.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.592 -0.693 . . . . 0.0 109.598 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.413 ' HE3' ' HB2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -86.46 -46.73 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.97 . . . . 0.0 109.739 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 t30 51.28 24.87 2.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 108.885 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 76.8 t -78.95 157.82 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.556 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.3 p-10 -90.34 146.26 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 ttmt 77.03 -2.25 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.1 mt -95.36 107.26 19.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 109.364 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -88.97 175.97 7.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 4.6 mtm180 -78.75 -24.95 44.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.765 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -22.97 54.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.583 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.93 -43.68 64.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.697 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.572 HG12 ' CE1' ' A' ' 18' ' ' PHE . 76.6 t -83.45 -26.59 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 46' ' ' ARG . . . -76.19 -20.02 57.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 m -78.12 -45.61 22.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.73 -26.6 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 109.241 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.7 tp -81.05 -22.3 39.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 -29.28 42.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.683 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.73 -24.8 33.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.563 ' CD2' HD13 ' A' ' 60' ' ' LEU . 25.1 t80 -80.65 -48.64 12.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.232 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -40.49 75.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 42.7 t -65.8 -30.79 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.25 -11.85 57.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.563 HD13 ' CD2' ' A' ' 56' ' ' PHE . 11.3 mt -97.82 4.42 49.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 7.6 pttt -95.76 -12.34 25.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.671 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.453 ' HD3' ' HG2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -130.34 -33.05 1.72 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.764 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 60' ' ' LEU . 8.6 p -53.39 155.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.326 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.423 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 3' ' ' GLN . . . -96.84 136.2 37.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 1.2 mp0 66.47 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 174.22 1.4 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 57.32 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' ARG . 34.8 Cg_endo -76.85 150.82 30.86 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.449 2.099 . . . . 0.0 110.391 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 6' ' ' PRO . 2.0 ptm180 -42.62 110.36 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.602 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 ' CG1' ' CD1' ' A' ' 14' ' ' LEU . 2.5 t -95.49 106.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 109.218 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 14.8 tp -107.09 -51.4 2.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.322 -0.861 . . . . 0.0 109.306 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 34.5 m95 -164.17 74.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.2 p -113.78 174.88 5.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.51 -30.89 5.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -51.52 47.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.166 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.55 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 11.9 mt -62.03 -23.1 66.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.442 -0.786 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.535 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 3.9 t60 -71.62 -26.5 62.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.01 -37.61 72.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -72.85 -47.51 45.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 62.9 t80 -68.93 -22.29 64.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.535 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 21.8 mt -82.15 -39.67 22.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.912 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.17 -22.57 44.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.112 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 38' ' ' LEU . . . -79.35 -41.24 28.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 108.834 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 28.3 t -70.59 -45.75 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.94 -43.72 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.15 -23.22 62.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.529 -0.732 . . . . 0.0 109.688 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 HD13 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mt -112.61 -0.57 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.817 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . 78.18 107.16 0.19 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HA ' HG11 ' A' ' 22' ' ' VAL . 9.5 p -52.28 -19.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -1.057 . . . . 0.0 109.921 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 -42.28 65.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -116.84 14.48 15.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' GLY . . . -89.22 133.45 34.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.8 m -115.89 160.24 36.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.397 -0.814 . . . . 0.0 109.069 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.6 Cg_endo -76.18 -17.27 17.17 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.47 2.113 . . . . 0.0 110.253 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -71.54 -54.79 9.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.171 -0.956 . . . . 0.0 109.31 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -38.47 80.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.218 -0.927 . . . . 0.0 108.838 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.7 mt -63.43 -25.34 38.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.575 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.1 tp -51.75 -36.2 46.38 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -73.34 -35.12 65.97 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' CD1' HD13 ' A' ' 25' ' ' LEU . 5.0 mt -58.01 -35.77 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.554 -0.716 . . . . 0.0 109.336 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.0 mmm -78.98 -51.28 9.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 57.94 25.75 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 44' ' ' LEU . 72.8 t -82.27 146.54 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.295 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.0 p30 -80.32 145.92 31.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.57 0.75 3.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.658 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' A' ' 41' ' ' VAL . 4.0 mm? -103.11 137.55 41.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.65 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -118.46 173.85 6.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.4 ptt180 -77.85 -19.72 54.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.18 -43.21 53.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.51 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -61.65 -36.42 80.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.31 -25.22 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -76.18 -20.7 57.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -77.96 -45.73 23.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -62.45 -26.22 68.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.4 tp -76.19 -29.23 57.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -77.29 -26.43 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.44 -38.49 34.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.559 ' CD2' HD12 ' A' ' 60' ' ' LEU . 11.3 t80 -64.82 -43.87 91.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.396 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -58.1 -40.86 82.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.973 . . . . 0.0 108.38 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 56.1 t -65.39 -30.79 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.454 ' O ' ' CG1' ' A' ' 63' ' ' VAL . . . -84.01 -11.75 56.3 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 56' ' ' PHE . 7.7 mt -91.01 4.52 51.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.486 -0.759 . . . . 0.0 109.936 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 13.9 pttp -98.12 -22.92 15.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 109.545 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 68.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.5 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 22.0 m -88.42 149.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.402 ' OXT' ' O ' ' A' ' 63' ' ' VAL . 11.0 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.39 120.01 13.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.463 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -130.04 75.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.1 75.18 1.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 61.45 132.42 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.49 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 35.6 Cg_endo -78.25 130.05 9.91 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.444 2.096 . . . . 0.0 110.362 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' PRO . 9.1 ptp180 -43.77 131.65 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.709 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' CD1' ' A' ' 14' ' ' LEU . 2.6 t -129.7 83.02 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.19 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 7.4 tp -108.78 -27.49 9.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.125 -0.984 . . . . 0.0 108.657 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 3.0 m95 -174.1 67.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.8 p -113.53 175.8 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.855 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -50.42 -28.37 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.784 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.77 -55.31 7.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.408 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' CD1' HG13 ' A' ' 8' ' ' VAL . 10.2 mt -62.56 -19.64 63.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.576 ' CG ' HD13 ' A' ' 19' ' ' LEU . 15.8 t-160 -80.69 -25.38 38.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.93 -34.23 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -0.927 . . . . 0.0 109.476 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -78.54 -40.61 34.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.208 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.529 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 44.8 t80 -74.07 -22.61 59.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.576 HD13 ' CG ' ' A' ' 15' ' ' HIS . 11.6 mt -82.48 -37.44 25.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.27 -24.94 51.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.106 -0.996 . . . . 0.0 109.296 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . . . -75.93 -39.7 55.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 17.1 t -68.51 -47.37 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 108.879 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.57 -41.75 90.91 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.566 0.698 . . . . 0.0 109.187 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -56.09 -25.86 47.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 109.606 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.8 mt -109.32 -6.19 15.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 110.031 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 110.25 0.77 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.17 -19.0 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -1.073 . . . . 0.0 109.831 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.23 48.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -111.08 14.42 21.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 0.0 109.822 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.38 134.42 36.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.997 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -120.99 160.55 44.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 108.951 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.72 -24.7 11.47 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.371 2.048 . . . . 0.0 110.208 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.91 -53.82 18.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.362 -0.836 . . . . 0.0 109.062 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.59 -40.21 84.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.324 -0.86 . . . . 0.0 109.125 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.5 mt -65.1 -26.3 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.655 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 46' ' ' ARG . 47.9 tp -52.51 -36.3 55.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.11 -34.22 63.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.3 mt -58.99 -34.41 71.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 109.406 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 mmm -80.85 -51.49 8.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.17 23.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 108.936 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.519 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 20.5 t -80.65 156.83 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.485 -0.759 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 26.5 p30 -88.07 146.54 25.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 76.06 1.78 3.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 14.2 mt -106.16 117.71 34.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.516 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.39 167.97 9.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.532 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 38.6 ttp180 -76.24 -21.47 56.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.27 -29.43 48.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -68.59 -42.18 78.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.409 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 -25.09 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 46' ' ' ARG . . . -70.33 -20.51 62.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 m -80.79 -42.03 22.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.892 . . . . 0.0 109.507 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -75.4 -28.26 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -80.84 -22.96 39.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -79.56 -38.11 34.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.39 -26.52 55.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.559 ' CE2' HD11 ' A' ' 60' ' ' LEU . 13.0 t80 -77.67 -46.62 21.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.403 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -58.02 -42.06 84.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.93 -37.87 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.25 60.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD11 ' CE2' ' A' ' 56' ' ' PHE . 11.4 mt -98.29 -15.41 19.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.6 -29.53 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -74.38 -61.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -48.95 127.59 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.504 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.33 0.586 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 1' ' ' THR . . . 165.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -110.42 124.81 52.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.401 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 136.79 19.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -136.74 99.91 10.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.331 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' ARG . 34.9 Cg_endo -76.96 115.22 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.526 2.15 . . . . 0.0 110.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER 45.22 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.548 ' CG1' ' HG ' ' A' ' 14' ' ' LEU . 2.2 t -88.15 87.84 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.117 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 13.0 tp -108.81 -24.56 11.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.26 -0.9 . . . . 0.0 109.004 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 13.2 m95 -171.74 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 108.883 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -113.54 175.42 5.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -47.74 -29.24 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 109.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.59 -53.65 15.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HG ' ' CG1' ' A' ' 8' ' ' VAL . 11.4 mt -62.51 -20.26 64.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.022 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.543 ' CE1' HD12 ' A' ' 19' ' ' LEU . 17.3 t-160 -79.05 -22.39 45.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 109.921 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -77.34 -31.04 54.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -77.09 -42.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 32.3 t80 -73.36 -25.48 60.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD12 ' CE1' ' A' ' 15' ' ' HIS . 11.8 mt -82.2 -33.87 29.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.717 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 -22.96 45.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.134 -0.979 . . . . 0.0 109.359 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' O ' ' CD1' ' A' ' 25' ' ' LEU . . . -78.46 -41.23 33.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.234 -0.916 . . . . 0.0 108.644 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 15.5 t -65.69 -47.97 84.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.15 -44.81 95.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.666 -0.646 . . . . 0.0 109.332 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -61.43 -22.93 65.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.771 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -108.16 -3.92 18.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.768 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.53 108.52 0.81 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 22' ' ' VAL . 11.4 p -54.56 -18.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -1.094 . . . . 0.0 109.738 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.82 -46.79 77.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.83 13.75 15.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.85 97.47 4.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.657 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 33.1 m -90.48 159.88 40.45 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.279 -0.888 . . . . 0.0 108.923 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.99 -22.08 13.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.292 1.995 . . . . 0.0 109.936 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.11 -51.6 44.44 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.266 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -69.28 -44.39 71.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.154 -0.967 . . . . 0.0 108.951 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.9 mt -63.05 -23.49 33.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.08 -1.013 . . . . 0.0 108.606 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 29.4 tp -52.74 -39.37 62.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -36.49 68.86 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -57.37 -29.38 64.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.532 -0.73 . . . . 0.0 109.254 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.422 ' HB3' HG22 ' A' ' 41' ' ' VAL . 25.0 mtp -83.25 -49.58 9.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 53.84 24.98 4.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.213 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.524 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 58.7 t -84.5 144.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -81.33 147.82 29.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 9.8 ttpt 78.05 -3.16 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.583 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.2 mt -99.47 109.56 22.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 p -89.27 169.89 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.27 -23.57 54.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -32.08 62.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -68.07 -35.61 78.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.462 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 49' ' ' VAL . 95.7 t -83.25 -25.74 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.99 -24.13 48.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.253 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.8 m -76.36 -44.27 37.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.334 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -62.74 -30.46 71.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.19 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.4 tp -75.19 -23.79 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 8.7 mm100 -68.75 -32.88 72.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.842 . . . . 0.0 109.565 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -76.43 -29.38 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' CD2' HD13 ' A' ' 60' ' ' LEU . 9.7 t80 -74.36 -41.53 60.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 109.264 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -64.02 -45.49 88.7 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.43 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 92.7 t -65.28 -31.33 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' O ' ' CG1' ' A' ' 63' ' ' VAL . . . -82.65 -12.41 57.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 56' ' ' PHE . 12.3 mt -92.31 4.34 53.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.546 -0.721 . . . . 0.0 109.493 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.3 pttt -81.47 -11.28 59.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -137.92 -48.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 4.3 p -68.99 170.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.485 -179.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.38 71.36 0.87 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.372 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' LYS . 3.7 mt-30 -84.71 159.96 20.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' GLN . 22.3 mttt -52.83 -173.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -75.81 121.02 84.24 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.173 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 8' ' ' VAL . 36.2 Cg_endo -77.55 154.57 31.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.409 2.072 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -43.68 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.341 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 41.1 t -82.66 117.37 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 109.781 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.603 ' O ' ' CD2' ' A' ' 10' ' ' TRP . 22.2 tp -93.44 -60.44 1.78 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 11.4 m95 -150.26 76.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.431 HG23 HG13 ' A' ' 8' ' ' VAL . 22.8 p -113.76 175.82 5.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.11 -0.994 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 2.0 m170 -53.82 -21.14 6.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.22 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.62 -58.2 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.667 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 9.2 mt -82.33 -55.39 4.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.605 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 81.6 t60 -45.65 -25.19 0.44 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.687 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 10.6 m-20 -68.19 -48.81 64.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 109.673 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -68.25 -35.15 77.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CE1' HG23 ' A' ' 35' ' ' ILE . 52.7 t80 -69.95 -25.98 63.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 45.9 mt -77.7 -44.36 28.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -24.63 61.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 108.926 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 38' ' ' LEU . . . -74.27 -40.57 62.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 16.4 t -69.51 -46.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.0 108.906 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.33 -40.25 85.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.412 ' ND1' ' C ' ' A' ' 24' ' ' HIS . 8.4 t-80 -54.82 -27.54 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.518 -0.739 . . . . 0.0 109.354 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' CD1' ' A' ' 38' ' ' LEU . 3.5 mt -106.53 -9.03 16.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . 94.99 111.39 2.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.9 -18.33 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -1.098 . . . . 0.0 110.088 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.58 -43.19 39.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.216 -0.928 . . . . 0.0 110.648 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -116.72 14.87 15.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 110.257 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' CB ' HG11 ' A' ' 22' ' ' VAL . . . -69.22 124.06 22.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.984 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 23.2 m -106.17 160.4 26.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 108.994 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.8 Cg_endo -76.59 -23.57 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.347 2.031 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -69.36 -52.72 24.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.401 -0.812 . . . . 0.0 109.382 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 14.2 mtpp -67.13 -38.97 86.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -0.86 . . . . 0.0 109.354 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG23 ' CE1' ' A' ' 18' ' ' PHE . 1.7 mt -67.23 -24.72 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.999 -1.063 . . . . 0.0 108.863 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' A' ' 46' ' ' ARG . 58.0 tp -54.09 -38.97 65.9 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -74.37 -35.85 63.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.562 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.3 mt -57.21 -28.79 63.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.589 -0.694 . . . . 0.0 109.343 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.403 ' HE1' HD13 ' A' ' 44' ' ' LEU . 36.8 mmm -82.54 -43.94 16.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.408 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 50.85 23.77 1.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 93.7 t -87.48 155.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.559 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.6 p-10 -90.1 140.71 29.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER 80.22 -8.48 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.528 -0.732 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 10.5 mt -84.2 125.37 32.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.96 -1.088 . . . . 0.0 109.152 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 p -109.34 158.91 17.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB3' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -78.17 -17.79 56.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.412 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -74.13 -22.91 59.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -80.47 -37.7 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.619 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.485 HG11 ' CE1' ' A' ' 18' ' ' PHE . 69.0 t -83.02 -24.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.35 -39.39 59.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -72.12 -38.5 69.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.516 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.7 t60 -70.04 -25.98 63.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.126 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.56 -47.61 46.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.9 61.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.507 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -83.27 -23.3 32.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.671 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 32.7 t80 -73.34 -41.78 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.29 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -61.95 -43.62 98.47 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.97 -34.47 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -11.8 59.79 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 9.7 mt -79.2 5.16 12.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.475 -0.765 . . . . 0.0 109.62 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -93.41 -27.17 16.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.97 59.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 11.4 p -121.42 75.55 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.459 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' A' ' 3' ' ' GLN . . . -134.96 83.98 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 71.71 139.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.605 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' LYS . 4.0 mtpp -129.05 73.65 1.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HG2' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER 50.96 99.37 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.53 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 7' ' ' ARG . 36.4 Cg_endo -79.47 114.68 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.561 2.174 . . . . 0.0 110.432 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' PRO . 14.2 mtt180 52.51 105.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.822 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.534 ' CG1' ' HG ' ' A' ' 14' ' ' LEU . 2.8 t -90.54 114.31 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.103 -0.998 . . . . 0.0 109.635 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.592 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 16.6 tp -106.04 -35.96 7.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.163 -0.96 . . . . 0.0 108.889 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 8.3 m95 -170.82 70.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.453 ' OG1' HG13 ' A' ' 8' ' ' VAL . 40.8 p -113.75 175.92 5.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -54.13 -22.84 12.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -78.13 -61.34 2.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.439 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HG ' ' CG1' ' A' ' 8' ' ' VAL . 10.2 mt -57.79 -19.58 29.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.883 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.575 ' CD2' HD11 ' A' ' 19' ' ' LEU . 4.7 t60 -75.8 -32.94 60.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -67.42 -30.36 70.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -78.71 -38.12 39.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.517 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 60.7 t80 -75.19 -23.22 57.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.676 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.575 HD11 ' CD2' ' A' ' 15' ' ' HIS . 4.5 mt -82.48 -36.54 26.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.66 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.31 -24.5 50.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . . . -76.7 -43.32 38.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 108.768 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 27' ' ' VAL . 17.5 t -67.16 -45.7 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -59.54 -43.54 93.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -58.61 -23.22 58.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.534 -0.728 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.4 mt -112.83 -1.66 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.02 107.19 0.49 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.524 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 8.1 p -54.41 -18.58 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -1.146 . . . . 0.0 109.748 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -46.79 74.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.949 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -116.8 14.01 15.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.0 109.919 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.49 ' CB ' HG12 ' A' ' 22' ' ' VAL . . . -70.05 125.61 27.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.772 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 16.7 m -109.66 160.04 29.37 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.316 -0.865 . . . . 0.0 108.932 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.47 -19.25 15.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.41 2.074 . . . . 0.0 110.046 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.52 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -70.54 -55.13 9.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.397 -0.814 . . . . 0.0 109.03 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' CG2' ' A' ' 31' ' ' VAL . 16.7 mttp -67.92 -39.47 83.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.6 mt -68.0 -25.32 31.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.091 -1.043 . . . . 0.0 108.562 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.442 HD11 ' CA ' ' A' ' 46' ' ' ARG . 25.8 tp -53.63 -38.33 63.96 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.1 -35.64 66.64 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.4 mt -57.66 -31.39 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.627 -0.67 . . . . 0.0 109.419 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.3 mtt -79.96 -53.24 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 55.17 27.0 8.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.202 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 24.5 t -88.31 157.52 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -90.27 140.87 29.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 81.84 -7.44 1.39 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 110.033 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.53 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 16.9 mt -90.58 136.99 32.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -114.0 164.26 14.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.554 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 33' ' ' LYS . 32.7 ttp85 -78.73 -31.37 46.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.94 -22.87 63.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.429 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 3.9 m-20 -72.24 -36.52 69.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.12 -27.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.226 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.17 63.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.304 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.69 -50.26 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.378 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -54.39 -28.68 45.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 108.964 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.87 -35.33 64.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -63.41 -35.69 81.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -56.82 -32.81 66.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CE2' ' CD1' ' A' ' 60' ' ' LEU . 47.8 t80 -69.29 -49.07 59.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.156 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -53.04 -38.12 62.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.45 -41.38 92.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.45 -12.43 61.39 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.609 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 12.4 mt -91.37 -13.6 32.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.465 -0.772 . . . . 0.0 109.41 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 62' ' ' LYS . 66.4 tttt -68.56 -35.0 76.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -45.02 -26.99 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.396 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.83 142.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.99 -176.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.65 134.34 47.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 4.3 mmpt? -52.72 -179.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -109.62 100.55 42.67 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.385 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ARG . 34.6 Cg_endo -77.5 152.91 30.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.394 2.063 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' NH2' HD12 ' A' ' 9' ' ' LEU . 4.0 mmm-85 -43.07 100.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.555 ' CG1' ' CD1' ' A' ' 14' ' ' LEU . 2.2 t -86.95 89.92 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.96 . . . . 0.0 109.072 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 5.4 tp -99.91 -41.71 7.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.141 -0.974 . . . . 0.0 108.466 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 5.7 m95 -168.0 70.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p -103.95 175.78 5.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 109.815 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 -27.78 5.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.63 -56.55 4.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.555 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 8.4 mt -60.88 -19.26 59.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.581 ' CE1' ' CG ' ' A' ' 19' ' ' LEU . 4.0 t60 -77.33 -26.05 51.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.915 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.69 -43.69 53.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.75 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -78.39 -33.82 48.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 108.836 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.538 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 59.1 t80 -76.59 -23.19 53.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.35 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.581 ' CG ' ' CE1' ' A' ' 15' ' ' HIS . 13.7 mt -78.79 -37.77 40.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 109.628 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.81 50.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.142 -0.974 . . . . 0.0 108.902 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 38' ' ' LEU . . . -76.41 -43.43 40.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.312 -0.867 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 25.0 t -67.24 -45.76 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.733 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.96 -43.12 95.25 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.516 0.674 . . . . 0.0 109.262 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -58.28 -23.16 55.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.739 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -111.39 -4.49 14.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.152 -0.967 . . . . 0.0 110.067 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . 88.37 110.05 1.08 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 27' ' ' VAL . 13.7 p -54.07 -18.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -1.116 . . . . 0.0 109.909 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 29' ' ' ARG . 8.7 pt-20 -80.16 -37.41 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.75 14.5 15.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.176 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' CB ' HG12 ' A' ' 22' ' ' VAL . . . -79.32 135.27 36.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.163 -0.961 . . . . 0.0 110.091 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 35' ' ' ILE . 1.7 m -119.74 160.53 42.03 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.365 -0.835 . . . . 0.0 108.936 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HG3' HD22 ' A' ' 53' ' ' LEU . 33.9 Cg_endo -75.64 -24.21 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.409 2.073 . . . . 0.0 110.005 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.1 -52.42 28.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.371 -0.831 . . . . 0.0 109.298 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -69.18 -38.89 78.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.542 HG12 ' CD1' ' A' ' 25' ' ' LEU . 1.6 mt -67.8 -24.78 31.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.082 -1.011 . . . . 0.0 108.61 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 46' ' ' ARG . 20.3 tp -53.34 -37.92 62.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.99 -34.47 64.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -59.24 -31.64 69.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.442 -0.786 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 83.0 mmm -85.09 -50.26 7.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.7 t30 54.48 25.46 6.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.21 -0.932 . . . . 0.0 109.104 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 7.8 t -78.77 158.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.54 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 22.4 p30 -89.67 144.66 25.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 76.37 -0.5 3.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.4 mt -101.81 115.56 30.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 109.506 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -99.26 168.23 10.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.75 -18.23 60.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -32.94 61.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.481 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.24 -25.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.134 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -77.7 -20.85 52.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.281 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -76.63 -43.76 37.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 109.297 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.8 t60 -67.07 -30.75 70.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 32' ' ' PRO . 5.8 tp -75.25 -41.57 57.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.435 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -30.95 70.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -67.76 -27.46 66.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -72.61 -37.75 67.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.102 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -63.95 -43.53 95.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 61' ' ' LYS . 42.8 t -64.39 -34.06 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.23 -12.34 59.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -80.2 -27.31 38.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.447 -0.783 . . . . 0.0 109.577 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 58' ' ' VAL . 1.4 ptmt -79.44 -0.74 34.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -111.21 6.75 20.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 63' ' ' VAL . 9.3 p -158.87 123.55 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 109.451 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.478 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.472 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 13.9 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 1' ' ' THR . . . 72.31 60.98 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.13 55.49 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -178.24 48.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' LYS . 26.5 tttt 56.32 109.69 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.657 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 7' ' ' ARG . 35.4 Cg_endo -76.91 155.4 34.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.474 2.116 . . . . 0.0 110.317 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 6' ' ' PRO . 7.6 ptm180 -40.59 116.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.814 . . . . 0.0 109.729 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.539 ' CG1' ' HG ' ' A' ' 14' ' ' LEU . 2.3 t -94.08 93.28 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 109.326 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.544 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 11.5 tp -108.3 -32.03 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.544 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 14.9 m95 -168.97 68.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.873 . . . . 0.0 109.185 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.93 174.22 6.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -48.99 -29.21 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.213 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.11 -54.06 16.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.1 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HG ' ' CG1' ' A' ' 8' ' ' VAL . 11.9 mt -58.51 -20.08 42.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.58 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -78.58 -32.82 47.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.41 -38.25 65.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.763 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -74.33 -35.31 63.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.526 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 50.7 t80 -72.41 -26.88 62.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.883 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.54 -39.85 27.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -23.68 51.34 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.127 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 25' ' ' LEU . . . -77.43 -41.8 38.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.867 . . . . 0.0 108.967 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 21.3 t -69.6 -45.11 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 108.658 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -59.57 -42.31 92.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.476 0.655 . . . . 0.0 109.236 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -57.49 -24.26 54.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -0.759 . . . . 0.0 109.676 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -110.47 -4.83 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.22 110.1 0.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' HA ' HG11 ' A' ' 22' ' ' VAL . 6.3 p -53.94 -18.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -41.51 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -116.74 14.74 15.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.25 121.32 24.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.073 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 19.1 m -104.24 160.11 27.12 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 108.81 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.42 -25.76 9.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.355 2.037 . . . . 0.0 110.066 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.27 -50.26 54.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HB2' HG23 ' A' ' 31' ' ' VAL . 12.6 mttm -68.16 -40.71 82.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.151 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.57 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.6 mt -63.88 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.07 . . . . 0.0 108.681 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.6 tp -54.2 -35.0 61.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 3.0 p30 -78.99 -28.93 43.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 6.2 mt -63.36 -31.83 73.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.495 -0.753 . . . . 0.0 109.129 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.441 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 1.8 mtt -89.12 -40.95 12.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 52.25 25.37 3.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 109.051 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 19.5 t -80.93 146.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 109.582 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 17.6 p-10 -89.82 149.92 22.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.344 -0.847 . . . . 0.0 109.516 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 79.07 -3.76 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -93.41 130.3 39.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.304 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -102.59 160.42 14.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 23.6 ptt85 -77.97 -21.97 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -29.97 62.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.41 -25.32 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -78.55 -21.73 48.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 m -78.95 -43.02 25.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -67.81 -27.39 66.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -74.6 -38.77 62.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -67.97 -40.87 83.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -72.35 -31.68 65.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 60' ' ' LEU . 14.0 t80 -65.77 -43.68 88.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.328 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -57.48 -41.04 79.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 108.334 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.98 -34.54 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.01 59.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 56' ' ' PHE . 11.2 mt -88.09 -11.81 46.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 109.525 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.4 5.07 4.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.538 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -12.58 10.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 63' ' ' VAL . 4.7 p -75.19 131.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.443 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.3 177.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -114.34 51.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 3' ' ' GLN . 6.4 mttp 43.66 52.38 6.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.408 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -164.48 107.17 0.86 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 7' ' ' ARG . 34.7 Cg_endo -77.18 155.34 33.12 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.377 2.051 . . . . 0.0 110.11 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -40.24 103.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 109.687 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' CG1' ' CD1' ' A' ' 14' ' ' LEU . 2.2 t -65.46 87.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.585 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 8.5 tp -112.26 -27.53 8.29 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 14.9 m95 -169.3 60.61 0.05 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -114.08 175.82 5.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 30.2 t-80 -47.81 -22.05 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.697 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.77 -50.75 10.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.982 -1.074 . . . . 0.0 109.574 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 10.4 mt -85.05 -58.28 2.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.987 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.467 ' CE1' ' HG ' ' A' ' 19' ' ' LEU . 52.9 t-80 -49.46 -22.08 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 2.7 m120 -73.4 -42.24 62.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.51 -36.63 84.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 109.352 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.539 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 47.1 t80 -69.62 -32.92 71.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.467 ' HG ' ' CE1' ' A' ' 15' ' ' HIS . 11.5 mt -70.38 -45.49 65.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.11 70.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . . . -70.79 -40.36 72.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.229 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 19.7 t -63.56 -48.16 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.28 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -59.18 -44.11 92.18 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 109.326 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.54 -22.89 65.55 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 110.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.6 mt -110.45 -1.69 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.03 108.45 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 22' ' ' VAL . 2.9 p -53.13 -19.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -1.107 . . . . 0.0 109.557 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.61 -44.06 83.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -116.94 13.16 14.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -0.999 . . . . 0.0 110.159 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.19 109.01 15.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.878 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 35' ' ' ILE . 2.9 m -99.67 160.49 27.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 108.949 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.13 -27.32 8.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.434 2.089 . . . . 0.0 110.022 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.48 -48.42 64.51 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.471 -0.768 . . . . 0.0 109.248 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -70.17 -42.72 72.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.565 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.8 mt -66.61 -24.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.014 -1.053 . . . . 0.0 108.634 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 46' ' ' ARG . 10.8 tp -56.16 -31.02 62.99 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.61 -32.14 57.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.565 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 52.1 mt -57.87 -37.91 74.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.113 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.431 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 2.2 mmm -84.37 -47.95 10.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.769 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 49.24 25.09 1.12 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 108.804 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 11.9 t -78.55 159.54 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.527 -0.733 . . . . 0.0 109.81 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.2 p-10 -86.18 147.72 25.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 109.223 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 78.9 -6.39 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 109.603 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.513 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 11.7 mt -102.86 102.64 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.447 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 p -91.73 169.25 10.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 14.2 ptm180 -69.96 -18.6 63.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.852 . . . . 0.0 109.669 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -76.76 -24.26 52.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.747 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.37 -33.47 37.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 4.3 t -83.33 -30.28 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.178 -0.951 . . . . 0.0 108.775 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.88 43.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.128 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -80.14 -42.12 24.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.278 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 15' ' ' HIS . 55.7 t-80 -69.85 -30.6 68.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp -77.81 -35.19 51.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.03 -30.81 62.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -29.21 61.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CD2' HD13 ' A' ' 60' ' ' LEU . 8.9 t80 -74.69 -44.29 50.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.259 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -58.79 -42.39 88.95 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.93 -37.81 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.13 60.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 56' ' ' PHE . 10.1 mt -90.07 -17.38 27.85 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.668 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -103.65 11.86 35.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.476 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 29.25 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 63' ' ' VAL . 3.5 p -117.62 62.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.538 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -44.91 127.29 6.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.558 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.26 88.01 4.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -155.49 67.86 0.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.65 105.2 56.49 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.322 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 35.1 Cg_endo -77.72 127.37 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.418 2.079 . . . . 0.0 110.351 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 46.5 mtt85 65.61 128.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.888 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.556 ' CG1' ' HG ' ' A' ' 14' ' ' LEU . 2.1 t -137.79 97.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 6.6 tp -106.53 -32.48 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 12.8 m95 -169.07 70.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.145 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 p -113.93 174.18 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -0.963 . . . . 0.0 109.767 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.15 9.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.221 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -67.41 -51.54 50.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.373 -0.829 . . . . 0.0 109.139 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' HG ' ' CG1' ' A' ' 8' ' ' VAL . 11.7 mt -64.57 -19.97 65.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.431 -0.793 . . . . 0.0 109.983 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.513 ' NE2' HD12 ' A' ' 19' ' ' LEU . 15.2 t60 -80.91 -22.19 39.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 110.03 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.46 -32.1 42.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.918 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -80.41 -35.86 34.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 18.3 t80 -76.96 -23.37 52.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.539 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.513 HD12 ' NE2' ' A' ' 15' ' ' HIS . 12.8 mt -83.01 -35.77 25.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.666 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.58 -26.86 55.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.004 . . . . 0.0 109.274 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 25' ' ' LEU . . . -75.03 -41.55 58.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.176 -0.953 . . . . 0.0 108.786 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 17.3 t -67.37 -47.9 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.847 . . . . 0.0 108.985 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -59.52 -41.88 90.99 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.502 0.667 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 24' ' ' HIS . 21.1 t-160 -58.91 -24.0 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.505 -0.747 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 38' ' ' LEU . 3.4 mt -108.5 -7.5 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.96 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 109.46 0.27 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.03 -20.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -1.07 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.17 -41.21 64.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.818 . . . . 0.0 110.24 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.27 14.73 15.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.003 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.25 132.0 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.4 m -110.36 160.25 29.13 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG3' HD21 ' A' ' 53' ' ' LEU . 35.0 Cg_endo -77.4 -25.52 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.367 2.045 . . . . 0.0 110.369 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 9.9 tmtt? -68.43 -52.93 27.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.301 -0.875 . . . . 0.0 109.309 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -66.21 -39.49 89.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.314 -0.866 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.543 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.5 mt -65.92 -26.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.995 -1.065 . . . . 0.0 108.691 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' A' ' 46' ' ' ARG . 17.3 tp -52.78 -36.1 57.6 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.31 -34.82 68.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.543 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.9 mt -57.09 -37.27 71.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.529 -0.732 . . . . 0.0 109.125 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.7 mmm -76.56 -52.73 9.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 51.24 24.63 2.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 108.951 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 66.4 t -79.91 153.31 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 5.6 p-10 -90.03 143.1 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.9 OUTLIER 82.46 -7.31 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 13.1 mt -91.38 143.46 26.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 109.53 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -118.31 163.74 16.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.511 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 59.7 ttp85 -73.76 -19.07 60.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -24.61 47.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.04 -44.77 65.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 49' ' ' VAL . 55.5 t -83.24 -25.81 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.25 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -19.99 58.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.309 -0.869 . . . . 0.0 109.09 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -74.48 -48.03 29.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.565 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -60.67 -37.41 81.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.975 . . . . 0.0 109.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.422 HD21 ' HG3' ' A' ' 32' ' ' PRO . 6.1 tp -64.72 -43.52 93.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -68.8 -25.68 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -71.9 -29.4 64.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.51 ' CE2' HD13 ' A' ' 60' ' ' LEU . 11.1 t80 -68.13 -48.15 66.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.212 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -54.16 -38.18 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.78 -40.04 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -14.55 62.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.51 HD13 ' CE2' ' A' ' 56' ' ' PHE . 11.9 mt -92.86 -20.82 20.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.287 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -88.51 -66.19 0.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -94.16 62.31 3.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 109.422 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -57.27 177.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 151.14 17.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.53 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.513 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -171.69 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -65.32 134.38 95.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' C ' ' CG ' ' A' ' 7' ' ' ARG . 36.2 Cg_endo -79.05 134.71 11.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.561 2.174 . . . . 0.0 110.812 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.483 ' CG ' ' C ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER 38.01 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 110.514 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.532 HG12 ' CD1' ' A' ' 14' ' ' LEU . 2.5 t -76.26 89.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 108.978 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 18.2 tp -102.19 -37.58 8.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.149 -0.97 . . . . 0.0 109.256 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 15.9 m95 -172.15 73.93 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.096 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -113.48 175.21 5.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -49.72 -24.75 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.24 -54.52 7.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.532 ' CD1' HG12 ' A' ' 8' ' ' VAL . 10.9 mt -60.44 -20.1 58.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.418 -0.801 . . . . 0.0 109.803 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -75.93 -28.65 58.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.836 . . . . 0.0 109.7 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -69.39 -42.74 74.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -72.22 -37.76 69.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.119 -0.988 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 76.9 t80 -73.66 -22.43 59.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.32 -0.863 . . . . 0.0 109.836 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.624 ' CD1' ' CE1' ' A' ' 15' ' ' HIS . 10.6 mt -83.2 -39.07 21.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.804 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.36 -23.78 50.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.053 -1.029 . . . . 0.0 109.189 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' HB1' ' CB ' ' A' ' 38' ' ' LEU . . . -76.85 -39.52 50.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.244 -0.91 . . . . 0.0 109.011 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.561 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 17.4 t -71.36 -47.35 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 108.605 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.29 -40.67 86.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -56.7 -27.74 59.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.532 -0.73 . . . . 0.0 109.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.2 mt -105.19 -7.78 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.4 110.7 1.1 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -48.55 -23.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -1.131 . . . . 0.0 109.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.52 -45.88 71.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.76 . . . . 0.0 110.023 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -111.49 14.53 21.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' CB ' HG11 ' A' ' 22' ' ' VAL . . . -76.72 117.24 18.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 110.008 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -110.44 160.84 27.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.38 -26.86 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.28 1.986 . . . . 0.0 110.26 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 7.3 tmtt? -68.53 -50.96 48.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HB2' HG22 ' A' ' 31' ' ' VAL . 2.1 mmtt -69.36 -42.58 75.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.561 ' CD1' ' CG2' ' A' ' 22' ' ' VAL . 1.5 mt -63.34 -25.28 38.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.75 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 17.1 tp -52.48 -36.76 55.65 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.45 -33.12 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.25 -35.15 74.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.536 -0.727 . . . . 0.0 109.597 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 mmt -79.0 -48.08 15.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.371 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t30 53.36 23.54 3.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.535 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 18.8 t -86.77 158.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.08 148.78 24.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.187 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.7 ttmt 77.0 -2.95 2.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.535 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 13.5 mt -101.57 95.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -90.89 176.95 6.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -72.75 -18.98 61.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -34.23 42.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -73.53 -38.49 65.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 109.574 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -82.97 -25.9 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.196 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 46' ' ' ARG . . . -69.78 -22.14 63.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.415 -0.803 . . . . 0.0 109.308 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 m -74.55 -49.34 22.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.425 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 6.5 t60 -55.45 -29.0 57.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp -75.16 -33.75 61.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -65.3 -30.54 71.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 109.307 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 52' ' ' HIS . 1.6 mtpp -72.59 -20.74 61.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -68.7 -42.3 77.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.78 -42.62 97.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 108.416 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -65.46 -31.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 -10.94 58.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 12.3 mt -76.17 5.54 6.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.554 -0.716 . . . . 0.0 109.657 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 60' ' ' LEU . 5.4 ttmm 72.82 56.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 61' ' ' LYS . 3.7 ttpt 35.08 71.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.184 0.516 . . . . 0.0 110.252 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 64' ' ' SER . 71.3 t -126.37 160.74 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.596 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.505 ' N ' HG11 ' A' ' 63' ' ' VAL . 45.7 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.482 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 1' ' ' THR . . . 178.71 158.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 65.86 65.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 95.11 2.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.532 ' HE3' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -123.06 101.33 38.78 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.191 -0.943 . . . . 0.0 110.218 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.41 113.74 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.174 1.916 . . . . 0.0 108.966 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER 62.22 84.45 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.087 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.548 ' CG2' HD11 ' A' ' 14' ' ' LEU . 2.1 t -39.76 130.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.0 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.621 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 14.3 tp -117.54 -60.97 1.76 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.54 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.621 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 6.0 m95 179.48 72.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.594 -0.691 . . . . 0.0 109.387 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.532 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 73.2 p -83.45 162.83 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.131 -0.981 . . . . 0.0 109.44 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -55.24 -25.25 32.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -83.71 -46.41 12.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.548 HD11 ' CG2' ' A' ' 8' ' ' VAL . 67.7 mt -64.98 -19.56 66.04 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.551 -0.718 . . . . 0.0 109.742 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.621 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 70.2 t60 -79.51 -22.33 44.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -0.922 . . . . 0.0 109.297 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -71.31 -28.39 64.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.563 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -80.43 -38.68 29.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.522 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 92.8 t80 -75.7 -24.13 56.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 11.8 mt -75.84 -41.69 51.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.536 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.09 -24.65 59.51 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.13 -0.982 . . . . 0.0 109.347 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -77.27 -41.86 39.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 19.7 t -66.61 -45.49 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.931 . . . . 0.0 108.889 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -61.62 -45.28 94.74 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.547 0.689 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -62.6 -23.4 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.462 -0.774 . . . . 0.0 110.205 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' CD1' ' CD1' ' A' ' 38' ' ' LEU . 2.2 mt -107.89 -3.45 18.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 109.847 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . 77.36 107.64 0.16 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 27' ' ' VAL . 8.0 p -51.5 -21.01 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -1.12 . . . . 0.0 109.52 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.8 -45.07 91.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -116.75 13.81 15.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 26' ' ' GLY . . . -83.21 118.53 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.083 -1.01 . . . . 0.0 109.714 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 35' ' ' ILE . 1.8 m -105.6 160.02 27.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 108.927 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.55 -26.21 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.406 2.07 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.85 -51.02 44.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 109.242 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -69.81 -41.42 75.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.085 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.53 HG12 ' CD1' ' A' ' 25' ' ' LEU . 1.5 mt -65.65 -24.76 35.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.54 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 27.2 tp -52.99 -38.84 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.22 -35.18 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 4.5 mt -58.09 -32.69 68.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 109.599 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.458 ' HE1' ' HB2' ' A' ' 18' ' ' PHE . 2.5 mmt -71.33 -43.37 67.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.469 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.84 26.98 8.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.951 . . . . 0.0 109.041 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 58.6 t -97.13 148.09 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.138 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.8 p-10 -84.33 148.35 26.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.87 -0.9 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.75 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -100.16 110.22 22.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.132 -0.98 . . . . 0.0 109.392 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -96.21 172.14 8.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.4 ptt180 -76.64 -17.89 58.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.923 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.78 -34.5 60.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -65.4 -38.76 90.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.14 -25.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.062 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 46' ' ' ARG . . . -71.33 -28.02 63.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.845 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -70.55 -50.51 36.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.853 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.34 -32.01 68.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.07 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.0 tp -78.23 -24.39 47.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.25 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.02 73.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.874 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 31.9 mmtt -56.51 -33.92 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.108 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CE2' HD12 ' A' ' 60' ' ' LEU . 8.9 t80 -69.18 -45.68 69.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 108.899 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.25 -38.01 62.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.017 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.8 t -65.79 -37.14 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.85 -12.12 60.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.569 HD12 ' CE2' ' A' ' 56' ' ' PHE . 7.9 mt -101.96 -4.12 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.52 -0.737 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -46.63 -57.35 4.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.217 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.514 -0.741 . . . . 0.0 109.238 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.56 114.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.446 179.802 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.29 63.99 0.94 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' LYS . 1.7 tt0 61.81 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 1.6 tptt -43.95 118.19 1.39 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.367 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' ' CG2' ' A' ' 8' ' ' VAL . 2.1 ttpm? -39.21 99.24 0.19 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.703 -0.623 . . . . 0.0 109.642 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 7' ' ' ARG . 37.1 Cg_endo -82.44 113.8 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.57 2.18 . . . . 0.0 110.878 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER 29.77 98.48 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.084 0.468 . . . . 0.0 110.942 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 14' ' ' LEU . 3.0 t -50.38 89.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 10.5 tp -116.12 -27.12 7.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 22.1 m95 -172.57 66.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.011 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -113.69 173.27 6.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.813 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 26.4 p80 -50.59 -27.29 6.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.326 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.0 -54.49 9.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' CD1' HG11 ' A' ' 8' ' ' VAL . 11.6 mt -54.59 -24.53 21.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.536 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 1.4 t60 -72.43 -36.83 68.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 12' ' ' HIS . 20.3 m120 -71.37 -25.14 62.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.861 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -79.55 -41.68 26.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 63.0 t80 -70.06 -23.57 63.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 15' ' ' HIS . 23.2 mt -80.32 -43.84 20.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.962 . . . . 0.0 109.53 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -22.7 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.112 -0.993 . . . . 0.0 109.262 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 25' ' ' LEU . . . -76.34 -43.94 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 0.0 108.707 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 18' ' ' PHE . 15.0 t -64.01 -47.9 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.88 . . . . 0.0 108.915 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -59.52 -44.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.608 0.718 . . . . 0.0 109.137 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -58.14 -23.34 54.78 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.535 ' CD1' HG12 ' A' ' 35' ' ' ILE . 2.9 mt -110.16 -4.9 15.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.994 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.84 109.11 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 8.3 p -52.88 -19.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -1.068 . . . . 0.0 109.798 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 -45.45 75.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.51 14.03 15.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 109.897 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . . . -72.1 105.4 3.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 34' ' ' LYS . 5.9 m -93.17 160.46 33.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.009 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 35.0 Cg_endo -76.86 -29.2 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.426 2.084 . . . . 0.0 110.068 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 6.7 tmtt? -65.84 -49.6 67.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.208 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 2.0 mtpt -67.36 -45.01 77.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.56 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 1.8 mt -62.8 -23.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.698 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 55.3 tp -53.81 -36.93 63.01 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -74.79 -31.43 61.74 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 5.7 mt -59.74 -32.76 70.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.433 ' HB3' HG22 ' A' ' 41' ' ' VAL . 42.2 mmm -84.36 -49.99 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.817 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.55 23.65 1.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 108.932 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 8.7 t -82.05 151.93 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.708 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.78 150.03 23.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.569 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 77.17 -2.35 2.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.661 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 12.9 mt -99.04 104.09 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -82.73 162.67 21.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.6 -19.04 63.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.965 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -26.49 38.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -41.53 71.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.24 -30.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.35 -20.01 62.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -75.79 -50.06 16.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.862 . . . . 0.0 109.227 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -57.11 -31.23 65.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.209 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.3 tp -79.31 -27.47 42.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -68.36 -25.86 65.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -71.08 -28.62 64.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CE2' HD11 ' A' ' 60' ' ' LEU . 8.9 t80 -81.84 -51.73 7.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 mtp85 -54.88 -40.02 69.3 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.58 -42.67 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.411 ' O ' HG12 ' A' ' 63' ' ' VAL . . . -69.58 -12.28 61.52 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 56' ' ' PHE . 4.9 mt -102.77 -12.91 17.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.4 -0.813 . . . . 0.0 109.443 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -76.4 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.75 78.14 9.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.543 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 12.0 p -162.36 116.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.462 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.59 5.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.443 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -79.36 105.75 10.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.917 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' LYS . 8.5 pttt -171.67 61.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.29 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HB3' HG23 ' A' ' 8' ' ' VAL . 15.4 mtmm 54.49 99.71 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.243 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' O ' ' CG ' ' A' ' 7' ' ' ARG . 35.7 Cg_endo -79.12 114.03 3.29 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.344 2.029 . . . . 0.0 110.59 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 38.28 54.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.654 . . . . 0.0 110.293 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 2.5 t -82.05 83.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.06 . . . . 0.0 109.123 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 13.1 tp -107.68 -29.22 9.26 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 108.774 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 6.9 m95 -176.3 69.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -112.57 175.35 5.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -49.64 -22.48 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.309 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -53.67 7.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' CD1' HG11 ' A' ' 8' ' ' VAL . 10.5 mt -62.76 -20.19 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 110.101 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.526 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 27.7 t60 -78.72 -22.57 46.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.778 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -75.29 -41.05 58.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.055 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 37.2 t80 -69.21 -22.2 63.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.439 -0.788 . . . . 0.0 109.723 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 20.0 mt -81.05 -44.38 18.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.98 59.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.954 -1.091 . . . . 0.0 109.165 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -77.29 -43.49 33.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 0.0 109.104 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 35' ' ' ILE . 21.3 t -64.64 -43.69 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 108.969 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -57.92 -43.31 86.14 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.644 0.735 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.491 ' CD2' ' O ' ' A' ' 24' ' ' HIS . 14.4 t60 -62.0 -23.11 66.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.316 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -111.04 -2.34 15.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.0 110.195 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 108.59 0.31 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 27' ' ' VAL . 11.9 p -53.27 -18.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -1.069 . . . . 0.0 109.892 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -65.87 -47.28 75.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.785 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 mtp85 -117.08 13.85 14.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.23 9.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' CG2' ' HG3' ' A' ' 34' ' ' LYS . 10.7 m -105.48 159.97 27.65 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.2 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.344 2.029 . . . . 0.0 110.036 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 1.4 tmtt? -70.16 -43.84 70.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -70.57 -46.32 63.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.328 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.553 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -64.69 -25.7 38.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.277 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 46' ' ' ARG . 24.5 tp -52.29 -34.57 47.31 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.1 -34.69 59.51 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 35' ' ' ILE . 4.0 mt -57.92 -33.87 69.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.694 -0.629 . . . . 0.0 109.665 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.9 mtp -86.43 -47.4 9.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.85 23.89 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 45.2 t -77.98 157.82 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 0.0 109.543 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 p30 -84.14 143.44 29.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 75.9 4.47 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.541 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB ' ' A' ' 41' ' ' VAL . 12.5 mt -111.75 100.59 9.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 p -94.03 169.89 9.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.388 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -59.96 -23.27 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.269 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 44.3 tp10 -73.57 -32.62 64.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.339 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.25 -34.73 78.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.45 -30.35 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.888 . . . . 0.0 109.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.42 -20.12 60.16 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.361 -0.837 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -75.95 -48.48 21.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.119 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -58.6 -37.75 76.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.012 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.7 -39.43 80.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.29 -29.9 70.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.239 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -60.85 -36.55 79.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.82 -46.86 83.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 0.0 108.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -54.3 -36.57 63.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.59 -38.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 61' ' ' LYS . 12.8 mt -80.37 5.89 13.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.633 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 9.3 ttmm 87.67 76.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.412 0.625 . . . . 0.0 109.532 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' LYS . 7.6 tptp 42.41 59.88 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.76 . . . . 0.0 109.571 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.37 56.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.356 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 41' ' ' VAL . 10.5 mt -58.58 -19.99 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.911 ' CE1' HD11 ' A' ' 19' ' ' LEU . 46.8 t-80 -80.41 -30.26 37.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.691 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -72.55 -33.27 66.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD2' HD23 ' A' ' 14' ' ' LEU . 75.0 mttt -73.83 -42.62 60.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.4 t80 -67.28 -22.57 65.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.873 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 15' ' ' HIS . 43.6 mt -81.53 -44.88 16.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.672 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.74 -19.96 60.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.123 -0.986 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.032 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.56 -38.87 33.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -0.953 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 18' ' ' PHE . 18.7 t -71.26 -47.14 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.57 -43.14 97.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.585 0.707 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -58.92 -22.84 60.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 38' ' ' LEU . 2.7 mt -112.54 -1.73 14.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.6 107.59 0.29 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.62 -19.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -1.091 . . . . 0.0 109.771 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.21 -43.34 70.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -116.8 14.24 15.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.027 . . . . 0.0 110.101 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.6 120.16 23.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.5 m -100.63 157.18 34.2 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 108.969 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.9 Cg_endo -77.23 -24.11 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.404 2.069 . . . . 0.0 110.144 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.12 -52.98 28.72 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.225 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.726 ' H ' HG23 ' A' ' 31' ' ' VAL . 20.2 mmtp -67.99 -41.83 81.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.153 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -64.53 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.608 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 46' ' ' ARG . 43.2 tp -53.5 -35.72 60.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.49 -33.72 67.16 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.032 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.4 mt -57.31 -38.48 74.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.425 -0.797 . . . . 0.0 109.045 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mmt -73.55 -51.47 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 t30 56.39 26.4 10.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 21.7 t -94.0 154.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 16.6 p30 -80.3 146.82 31.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.316 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 77.19 -2.23 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.6 mt -102.35 119.24 38.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 109.485 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.86 -179.99 3.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.504 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 36' ' ' LEU . 3.8 ptt-85 -77.07 -26.95 54.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 75.2 tt0 -72.53 -23.01 60.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -76.42 -36.46 58.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.45 -25.9 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 0.0 109.151 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.4 56.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.324 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -77.91 -46.15 22.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -63.66 -30.33 71.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.858 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.311 0.576 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 14' ' ' LEU . 9.7 mt -62.26 -19.16 62.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 109.811 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.8 t60 -79.96 -23.83 41.39 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -71.7 -28.91 64.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -79.01 -47.95 15.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.133 -0.979 . . . . 0.0 109.139 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.997 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.2 t80 -69.86 -22.21 63.28 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 19' ' ' LEU . 12.4 mt -78.54 -39.45 37.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 109.74 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.88 -24.34 55.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.192 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.91 -43.66 34.71 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 108.737 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.7 t -65.38 -46.44 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 108.814 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.58 -44.79 95.81 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.522 0.677 . . . . 0.0 109.391 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -59.49 -23.09 62.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 0.0 109.918 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 38' ' ' LEU . 4.7 mt -107.25 -7.03 16.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.02 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.78 108.94 0.55 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.1 -18.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.46 -46.58 79.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 13.66 15.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.8 108.93 8.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 17.2 m -96.66 160.11 30.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 109.037 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.99 9.98 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.443 2.096 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -69.65 -48.81 58.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.347 -0.845 . . . . 0.0 109.302 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 66.8 mmtt -69.9 -42.89 72.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 109.18 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.993 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -65.9 -24.68 34.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.031 -1.043 . . . . 0.0 108.433 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 46' ' ' ARG . 19.0 tp -54.65 -32.6 59.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.21 -32.05 55.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 25' ' ' LEU . 5.1 mt -60.12 -36.45 77.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.592 -0.693 . . . . 0.0 109.598 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.46 -46.73 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.97 . . . . 0.0 109.739 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 t30 51.28 24.87 2.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 108.885 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.986 ' HB ' HD12 ' A' ' 44' ' ' LEU . 76.8 t -78.95 157.82 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.556 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.3 p-10 -90.34 146.26 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 ttmt 77.03 -2.25 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.1 mt -95.36 107.26 19.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 109.364 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -88.97 175.97 7.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HG3' HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -78.75 -24.95 44.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.765 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -22.97 54.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.583 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.93 -43.68 64.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.697 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG1' ' CE1' ' A' ' 18' ' ' PHE . 76.6 t -83.45 -26.59 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.19 -20.02 57.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 m -78.12 -45.61 22.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.73 -26.6 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 109.241 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.7 tp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 14' ' ' LEU . 11.9 mt -62.03 -23.1 66.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.442 -0.786 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 1.068 ' CE1' HD11 ' A' ' 19' ' ' LEU . 10.8 t-160 -71.62 -26.5 62.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.01 -37.61 72.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -72.85 -47.51 45.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 22' ' ' VAL . 62.9 t80 -68.93 -22.29 64.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.068 HD11 ' CE1' ' A' ' 15' ' ' HIS . 21.8 mt -82.15 -39.67 22.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.912 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.17 -22.57 44.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.112 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.35 -41.24 28.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 108.834 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 18' ' ' PHE . 28.3 t -70.59 -45.75 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.94 -43.72 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.15 -23.22 62.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.529 -0.732 . . . . 0.0 109.688 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mt -112.61 -0.57 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.817 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.18 107.16 0.19 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 9.5 p -52.28 -19.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -1.057 . . . . 0.0 109.921 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 -42.28 65.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -116.84 14.48 15.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -89.22 133.45 34.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.8 m -115.89 160.24 36.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.397 -0.814 . . . . 0.0 109.069 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.6 Cg_endo -76.18 -17.27 17.17 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.47 2.113 . . . . 0.0 110.253 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -71.54 -54.79 9.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.171 -0.956 . . . . 0.0 109.31 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -68.7 -38.47 80.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.218 -0.927 . . . . 0.0 108.838 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.003 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -63.43 -25.34 38.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.575 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 46' ' ' ARG . 23.1 tp -51.75 -36.2 46.38 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -73.34 -35.12 65.97 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.003 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.0 mt -58.01 -35.77 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.554 -0.716 . . . . 0.0 109.336 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.0 mmm -78.98 -51.28 9.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.94 25.75 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 44' ' ' LEU . 72.8 t -82.27 146.54 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.295 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.0 p30 -80.32 145.92 31.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.57 0.75 3.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.658 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 41' ' ' VAL . 4.0 mm? -103.11 137.55 41.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.65 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -118.46 173.85 6.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' HD22 ' A' ' 36' ' ' LEU . 1.4 ptt180 -77.85 -19.72 54.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.18 -43.21 53.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.51 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -61.65 -36.42 80.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.31 -25.22 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.18 -20.7 57.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -77.96 -45.73 23.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -62.45 -26.22 68.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.4 tp . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.401 0.619 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 14' ' ' LEU . 10.2 mt -62.56 -19.64 63.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.758 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.4 t60 -80.69 -25.38 38.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -72.93 -34.23 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -0.927 . . . . 0.0 109.476 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -78.54 -40.61 34.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.208 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.982 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.8 t80 -74.07 -22.61 59.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.758 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.6 mt -82.48 -37.44 25.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.27 -24.94 51.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.106 -0.996 . . . . 0.0 109.296 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.853 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.93 -39.7 55.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.1 t -68.51 -47.37 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 108.879 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.57 -41.75 90.91 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.566 0.698 . . . . 0.0 109.187 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -56.09 -25.86 47.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 109.606 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.983 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.8 mt -109.32 -6.19 15.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 110.031 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 110.25 0.77 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.17 -19.0 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -1.073 . . . . 0.0 109.831 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.23 48.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -111.08 14.42 21.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 0.0 109.822 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.38 134.42 36.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.997 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -120.99 160.55 44.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 108.951 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.72 -24.7 11.47 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.371 2.048 . . . . 0.0 110.208 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.91 -53.82 18.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.362 -0.836 . . . . 0.0 109.062 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 33' ' ' LYS . 2.0 mmtp -67.59 -40.21 84.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.324 -0.86 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.015 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.1 -26.3 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.655 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.046 HD22 ' HB2' ' A' ' 46' ' ' ARG . 47.9 tp -52.51 -36.3 55.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.11 -34.22 63.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.3 mt -58.99 -34.41 71.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 109.406 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.444 ' HB3' HG23 ' A' ' 41' ' ' VAL . 64.1 mmm -80.85 -51.49 8.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.17 23.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 108.936 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.949 ' HB ' HD12 ' A' ' 44' ' ' LEU . 20.5 t -80.65 156.83 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.485 -0.759 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 26.5 p30 -88.07 146.54 25.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 76.06 1.78 3.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.949 HD12 ' HB ' ' A' ' 41' ' ' VAL . 14.2 mt -106.16 117.71 34.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.516 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.39 167.97 9.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 1.046 ' HB2' HD22 ' A' ' 36' ' ' LEU . 38.6 ttp180 -76.24 -21.47 56.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.27 -29.43 48.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -68.59 -42.18 78.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.409 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 -25.09 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.33 -20.51 62.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 m -80.79 -42.03 22.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.892 . . . . 0.0 109.507 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -75.4 -28.26 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.412 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.409 0.623 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 14' ' ' LEU . 11.4 mt -62.51 -20.26 64.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.022 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.718 ' CE1' HD11 ' A' ' 19' ' ' LEU . 17.3 t-160 -79.05 -22.39 45.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 109.921 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -77.34 -31.04 54.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -77.09 -42.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.3 t80 -73.36 -25.48 60.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.8 mt -82.2 -33.87 29.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.717 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 -22.96 45.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.134 -0.979 . . . . 0.0 109.359 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -78.46 -41.23 33.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.234 -0.916 . . . . 0.0 108.644 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.5 t -65.69 -47.97 84.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.15 -44.81 95.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.666 -0.646 . . . . 0.0 109.332 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -61.43 -22.93 65.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.771 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -108.16 -3.92 18.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.768 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.53 108.52 0.81 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 22' ' ' VAL . 11.4 p -54.56 -18.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -1.094 . . . . 0.0 109.738 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.82 -46.79 77.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.83 13.75 15.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.582 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.85 97.47 4.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.707 HG23 ' H ' ' A' ' 34' ' ' LYS . 33.1 m -90.48 159.88 40.45 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.279 -0.888 . . . . 0.0 108.923 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.99 -22.08 13.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.292 1.995 . . . . 0.0 109.936 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.11 -51.6 44.44 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.266 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.707 ' H ' HG23 ' A' ' 31' ' ' VAL . 23.1 mmtm -69.28 -44.39 71.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.154 -0.967 . . . . 0.0 108.951 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.977 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.9 mt -63.05 -23.49 33.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.08 -1.013 . . . . 0.0 108.606 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.757 HD22 ' HB2' ' A' ' 46' ' ' ARG . 29.4 tp -52.74 -39.37 62.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -36.49 68.86 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.012 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.6 mt -57.37 -29.38 64.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.532 -0.73 . . . . 0.0 109.254 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.0 mtp -83.25 -49.58 9.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 53.84 24.98 4.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.213 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.947 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.7 t -84.5 144.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -81.33 147.82 29.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 9.8 ttpt 78.05 -3.16 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.583 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.947 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.2 mt -99.47 109.56 22.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 p -89.27 169.89 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.757 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.27 -23.57 54.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -32.08 62.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -68.07 -35.61 78.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.462 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 32' ' ' PRO . 95.7 t -83.25 -25.74 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.99 -24.13 48.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.253 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.8 m -76.36 -44.27 37.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.334 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -62.74 -30.46 71.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.19 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.4 tp . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.276 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 14' ' ' LEU . 9.2 mt -82.33 -55.39 4.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.956 ' CD2' HD11 ' A' ' 19' ' ' LEU . 81.6 t60 -45.65 -25.19 0.44 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.687 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -68.19 -48.81 64.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -68.25 -35.15 77.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.994 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.7 t80 -69.95 -25.98 63.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.956 HD11 ' CD2' ' A' ' 15' ' ' HIS . 45.9 mt -77.7 -44.36 28.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -24.63 61.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 108.926 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.697 ' HA ' HD22 ' A' ' 38' ' ' LEU . . . -74.27 -40.57 62.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.994 HG23 ' O ' ' A' ' 18' ' ' PHE . 16.4 t -69.51 -46.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.0 108.906 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.33 -40.25 85.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.412 ' ND1' ' C ' ' A' ' 24' ' ' HIS . 8.4 t-80 -54.82 -27.54 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.518 -0.739 . . . . 0.0 109.354 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.978 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.5 mt -106.53 -9.03 16.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.99 111.39 2.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.9 -18.33 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -1.098 . . . . 0.0 110.088 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.58 -43.19 39.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.216 -0.928 . . . . 0.0 110.648 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -116.72 14.87 15.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 110.257 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -69.22 124.06 22.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.984 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 23.2 m -106.17 160.4 26.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 108.994 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.8 Cg_endo -76.59 -23.57 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.347 2.031 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -69.36 -52.72 24.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.401 -0.812 . . . . 0.0 109.382 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 14.2 mtpp -67.13 -38.97 86.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -0.86 . . . . 0.0 109.354 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.95 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -67.23 -24.72 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.999 -1.063 . . . . 0.0 108.863 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 46' ' ' ARG . 58.0 tp -54.09 -38.97 65.9 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -74.37 -35.85 63.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.978 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.3 mt -57.21 -28.79 63.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.589 -0.694 . . . . 0.0 109.343 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.8 mmm -82.54 -43.94 16.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 0.2 OUTLIER 50.85 23.77 1.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.014 ' HB ' HD12 ' A' ' 44' ' ' LEU . 93.7 t -87.48 155.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.559 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.6 p-10 -90.1 140.71 29.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER 80.22 -8.48 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.528 -0.732 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.014 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.5 mt -84.2 125.37 32.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.96 -1.088 . . . . 0.0 109.152 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 p -109.34 158.91 17.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -78.17 -17.79 56.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.412 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -74.13 -22.91 59.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -80.47 -37.7 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.619 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.497 HG11 ' CE1' ' A' ' 18' ' ' PHE . 69.0 t -83.02 -24.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.35 -39.39 59.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -72.12 -38.5 69.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.516 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -70.04 -25.98 63.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.126 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.353 0.596 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 14' ' ' LEU . 10.2 mt -57.79 -19.58 29.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.883 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.875 ' NE2' HD11 ' A' ' 19' ' ' LEU . 4.7 t60 -75.8 -32.94 60.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -67.42 -30.36 70.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HD2' HD23 ' A' ' 14' ' ' LEU . 16.7 mttm -78.71 -38.12 39.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.955 ' O ' HG23 ' A' ' 22' ' ' VAL . 60.7 t80 -75.19 -23.22 57.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.676 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.875 HD11 ' NE2' ' A' ' 15' ' ' HIS . 4.5 mt -82.48 -36.54 26.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.66 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.31 -24.5 50.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.7 -43.32 38.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 108.768 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.5 t -67.16 -45.7 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -59.54 -43.54 93.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -58.61 -23.22 58.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.534 -0.728 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -112.83 -1.66 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.02 107.19 0.49 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 22' ' ' VAL . 8.1 p -54.41 -18.58 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -1.146 . . . . 0.0 109.748 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -46.79 74.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.949 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -116.8 14.01 15.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.0 109.919 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.567 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -70.05 125.61 27.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.772 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 34' ' ' LYS . 16.7 m -109.66 160.04 29.37 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.316 -0.865 . . . . 0.0 108.932 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.47 -19.25 15.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.41 2.074 . . . . 0.0 110.046 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -70.54 -55.13 9.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.397 -0.814 . . . . 0.0 109.03 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 31' ' ' VAL . 16.7 mttp -67.92 -39.47 83.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.951 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -68.0 -25.32 31.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.091 -1.043 . . . . 0.0 108.562 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 46' ' ' ARG . 25.8 tp -53.63 -38.33 63.96 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.1 -35.64 66.64 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.4 mt -57.66 -31.39 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.627 -0.67 . . . . 0.0 109.419 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.413 ' SD ' HD13 ' A' ' 44' ' ' LEU . 3.3 mtt -79.96 -53.24 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t30 55.17 27.0 8.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.202 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.97 ' HB ' HD12 ' A' ' 44' ' ' LEU . 24.5 t -88.31 157.52 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -90.27 140.87 29.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 81.84 -7.44 1.39 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 110.033 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.97 HD12 ' HB ' ' A' ' 41' ' ' VAL . 16.9 mt -90.58 136.99 32.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -114.0 164.26 14.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.554 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.853 ' HB2' HD22 ' A' ' 36' ' ' LEU . 32.7 ttp85 -78.73 -31.37 46.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.94 -22.87 63.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.418 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 3.9 m-20 -72.24 -36.52 69.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.12 -27.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.226 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.17 63.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.304 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.69 -50.26 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.378 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -54.39 -28.68 45.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 108.964 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 14' ' ' LEU . 8.4 mt -60.88 -19.26 59.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 1.126 ' CE1' HD11 ' A' ' 19' ' ' LEU . 10.0 t-160 -77.33 -26.05 51.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.915 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.69 -43.69 53.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.75 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -78.39 -33.82 48.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 108.836 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.972 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.1 t80 -76.59 -23.19 53.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.35 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.126 HD11 ' CE1' ' A' ' 15' ' ' HIS . 13.7 mt -78.79 -37.77 40.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 109.628 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.81 50.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.142 -0.974 . . . . 0.0 108.902 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.41 -43.43 40.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.312 -0.867 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 18' ' ' PHE . 25.0 t -67.24 -45.76 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.733 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.96 -43.12 95.25 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.516 0.674 . . . . 0.0 109.262 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -58.28 -23.16 55.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.739 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.936 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -111.39 -4.49 14.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.152 -0.967 . . . . 0.0 110.067 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 110.05 1.08 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 22' ' ' VAL . 13.7 p -54.07 -18.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -1.116 . . . . 0.0 109.909 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 29' ' ' ARG . 8.7 pt-20 -80.16 -37.41 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.75 14.5 15.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.176 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.163 -0.961 . . . . 0.0 110.091 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.7 m -119.74 160.53 42.03 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.365 -0.835 . . . . 0.0 108.936 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.854 ' HD3' HD22 ' A' ' 53' ' ' LEU . 33.9 Cg_endo -75.64 -24.21 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.409 2.073 . . . . 0.0 110.005 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.1 -52.42 28.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.371 -0.831 . . . . 0.0 109.298 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 31' ' ' VAL . 13.4 mttt -69.18 -38.89 78.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.005 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -67.8 -24.78 31.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.082 -1.011 . . . . 0.0 108.61 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.007 HD22 ' HB3' ' A' ' 46' ' ' ARG . 20.3 tp -53.34 -37.92 62.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.99 -34.47 64.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.005 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -59.24 -31.64 69.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.442 -0.786 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.681 ' HB3' HG23 ' A' ' 41' ' ' VAL . 83.0 mmm -85.09 -50.26 7.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.7 t30 54.48 25.46 6.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.21 -0.932 . . . . 0.0 109.104 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.878 ' HB ' HD12 ' A' ' 44' ' ' LEU . 7.8 t -78.77 158.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.54 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 22.4 p30 -89.67 144.66 25.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 76.37 -0.5 3.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.878 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.4 mt -101.81 115.56 30.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 109.506 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -99.26 168.23 10.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 1.007 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.75 -18.23 60.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -32.94 61.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.24 -25.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.134 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 32' ' ' PRO . . . -77.7 -20.85 52.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.281 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -76.63 -43.76 37.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 109.297 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -67.07 -30.75 70.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.854 HD22 ' HD3' ' A' ' 32' ' ' PRO . 5.8 tp . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' CG ' ' HE3' ' A' ' 17' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 14' ' ' LEU . 11.9 mt -58.51 -20.08 42.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.58 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -78.58 -32.82 47.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.41 -38.25 65.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.763 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.409 ' HE3' ' CG ' ' A' ' 13' ' ' GLU . 74.2 mttt -74.33 -35.31 63.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.7 t80 -72.41 -26.88 62.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.883 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 19' ' ' LEU . 12.6 mt -80.54 -39.85 27.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -23.68 51.34 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.127 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.43 -41.8 38.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.867 . . . . 0.0 108.967 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -69.6 -45.11 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 108.658 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -59.57 -42.31 92.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.476 0.655 . . . . 0.0 109.236 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -57.49 -24.26 54.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -0.759 . . . . 0.0 109.676 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.048 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -110.47 -4.83 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.22 110.1 0.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 22' ' ' VAL . 6.3 p -53.94 -18.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -41.51 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -116.74 14.74 15.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -78.25 121.32 24.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.073 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.1 m -104.24 160.11 27.12 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 108.81 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.42 -25.76 9.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.355 2.037 . . . . 0.0 110.066 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.27 -50.26 54.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 12.6 mttm -68.16 -40.71 82.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.151 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.03 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -63.88 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.07 . . . . 0.0 108.681 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.6 tp -54.2 -35.0 61.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 3.0 p30 -78.99 -28.93 43.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.048 ' CD1' HD11 ' A' ' 25' ' ' LEU . 6.2 mt -63.36 -31.83 73.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.495 -0.753 . . . . 0.0 109.129 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 41' ' ' VAL . 1.8 mtt -89.12 -40.95 12.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 52.25 25.37 3.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 109.051 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 19.5 t -80.93 146.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 109.582 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 17.6 p-10 -89.82 149.92 22.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.344 -0.847 . . . . 0.0 109.516 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 79.07 -3.76 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -93.41 130.3 39.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.304 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -102.59 160.42 14.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -77.97 -21.97 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -29.97 62.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.41 -25.32 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.55 -21.73 48.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 m -78.95 -43.02 25.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -67.81 -27.39 66.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.33 0.586 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 14' ' ' LEU . 10.4 mt -85.05 -58.28 2.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.987 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.499 ' HE1' HD11 ' A' ' 19' ' ' LEU . 52.9 t-80 -49.46 -22.08 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.4 -42.24 62.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.51 -36.63 84.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 109.352 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.063 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.1 t80 -69.62 -32.92 71.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD11 ' HE1' ' A' ' 15' ' ' HIS . 11.5 mt -70.38 -45.49 65.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.11 70.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -70.79 -40.36 72.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.229 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -63.56 -48.16 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.28 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -59.18 -44.11 92.18 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 109.326 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.54 -22.89 65.55 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 110.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 38' ' ' LEU . 2.6 mt -110.45 -1.69 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.03 108.45 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 p -53.13 -19.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -1.107 . . . . 0.0 109.557 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.61 -44.06 83.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -116.94 13.16 14.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -0.999 . . . . 0.0 110.159 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -81.19 109.01 15.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.878 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.9 m -99.67 160.49 27.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 108.949 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.13 -27.32 8.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.434 2.089 . . . . 0.0 110.022 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.48 -48.42 64.51 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.471 -0.768 . . . . 0.0 109.248 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -70.17 -42.72 72.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.858 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -66.61 -24.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.014 -1.053 . . . . 0.0 108.634 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.948 HD22 ' HB3' ' A' ' 46' ' ' ARG . 10.8 tp -56.16 -31.02 62.99 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.61 -32.14 57.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 25' ' ' LEU . 52.1 mt -57.87 -37.91 74.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.113 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.775 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 mmm -84.37 -47.95 10.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.769 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 49.24 25.09 1.12 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 108.804 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.946 ' HB ' HD12 ' A' ' 44' ' ' LEU . 11.9 t -78.55 159.54 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.527 -0.733 . . . . 0.0 109.81 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.2 p-10 -86.18 147.72 25.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 109.223 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 78.9 -6.39 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 109.603 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.946 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.7 mt -102.86 102.64 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.447 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 p -91.73 169.25 10.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.948 ' HB3' HD22 ' A' ' 36' ' ' LEU . 14.2 ptm180 -69.96 -18.6 63.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.852 . . . . 0.0 109.669 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -76.76 -24.26 52.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.747 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.37 -33.47 37.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 4.3 t -83.33 -30.28 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.178 -0.951 . . . . 0.0 108.775 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.88 43.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.128 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -80.14 -42.12 24.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.278 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -69.85 -30.6 68.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.7 mt -64.57 -19.97 65.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.431 -0.793 . . . . 0.0 109.983 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.593 ' NE2' HD11 ' A' ' 19' ' ' LEU . 15.2 t60 -80.91 -22.19 39.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 110.03 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -79.46 -32.1 42.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.918 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -80.41 -35.86 34.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.946 ' O ' HG23 ' A' ' 22' ' ' VAL . 18.3 t80 -76.96 -23.37 52.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.539 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 ' NE2' ' A' ' 15' ' ' HIS . 12.8 mt -83.01 -35.77 25.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.666 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.58 -26.86 55.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.004 . . . . 0.0 109.274 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.03 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.03 -41.55 58.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.176 -0.953 . . . . 0.0 108.786 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.3 t -67.37 -47.9 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.847 . . . . 0.0 108.985 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -59.52 -41.88 90.99 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.502 0.667 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.91 -24.0 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.505 -0.747 . . . . 0.0 109.866 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 38' ' ' LEU . 3.4 mt -108.5 -7.5 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.96 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 109.46 0.27 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.03 -20.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -1.07 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.17 -41.21 64.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.818 . . . . 0.0 110.24 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.27 14.73 15.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.003 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -92.25 132.0 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.4 m -110.36 160.25 29.13 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.4 -25.52 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.367 2.045 . . . . 0.0 110.369 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 9.9 tmtt? -68.43 -52.93 27.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.301 -0.875 . . . . 0.0 109.309 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -66.21 -39.49 89.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.314 -0.866 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.053 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.92 -26.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.995 -1.065 . . . . 0.0 108.691 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.904 HD22 ' HB2' ' A' ' 46' ' ' ARG . 17.3 tp -52.78 -36.1 57.6 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.31 -34.82 68.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.053 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.9 mt -57.09 -37.27 71.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.529 -0.732 . . . . 0.0 109.125 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.7 mmm -76.56 -52.73 9.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.6 t30 51.24 24.63 2.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 108.951 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.005 ' HB ' HD12 ' A' ' 44' ' ' LEU . 66.4 t -79.91 153.31 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 5.6 p-10 -90.03 143.1 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.9 OUTLIER 82.46 -7.31 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.005 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.1 mt -91.38 143.46 26.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 109.53 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -118.31 163.74 16.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.904 ' HB2' HD22 ' A' ' 36' ' ' LEU . 59.7 ttp85 -73.76 -19.07 60.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -24.61 47.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.04 -44.77 65.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.5 t -83.24 -25.81 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.25 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -19.99 58.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.309 -0.869 . . . . 0.0 109.09 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -74.48 -48.03 29.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.565 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -60.67 -37.41 81.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.975 . . . . 0.0 109.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 14' ' ' LEU . 10.9 mt -60.44 -20.1 58.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.418 -0.801 . . . . 0.0 109.803 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.721 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -75.93 -28.65 58.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.836 . . . . 0.0 109.7 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -69.39 -42.74 74.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -72.22 -37.76 69.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.119 -0.988 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.949 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.9 t80 -73.66 -22.43 59.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.32 -0.863 . . . . 0.0 109.836 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.721 HD11 ' CE1' ' A' ' 15' ' ' HIS . 10.6 mt -83.2 -39.07 21.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.804 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.36 -23.78 50.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.053 -1.029 . . . . 0.0 109.189 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.85 -39.52 50.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.244 -0.91 . . . . 0.0 109.011 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 35' ' ' ILE . 17.4 t -71.36 -47.35 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 108.605 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.29 -40.67 86.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -56.7 -27.74 59.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.532 -0.73 . . . . 0.0 109.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.964 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.2 mt -105.19 -7.78 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.4 110.7 1.1 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -48.55 -23.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -1.131 . . . . 0.0 109.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.52 -45.88 71.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.76 . . . . 0.0 110.023 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -111.49 14.53 21.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.605 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.72 117.24 18.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 110.008 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -110.44 160.84 27.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.38 -26.86 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.28 1.986 . . . . 0.0 110.26 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 7.3 tmtt? -68.53 -50.96 48.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.1 mmtt -69.36 -42.58 75.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -63.34 -25.28 38.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.75 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.813 HD22 ' CG ' ' A' ' 46' ' ' ARG . 17.1 tp -52.48 -36.76 55.65 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.45 -33.12 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.25 -35.15 74.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.536 -0.727 . . . . 0.0 109.597 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.448 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.3 mmt -79.0 -48.08 15.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.371 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t30 53.36 23.54 3.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.022 ' HB ' HD12 ' A' ' 44' ' ' LEU . 18.8 t -86.77 158.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.08 148.78 24.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.187 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.7 ttmt 77.0 -2.95 2.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.022 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.5 mt -101.57 95.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -90.89 176.95 6.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.813 ' CG ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -72.75 -18.98 61.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -34.23 42.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -73.53 -38.49 65.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 109.574 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -82.97 -25.9 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.196 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -69.78 -22.14 63.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.415 -0.803 . . . . 0.0 109.308 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 m -74.55 -49.34 22.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -55.45 -29.0 57.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.835 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.459 0.647 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 14' ' ' LEU . 67.7 mt -64.98 -19.56 66.04 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.551 -0.718 . . . . 0.0 109.742 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.621 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 70.2 t60 -79.51 -22.33 44.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -0.922 . . . . 0.0 109.297 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -71.31 -28.39 64.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.563 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -80.43 -38.68 29.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.021 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.8 t80 -75.7 -24.13 56.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 11.8 mt -75.84 -41.69 51.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.536 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.09 -24.65 59.51 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.13 -0.982 . . . . 0.0 109.347 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.27 -41.86 39.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -66.61 -45.49 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.931 . . . . 0.0 108.889 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -61.62 -45.28 94.74 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.547 0.689 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -62.6 -23.4 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.462 -0.774 . . . . 0.0 110.205 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.2 mt -107.89 -3.45 18.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 109.847 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.36 107.64 0.16 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 8.0 p -51.5 -21.01 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -1.12 . . . . 0.0 109.52 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.8 -45.07 91.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -116.75 13.81 15.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 27' ' ' VAL . . . -83.21 118.53 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.083 -1.01 . . . . 0.0 109.714 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -105.6 160.02 27.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 108.927 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.55 -26.21 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.406 2.07 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.85 -51.02 44.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 109.242 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' A' ' 31' ' ' VAL . 62.6 mttm -69.81 -41.42 75.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.085 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.994 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.65 -24.76 35.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.54 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 46' ' ' ARG . 27.2 tp -52.99 -38.84 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.22 -35.18 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.5 mt -58.09 -32.69 68.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 109.599 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.33 -43.37 67.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.469 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.84 26.98 8.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.951 . . . . 0.0 109.041 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.969 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.6 t -97.13 148.09 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.138 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.8 p-10 -84.33 148.35 26.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.87 -0.9 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.75 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.969 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -100.16 110.22 22.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.132 -0.98 . . . . 0.0 109.392 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -96.21 172.14 8.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.754 ' HB3' HD22 ' A' ' 36' ' ' LEU . 4.4 ptt180 -76.64 -17.89 58.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.923 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.78 -34.5 60.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -65.4 -38.76 90.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.14 -25.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.062 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.33 -28.02 63.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.845 . . . . 0.0 109.349 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -70.55 -50.51 36.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.853 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.34 -32.01 68.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.07 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.0 tp . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.25 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 14' ' ' LEU . 11.6 mt -54.59 -24.53 21.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.924 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.4 t60 -72.43 -36.83 68.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -71.37 -25.14 62.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.861 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -79.55 -41.68 26.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.987 ' O ' HG23 ' A' ' 22' ' ' VAL . 63.0 t80 -70.06 -23.57 63.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.924 HD11 ' CE1' ' A' ' 15' ' ' HIS . 23.2 mt -80.32 -43.84 20.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.962 . . . . 0.0 109.53 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -22.7 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.112 -0.993 . . . . 0.0 109.262 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.059 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.34 -43.94 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 0.0 108.707 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.0 t -64.01 -47.9 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.88 . . . . 0.0 108.915 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -59.52 -44.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.608 0.718 . . . . 0.0 109.137 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -58.14 -23.34 54.78 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.035 HD11 HD11 ' A' ' 38' ' ' LEU . 2.9 mt -110.16 -4.9 15.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.994 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.84 109.11 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.88 -19.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -1.068 . . . . 0.0 109.798 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 -45.45 75.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.51 14.03 15.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 109.897 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -72.1 105.4 3.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 34' ' ' LYS . 5.9 m -93.17 160.46 33.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.009 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 35.0 Cg_endo -76.86 -29.2 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.426 2.084 . . . . 0.0 110.068 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 6.7 tmtt? -65.84 -49.6 67.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.208 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.0 mtpt -67.36 -45.01 77.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.039 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -62.8 -23.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.698 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 46' ' ' ARG . 55.3 tp -53.81 -36.93 63.01 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -74.79 -31.43 61.74 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.059 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.7 mt -59.74 -32.76 70.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 41' ' ' VAL . 42.2 mmm -84.36 -49.99 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.817 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.9 t30 51.55 23.65 1.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 108.932 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.034 ' HB ' HD12 ' A' ' 44' ' ' LEU . 8.7 t -82.05 151.93 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.708 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.78 150.03 23.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.569 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 77.17 -2.35 2.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.661 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.034 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.9 mt -99.04 104.09 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -82.73 162.67 21.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HB3' HD22 ' A' ' 36' ' ' LEU . 23.2 ptt180 -69.6 -19.04 63.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.965 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -26.49 38.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.7 -41.53 71.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.24 -30.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.35 -20.01 62.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -75.79 -50.06 16.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.862 . . . . 0.0 109.227 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -57.11 -31.23 65.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.209 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.3 tp . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' CE ' ' A' ' 39' ' ' MET . 10.5 mt -62.76 -20.19 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 110.101 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.75 ' CE1' HD11 ' A' ' 19' ' ' LEU . 6.5 t-80 -78.72 -22.57 46.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.778 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -75.29 -41.05 58.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.055 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.2 t80 -69.21 -22.2 63.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.439 -0.788 . . . . 0.0 109.723 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.75 HD11 ' CE1' ' A' ' 15' ' ' HIS . 20.0 mt -81.05 -44.38 18.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.98 59.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.954 -1.091 . . . . 0.0 109.165 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.981 ' CB ' HD13 ' A' ' 38' ' ' LEU . . . -77.29 -43.49 33.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 0.0 109.104 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -64.64 -43.69 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 108.969 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -57.92 -43.31 86.14 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.644 0.735 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -62.0 -23.11 66.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.316 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -111.04 -2.34 15.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.0 110.195 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 108.59 0.31 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.27 -18.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -1.069 . . . . 0.0 109.892 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -65.87 -47.28 75.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.785 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 mtp85 -117.08 13.85 14.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -63.07 119.23 9.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 34' ' ' LYS . 10.7 m -105.48 159.97 27.65 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.2 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.344 2.029 . . . . 0.0 110.036 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 1.4 tmtt? -70.16 -43.84 70.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.57 -46.32 63.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.328 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.972 ' HA ' HD12 ' A' ' 38' ' ' LEU . 2.9 mt -64.69 -25.7 38.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.277 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 46' ' ' ARG . 24.5 tp -52.29 -34.57 47.31 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.1 -34.69 59.51 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.981 HD13 ' CB ' ' A' ' 21' ' ' ALA . 4.0 mt -57.92 -33.87 69.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.694 -0.629 . . . . 0.0 109.665 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 41' ' ' VAL . 26.9 mtp -86.43 -47.4 9.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.85 23.89 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 44' ' ' LEU . 45.2 t -77.98 157.82 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 0.0 109.543 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 p30 -84.14 143.44 29.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 75.9 4.47 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.541 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 mt -111.75 100.59 9.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.505 ' C ' HD13 ' A' ' 36' ' ' LEU . 22.1 p -94.03 169.89 9.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.388 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -59.96 -23.27 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.269 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 44.3 tp10 -73.57 -32.62 64.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.339 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.25 -34.73 78.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.45 -30.35 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.888 . . . . 0.0 109.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.42 -20.12 60.16 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.361 -0.837 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -75.95 -48.48 21.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.119 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -58.6 -37.75 76.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.012 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.285 0.564 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 1' ' ' THR . . . 176.81 167.06 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -50.06 -179.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 5.4 tttt -155.58 55.2 0.62 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.576 ' CG ' HG22 ' A' ' 8' ' ' VAL . 9.7 ptpt -85.9 135.77 37.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 109.299 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 36.2 Cg_endo -78.69 136.2 13.43 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.487 2.125 . . . . 0.0 110.541 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 38.6 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.707 . . . . 0.0 110.062 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG22 ' CG ' ' A' ' 5' ' ' LYS . 12.0 t -67.92 125.19 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.32 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -91.26 -53.54 4.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -160.86 79.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.454 ' OG1' ' CG1' ' A' ' 8' ' ' VAL . 33.1 p -113.34 175.45 5.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.482 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -56.93 -20.5 23.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.74 -59.71 2.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 41' ' ' VAL . 10.5 mt -58.58 -19.99 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.911 ' CE1' HD11 ' A' ' 19' ' ' LEU . 46.8 t-80 -80.41 -30.26 37.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.691 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.55 -33.27 66.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD2' HD23 ' A' ' 14' ' ' LEU . 75.0 mttt -73.83 -42.62 60.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.4 t80 -67.28 -22.57 65.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.873 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 15' ' ' HIS . 43.6 mt -81.53 -44.88 16.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.672 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.74 -19.96 60.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.123 -0.986 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.032 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.56 -38.87 33.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -0.953 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 18' ' ' PHE . 18.7 t -71.26 -47.14 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.57 -43.14 97.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.585 0.707 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -58.92 -22.84 60.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 38' ' ' LEU . 2.7 mt -112.54 -1.73 14.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.6 107.59 0.29 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.62 -19.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -1.091 . . . . 0.0 109.771 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.21 -43.34 70.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -116.8 14.24 15.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.027 . . . . 0.0 110.101 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.6 120.16 23.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.5 m -100.63 157.18 34.2 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 108.969 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.9 Cg_endo -77.23 -24.11 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.404 2.069 . . . . 0.0 110.144 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.12 -52.98 28.72 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.225 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.726 ' H ' HG23 ' A' ' 31' ' ' VAL . 20.2 mmtp -67.99 -41.83 81.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.153 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -64.53 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.608 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 46' ' ' ARG . 43.2 tp -53.5 -35.72 60.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.49 -33.72 67.16 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.032 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.4 mt -57.31 -38.48 74.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.425 -0.797 . . . . 0.0 109.045 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mmt -73.55 -51.47 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 t30 56.39 26.4 10.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 21.7 t -94.0 154.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 16.6 p30 -80.3 146.82 31.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.316 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 77.19 -2.23 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.6 mt -102.35 119.24 38.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 109.485 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.86 -179.99 3.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.504 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 36' ' ' LEU . 3.8 ptt-85 -77.07 -26.95 54.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 75.2 tt0 -72.53 -23.01 60.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -76.42 -36.46 58.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.45 -25.9 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 0.0 109.151 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.4 56.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.324 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -77.91 -46.15 22.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -63.66 -30.33 71.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -71.55 -48.39 48.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -68.56 -19.26 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -79.91 -28.07 39.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.832 ' CE2' HD11 ' A' ' 60' ' ' LEU . 22.0 t80 -71.01 -46.41 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.44 -40.42 71.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.6 t -64.7 -38.7 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.567 ' O ' HG13 ' A' ' 63' ' ' VAL . . . -74.44 -12.22 60.44 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.832 HD11 ' CE2' ' A' ' 56' ' ' PHE . 5.7 mt -91.07 -27.27 18.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -61.16 -81.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -87.29 103.91 15.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.583 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -128.93 106.73 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.441 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.419 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.5 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 1' ' ' THR . . . 66.18 -178.42 0.2 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 152.19 29.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 3.9 mmtt -120.62 76.02 1.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.855 ' HG2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER 60.88 98.65 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' ARG . 36.6 Cg_endo -80.83 120.47 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.666 2.244 . . . . 0.0 110.262 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 6' ' ' PRO . 4.4 mtt180 43.58 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.855 HG22 ' HG2' ' A' ' 5' ' ' LYS . 58.3 t -51.53 117.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.963 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 7.0 tp -91.48 -38.55 12.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 108.809 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 7.4 m95 -169.85 76.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.074 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.724 HG23 HG13 ' A' ' 8' ' ' VAL . 51.6 p -111.06 176.09 5.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 109.588 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -57.97 -20.28 36.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.688 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -59.46 2.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.754 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.795 HD12 HG12 ' A' ' 8' ' ' VAL . 9.7 mt -62.26 -19.16 62.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 109.811 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 1.8 t60 -79.96 -23.83 41.39 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -71.7 -28.91 64.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -79.01 -47.95 15.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.133 -0.979 . . . . 0.0 109.139 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.997 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.2 t80 -69.86 -22.21 63.28 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 19' ' ' LEU . 12.4 mt -78.54 -39.45 37.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 109.74 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.88 -24.34 55.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.192 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.91 -43.66 34.71 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 108.737 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.7 t -65.38 -46.44 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 108.814 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.58 -44.79 95.81 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.522 0.677 . . . . 0.0 109.391 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -59.49 -23.09 62.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 0.0 109.918 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 38' ' ' LEU . 4.7 mt -107.25 -7.03 16.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.02 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.78 108.94 0.55 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.1 -18.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.46 -46.58 79.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 13.66 15.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.8 108.93 8.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 17.2 m -96.66 160.11 30.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 109.037 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.99 9.98 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.443 2.096 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -69.65 -48.81 58.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.347 -0.845 . . . . 0.0 109.302 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 66.8 mmtt -69.9 -42.89 72.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 109.18 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.993 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -65.9 -24.68 34.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.031 -1.043 . . . . 0.0 108.433 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 46' ' ' ARG . 19.0 tp -54.65 -32.6 59.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.21 -32.05 55.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 25' ' ' LEU . 5.1 mt -60.12 -36.45 77.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.592 -0.693 . . . . 0.0 109.598 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.46 -46.73 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.97 . . . . 0.0 109.739 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 t30 51.28 24.87 2.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 108.885 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.986 ' HB ' HD12 ' A' ' 44' ' ' LEU . 76.8 t -78.95 157.82 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.556 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.3 p-10 -90.34 146.26 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 ttmt 77.03 -2.25 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.1 mt -95.36 107.26 19.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 109.364 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -88.97 175.97 7.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HG3' HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -78.75 -24.95 44.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.765 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -22.97 54.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.583 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.93 -43.68 64.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.697 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG1' ' CE1' ' A' ' 18' ' ' PHE . 76.6 t -83.45 -26.59 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.19 -20.02 57.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 m -78.12 -45.61 22.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.73 -26.6 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 109.241 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.7 tp -81.05 -22.3 39.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -79.36 -29.28 42.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.683 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.73 -24.8 33.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.678 ' CE2' HD11 ' A' ' 60' ' ' LEU . 25.1 t80 -80.65 -48.64 12.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.232 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -40.49 75.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 42.7 t -65.8 -30.79 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.25 -11.85 57.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.678 HD11 ' CE2' ' A' ' 56' ' ' PHE . 11.3 mt -97.82 4.42 49.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 7.6 pttt -95.76 -12.34 25.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.671 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.494 ' HD3' ' HG2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -130.34 -33.05 1.72 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.764 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.574 HG11 HD23 ' A' ' 60' ' ' LEU . 8.6 p -53.39 155.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.326 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.423 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 3' ' ' GLN . . . -96.84 136.2 37.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 1.2 mp0 66.47 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 174.22 1.4 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 57.32 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' ARG . 34.8 Cg_endo -76.85 150.82 30.86 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.449 2.099 . . . . 0.0 110.391 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 6' ' ' PRO . 2.0 ptm180 -42.62 110.36 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.602 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.86 HG12 HD11 ' A' ' 14' ' ' LEU . 2.5 t -95.49 106.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 109.218 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 14.8 tp -107.09 -51.4 2.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.322 -0.861 . . . . 0.0 109.306 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 34.5 m95 -164.17 74.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.2 p -113.78 174.88 5.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.51 -30.89 5.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -51.52 47.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.166 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD11 HG12 ' A' ' 8' ' ' VAL . 11.9 mt -62.03 -23.1 66.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.442 -0.786 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 1.068 ' CE1' HD11 ' A' ' 19' ' ' LEU . 10.8 t-160 -71.62 -26.5 62.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.01 -37.61 72.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -72.85 -47.51 45.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 22' ' ' VAL . 62.9 t80 -68.93 -22.29 64.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.068 HD11 ' CE1' ' A' ' 15' ' ' HIS . 21.8 mt -82.15 -39.67 22.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.912 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.17 -22.57 44.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.112 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.35 -41.24 28.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 108.834 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 18' ' ' PHE . 28.3 t -70.59 -45.75 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.94 -43.72 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.15 -23.22 62.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.529 -0.732 . . . . 0.0 109.688 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mt -112.61 -0.57 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.817 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.18 107.16 0.19 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 9.5 p -52.28 -19.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -1.057 . . . . 0.0 109.921 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 -42.28 65.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -116.84 14.48 15.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -89.22 133.45 34.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.8 m -115.89 160.24 36.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.397 -0.814 . . . . 0.0 109.069 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.6 Cg_endo -76.18 -17.27 17.17 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.47 2.113 . . . . 0.0 110.253 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -71.54 -54.79 9.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.171 -0.956 . . . . 0.0 109.31 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -68.7 -38.47 80.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.218 -0.927 . . . . 0.0 108.838 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.003 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -63.43 -25.34 38.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.575 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 46' ' ' ARG . 23.1 tp -51.75 -36.2 46.38 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -73.34 -35.12 65.97 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.003 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.0 mt -58.01 -35.77 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.554 -0.716 . . . . 0.0 109.336 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.0 mmm -78.98 -51.28 9.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.94 25.75 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 44' ' ' LEU . 72.8 t -82.27 146.54 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.295 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.0 p30 -80.32 145.92 31.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.57 0.75 3.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.658 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 41' ' ' VAL . 4.0 mm? -103.11 137.55 41.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.65 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -118.46 173.85 6.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' HD22 ' A' ' 36' ' ' LEU . 1.4 ptt180 -77.85 -19.72 54.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.18 -43.21 53.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.51 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -61.65 -36.42 80.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.31 -25.22 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.18 -20.7 57.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -77.96 -45.73 23.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -62.45 -26.22 68.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.4 tp -76.19 -29.23 57.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -77.29 -26.43 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.44 -38.49 34.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.701 ' CE2' HD11 ' A' ' 60' ' ' LEU . 11.3 t80 -64.82 -43.87 91.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.396 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -58.1 -40.86 82.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.973 . . . . 0.0 108.38 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 56.1 t -65.39 -30.79 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.552 ' O ' HG12 ' A' ' 63' ' ' VAL . . . -84.01 -11.75 56.3 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD11 ' CE2' ' A' ' 56' ' ' PHE . 7.7 mt -91.01 4.52 51.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.486 -0.759 . . . . 0.0 109.936 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 13.9 pttp -98.12 -22.92 15.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 109.545 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 68.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.5 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 59' ' ' ALA . 22.0 m -88.42 149.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.402 ' OXT' ' O ' ' A' ' 63' ' ' VAL . 11.0 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.39 120.01 13.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.463 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -130.04 75.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.1 75.18 1.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 61.45 132.42 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.49 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.468 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 35.6 Cg_endo -78.25 130.05 9.91 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.444 2.096 . . . . 0.0 110.362 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' PRO . 9.1 ptp180 -43.77 131.65 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.709 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.763 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.6 t -129.7 83.02 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.19 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 7.4 tp -108.78 -27.49 9.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.125 -0.984 . . . . 0.0 108.657 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 3.0 m95 -174.1 67.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.8 p -113.53 175.8 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.855 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -50.42 -28.37 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.784 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.77 -55.31 7.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.408 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 8' ' ' VAL . 10.2 mt -62.56 -19.64 63.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.758 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.4 t60 -80.69 -25.38 38.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.93 -34.23 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -0.927 . . . . 0.0 109.476 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -78.54 -40.61 34.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.208 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.982 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.8 t80 -74.07 -22.61 59.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.758 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.6 mt -82.48 -37.44 25.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.27 -24.94 51.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.106 -0.996 . . . . 0.0 109.296 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.853 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.93 -39.7 55.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.1 t -68.51 -47.37 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 108.879 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.57 -41.75 90.91 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.566 0.698 . . . . 0.0 109.187 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -56.09 -25.86 47.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 109.606 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.983 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.8 mt -109.32 -6.19 15.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 110.031 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 110.25 0.77 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.17 -19.0 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -1.073 . . . . 0.0 109.831 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.23 48.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -111.08 14.42 21.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 0.0 109.822 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.38 134.42 36.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.997 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -120.99 160.55 44.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 108.951 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.72 -24.7 11.47 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.371 2.048 . . . . 0.0 110.208 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.91 -53.82 18.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.362 -0.836 . . . . 0.0 109.062 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 33' ' ' LYS . 2.0 mmtp -67.59 -40.21 84.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.324 -0.86 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.015 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.1 -26.3 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.655 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.046 HD22 ' HB2' ' A' ' 46' ' ' ARG . 47.9 tp -52.51 -36.3 55.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.11 -34.22 63.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.3 mt -58.99 -34.41 71.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 109.406 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.444 ' HB3' HG23 ' A' ' 41' ' ' VAL . 64.1 mmm -80.85 -51.49 8.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.17 23.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 108.936 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.949 ' HB ' HD12 ' A' ' 44' ' ' LEU . 20.5 t -80.65 156.83 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.485 -0.759 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 26.5 p30 -88.07 146.54 25.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 76.06 1.78 3.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.949 HD12 ' HB ' ' A' ' 41' ' ' VAL . 14.2 mt -106.16 117.71 34.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.516 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.39 167.97 9.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 1.046 ' HB2' HD22 ' A' ' 36' ' ' LEU . 38.6 ttp180 -76.24 -21.47 56.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.27 -29.43 48.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -68.59 -42.18 78.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.409 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 -25.09 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.33 -20.51 62.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 m -80.79 -42.03 22.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.892 . . . . 0.0 109.507 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -75.4 -28.26 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -80.84 -22.96 39.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -79.56 -38.11 34.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.39 -26.52 55.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' HD11 ' A' ' 60' ' ' LEU . 13.0 t80 -77.67 -46.62 21.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.403 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -58.02 -42.06 84.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.93 -37.87 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.25 60.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.62 HD11 ' CE2' ' A' ' 56' ' ' PHE . 11.4 mt -98.29 -15.41 19.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.6 -29.53 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -74.38 -61.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 63' ' ' VAL . 7.3 p -48.95 127.59 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.504 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.33 0.586 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 1' ' ' THR . . . 165.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -110.42 124.81 52.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.401 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 136.79 19.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.775 ' HD2' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -136.74 99.91 10.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.331 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' ARG . 34.9 Cg_endo -76.96 115.22 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.526 2.15 . . . . 0.0 110.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER 45.22 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.782 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.2 t -88.15 87.84 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.117 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 13.0 tp -108.81 -24.56 11.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.26 -0.9 . . . . 0.0 109.004 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 13.2 m95 -171.74 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 108.883 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -113.54 175.42 5.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -47.74 -29.24 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 109.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.59 -53.65 15.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 8' ' ' VAL . 11.4 mt -62.51 -20.26 64.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.022 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.718 ' CE1' HD11 ' A' ' 19' ' ' LEU . 17.3 t-160 -79.05 -22.39 45.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 109.921 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -77.34 -31.04 54.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -77.09 -42.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.3 t80 -73.36 -25.48 60.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.8 mt -82.2 -33.87 29.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.717 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 -22.96 45.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.134 -0.979 . . . . 0.0 109.359 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -78.46 -41.23 33.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.234 -0.916 . . . . 0.0 108.644 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.5 t -65.69 -47.97 84.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.15 -44.81 95.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.666 -0.646 . . . . 0.0 109.332 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -61.43 -22.93 65.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.771 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -108.16 -3.92 18.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.768 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.53 108.52 0.81 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 22' ' ' VAL . 11.4 p -54.56 -18.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -1.094 . . . . 0.0 109.738 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.82 -46.79 77.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.83 13.75 15.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.582 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.85 97.47 4.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.707 HG23 ' H ' ' A' ' 34' ' ' LYS . 33.1 m -90.48 159.88 40.45 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.279 -0.888 . . . . 0.0 108.923 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.99 -22.08 13.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.292 1.995 . . . . 0.0 109.936 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.11 -51.6 44.44 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.266 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.707 ' H ' HG23 ' A' ' 31' ' ' VAL . 23.1 mmtm -69.28 -44.39 71.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.154 -0.967 . . . . 0.0 108.951 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.977 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.9 mt -63.05 -23.49 33.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.08 -1.013 . . . . 0.0 108.606 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.757 HD22 ' HB2' ' A' ' 46' ' ' ARG . 29.4 tp -52.74 -39.37 62.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -36.49 68.86 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.012 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.6 mt -57.37 -29.38 64.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.532 -0.73 . . . . 0.0 109.254 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.0 mtp -83.25 -49.58 9.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 53.84 24.98 4.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.213 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.947 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.7 t -84.5 144.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -81.33 147.82 29.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 9.8 ttpt 78.05 -3.16 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.583 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.947 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.2 mt -99.47 109.56 22.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 p -89.27 169.89 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.757 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.27 -23.57 54.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -32.08 62.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -68.07 -35.61 78.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.462 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 32' ' ' PRO . 95.7 t -83.25 -25.74 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.99 -24.13 48.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.253 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.8 m -76.36 -44.27 37.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.334 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -62.74 -30.46 71.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.19 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.4 tp -75.19 -23.79 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 8.7 mm100 -68.75 -32.88 72.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.842 . . . . 0.0 109.565 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -76.43 -29.38 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HD11 ' A' ' 60' ' ' LEU . 9.7 t80 -74.36 -41.53 60.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 109.264 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -64.02 -45.49 88.7 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 92.7 t -65.28 -31.33 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.919 ' O ' HG12 ' A' ' 63' ' ' VAL . . . -82.65 -12.41 57.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.695 HD11 ' CE2' ' A' ' 56' ' ' PHE . 12.3 mt -92.31 4.34 53.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.546 -0.721 . . . . 0.0 109.493 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.3 pttt -81.47 -11.28 59.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -137.92 -48.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.919 HG12 ' O ' ' A' ' 59' ' ' ALA . 4.3 p -68.99 170.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.498 ' H ' HG22 ' A' ' 63' ' ' VAL . 52.3 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.485 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.38 71.36 0.87 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.372 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' LYS . 3.7 mt-30 -84.71 159.96 20.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' GLN . 22.3 mttt -52.83 -173.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -75.81 121.02 84.24 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.173 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 8' ' ' VAL . 36.2 Cg_endo -77.55 154.57 31.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.409 2.072 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -43.68 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.341 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 14' ' ' LEU . 41.1 t -82.66 117.37 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 109.781 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.603 ' O ' ' CD2' ' A' ' 10' ' ' TRP . 22.2 tp -93.44 -60.44 1.78 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 11.4 m95 -150.26 76.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' HIS . 22.8 p -113.76 175.82 5.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.11 -0.994 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 2.0 m170 -53.82 -21.14 6.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.22 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.62 -58.2 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.667 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD12 ' HB ' ' A' ' 8' ' ' VAL . 9.2 mt -82.33 -55.39 4.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.956 ' CD2' HD11 ' A' ' 19' ' ' LEU . 81.6 t60 -45.65 -25.19 0.44 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.687 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 10.6 m-20 -68.19 -48.81 64.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 109.673 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -68.25 -35.15 77.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.994 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.7 t80 -69.95 -25.98 63.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.956 HD11 ' CD2' ' A' ' 15' ' ' HIS . 45.9 mt -77.7 -44.36 28.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -24.63 61.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 108.926 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.697 ' HA ' HD22 ' A' ' 38' ' ' LEU . . . -74.27 -40.57 62.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.994 HG23 ' O ' ' A' ' 18' ' ' PHE . 16.4 t -69.51 -46.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.0 108.906 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.33 -40.25 85.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.412 ' ND1' ' C ' ' A' ' 24' ' ' HIS . 8.4 t-80 -54.82 -27.54 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.518 -0.739 . . . . 0.0 109.354 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.978 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.5 mt -106.53 -9.03 16.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.99 111.39 2.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.9 -18.33 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -1.098 . . . . 0.0 110.088 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.58 -43.19 39.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.216 -0.928 . . . . 0.0 110.648 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -116.72 14.87 15.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 110.257 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -69.22 124.06 22.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.984 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 23.2 m -106.17 160.4 26.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 108.994 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.8 Cg_endo -76.59 -23.57 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.347 2.031 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -69.36 -52.72 24.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.401 -0.812 . . . . 0.0 109.382 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 14.2 mtpp -67.13 -38.97 86.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -0.86 . . . . 0.0 109.354 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.95 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -67.23 -24.72 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.999 -1.063 . . . . 0.0 108.863 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 46' ' ' ARG . 58.0 tp -54.09 -38.97 65.9 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -74.37 -35.85 63.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.978 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.3 mt -57.21 -28.79 63.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.589 -0.694 . . . . 0.0 109.343 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.8 mmm -82.54 -43.94 16.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 0.2 OUTLIER 50.85 23.77 1.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.014 ' HB ' HD12 ' A' ' 44' ' ' LEU . 93.7 t -87.48 155.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.559 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.6 p-10 -90.1 140.71 29.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER 80.22 -8.48 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.528 -0.732 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.014 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.5 mt -84.2 125.37 32.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.96 -1.088 . . . . 0.0 109.152 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 p -109.34 158.91 17.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -78.17 -17.79 56.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.412 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -74.13 -22.91 59.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -80.47 -37.7 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.619 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.543 HG22 ' CZ2' ' A' ' 10' ' ' TRP . 69.0 t -83.02 -24.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.35 -39.39 59.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -72.12 -38.5 69.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.516 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 56' ' ' PHE . 10.3 t-80 -70.04 -25.98 63.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.126 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.56 -47.61 46.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.9 61.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.507 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -83.27 -23.3 32.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.671 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 32.7 t80 -73.34 -41.78 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.29 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.685 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -61.95 -43.62 98.47 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.97 -34.47 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -11.8 59.79 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 57' ' ' ARG . 9.7 mt -79.2 5.16 12.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.475 -0.765 . . . . 0.0 109.62 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -93.41 -27.17 16.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.97 59.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.743 ' O ' HG13 ' A' ' 63' ' ' VAL . 11.4 p -121.42 75.55 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.459 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 3' ' ' GLN . . . -134.96 83.98 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 71.71 139.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.605 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' LYS . 4.0 mtpp -129.05 73.65 1.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.963 ' HG2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER 50.96 99.37 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.53 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 7' ' ' ARG . 36.4 Cg_endo -79.47 114.68 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.561 2.174 . . . . 0.0 110.432 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' PRO . 14.2 mtt180 52.51 105.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.822 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.963 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.8 t -90.54 114.31 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.103 -0.998 . . . . 0.0 109.635 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.592 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 16.6 tp -106.04 -35.96 7.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.163 -0.96 . . . . 0.0 108.889 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 8.3 m95 -170.82 70.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.54 HG21 ' HE2' ' A' ' 5' ' ' LYS . 40.8 p -113.75 175.92 5.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 1.1 t-160 -54.13 -22.84 12.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.786 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -78.13 -61.34 2.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.439 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.607 HD12 HG12 ' A' ' 8' ' ' VAL . 10.2 mt -57.79 -19.58 29.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.883 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.875 ' NE2' HD11 ' A' ' 19' ' ' LEU . 4.7 t60 -75.8 -32.94 60.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 12' ' ' HIS . 4.8 m-80 -67.42 -30.36 70.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HD2' HD23 ' A' ' 14' ' ' LEU . 16.7 mttm -78.71 -38.12 39.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.955 ' O ' HG23 ' A' ' 22' ' ' VAL . 60.7 t80 -75.19 -23.22 57.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.676 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.875 HD11 ' NE2' ' A' ' 15' ' ' HIS . 4.5 mt -82.48 -36.54 26.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.66 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.31 -24.5 50.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.7 -43.32 38.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 108.768 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.5 t -67.16 -45.7 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -59.54 -43.54 93.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -58.61 -23.22 58.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.534 -0.728 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -112.83 -1.66 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.02 107.19 0.49 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 22' ' ' VAL . 8.1 p -54.41 -18.58 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -1.146 . . . . 0.0 109.748 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -46.79 74.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.949 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -116.8 14.01 15.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.0 109.919 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.567 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -70.05 125.61 27.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.772 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 34' ' ' LYS . 16.7 m -109.66 160.04 29.37 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.316 -0.865 . . . . 0.0 108.932 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.47 -19.25 15.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.41 2.074 . . . . 0.0 110.046 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -70.54 -55.13 9.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.397 -0.814 . . . . 0.0 109.03 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 31' ' ' VAL . 16.7 mttp -67.92 -39.47 83.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.951 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -68.0 -25.32 31.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.091 -1.043 . . . . 0.0 108.562 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 46' ' ' ARG . 25.8 tp -53.63 -38.33 63.96 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.1 -35.64 66.64 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.4 mt -57.66 -31.39 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.627 -0.67 . . . . 0.0 109.419 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.413 ' SD ' HD13 ' A' ' 44' ' ' LEU . 3.3 mtt -79.96 -53.24 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t30 55.17 27.0 8.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.202 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.97 ' HB ' HD12 ' A' ' 44' ' ' LEU . 24.5 t -88.31 157.52 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -90.27 140.87 29.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 81.84 -7.44 1.39 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 110.033 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.97 HD12 ' HB ' ' A' ' 41' ' ' VAL . 16.9 mt -90.58 136.99 32.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -114.0 164.26 14.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.554 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.853 ' HB2' HD22 ' A' ' 36' ' ' LEU . 32.7 ttp85 -78.73 -31.37 46.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.94 -22.87 63.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.418 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 3.9 m-20 -72.24 -36.52 69.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.12 -27.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.226 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.17 63.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.304 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.69 -50.26 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.378 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -54.39 -28.68 45.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 108.964 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.87 -35.33 64.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -63.41 -35.69 81.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -56.82 -32.81 66.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.897 ' CE2' HD11 ' A' ' 60' ' ' LEU . 47.8 t80 -69.29 -49.07 59.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.156 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -53.04 -38.12 62.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.45 -41.38 92.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.45 -12.43 61.39 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.897 HD11 ' CE2' ' A' ' 56' ' ' PHE . 12.4 mt -91.37 -13.6 32.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.465 -0.772 . . . . 0.0 109.41 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 62' ' ' LYS . 66.4 tttt -68.56 -35.0 76.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -45.02 -26.99 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.396 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 60' ' ' LEU . 7.3 p -59.83 142.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.99 -176.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.65 134.34 47.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 4.3 mmpt? -52.72 -179.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -109.62 100.55 42.67 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.385 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 4' ' ' LYS . 34.6 Cg_endo -77.5 152.91 30.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.394 2.063 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.453 ' NH2' HD13 ' A' ' 9' ' ' LEU . 4.0 mmm-85 -43.07 100.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.76 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.2 t -86.95 89.92 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.96 . . . . 0.0 109.072 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 5.4 tp -99.91 -41.71 7.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.141 -0.974 . . . . 0.0 108.466 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.681 ' HZ2' HG13 ' A' ' 49' ' ' VAL . 5.7 m95 -168.0 70.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p -103.95 175.78 5.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 109.815 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 -27.78 5.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.63 -56.55 4.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.649 HD11 HG12 ' A' ' 8' ' ' VAL . 8.4 mt -60.88 -19.26 59.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 1.126 ' CE1' HD11 ' A' ' 19' ' ' LEU . 10.0 t-160 -77.33 -26.05 51.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.915 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.69 -43.69 53.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.75 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -78.39 -33.82 48.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 108.836 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.972 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.1 t80 -76.59 -23.19 53.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.35 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.126 HD11 ' CE1' ' A' ' 15' ' ' HIS . 13.7 mt -78.79 -37.77 40.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 109.628 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.81 50.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.142 -0.974 . . . . 0.0 108.902 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.41 -43.43 40.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.312 -0.867 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 18' ' ' PHE . 25.0 t -67.24 -45.76 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.733 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.96 -43.12 95.25 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.516 0.674 . . . . 0.0 109.262 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -58.28 -23.16 55.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.739 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.936 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -111.39 -4.49 14.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.152 -0.967 . . . . 0.0 110.067 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 110.05 1.08 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 22' ' ' VAL . 13.7 p -54.07 -18.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -1.116 . . . . 0.0 109.909 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 29' ' ' ARG . 8.7 pt-20 -80.16 -37.41 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.75 14.5 15.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.176 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.163 -0.961 . . . . 0.0 110.091 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.7 m -119.74 160.53 42.03 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.365 -0.835 . . . . 0.0 108.936 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.854 ' HD3' HD22 ' A' ' 53' ' ' LEU . 33.9 Cg_endo -75.64 -24.21 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.409 2.073 . . . . 0.0 110.005 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.1 -52.42 28.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.371 -0.831 . . . . 0.0 109.298 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 31' ' ' VAL . 13.4 mttt -69.18 -38.89 78.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.005 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -67.8 -24.78 31.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.082 -1.011 . . . . 0.0 108.61 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.007 HD22 ' HB3' ' A' ' 46' ' ' ARG . 20.3 tp -53.34 -37.92 62.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.99 -34.47 64.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.005 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -59.24 -31.64 69.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.442 -0.786 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.681 ' HB3' HG23 ' A' ' 41' ' ' VAL . 83.0 mmm -85.09 -50.26 7.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.7 t30 54.48 25.46 6.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.21 -0.932 . . . . 0.0 109.104 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.878 ' HB ' HD12 ' A' ' 44' ' ' LEU . 7.8 t -78.77 158.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.54 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 22.4 p30 -89.67 144.66 25.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 76.37 -0.5 3.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.878 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.4 mt -101.81 115.56 30.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 109.506 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -99.26 168.23 10.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 1.007 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.75 -18.23 60.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -32.94 61.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 ' HZ2' ' A' ' 10' ' ' TRP . 5.0 t -83.24 -25.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.134 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 32' ' ' PRO . . . -77.7 -20.85 52.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.281 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -76.63 -43.76 37.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 109.297 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -67.07 -30.75 70.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.854 HD22 ' HD3' ' A' ' 32' ' ' PRO . 5.8 tp -75.25 -41.57 57.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.435 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -67.71 -30.95 70.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -67.76 -27.46 66.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -72.61 -37.75 67.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.102 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 60' ' ' LEU . 6.8 mtp180 -63.95 -43.53 95.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 61' ' ' LYS . 42.8 t -64.39 -34.06 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.23 -12.34 59.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 57' ' ' ARG . 9.8 mt -80.2 -27.31 38.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.447 -0.783 . . . . 0.0 109.577 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 58' ' ' VAL . 1.4 ptmt -79.44 -0.74 34.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -111.21 6.75 20.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 63' ' ' VAL . 9.3 p -158.87 123.55 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 109.451 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.478 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.652 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 13.9 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 1' ' ' THR . . . 72.31 60.98 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.13 55.49 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -178.24 48.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' LYS . 26.5 tttt 56.32 109.69 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.657 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 7' ' ' ARG . 35.4 Cg_endo -76.91 155.4 34.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.474 2.116 . . . . 0.0 110.317 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 6' ' ' PRO . 7.6 ptm180 -40.59 116.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.814 . . . . 0.0 109.729 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.3 t -94.08 93.28 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 109.326 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.544 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 11.5 tp -108.3 -32.03 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.544 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 14.9 m95 -168.97 68.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.873 . . . . 0.0 109.185 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.93 174.22 6.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -48.99 -29.21 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.213 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' CG ' ' HE3' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -69.11 -54.06 16.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.1 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.555 HD11 HG12 ' A' ' 8' ' ' VAL . 11.9 mt -58.51 -20.08 42.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.58 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -78.58 -32.82 47.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.41 -38.25 65.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.763 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.409 ' HE3' ' CG ' ' A' ' 13' ' ' GLU . 74.2 mttt -74.33 -35.31 63.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.7 t80 -72.41 -26.88 62.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.883 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 19' ' ' LEU . 12.6 mt -80.54 -39.85 27.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -23.68 51.34 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.127 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.43 -41.8 38.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.867 . . . . 0.0 108.967 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -69.6 -45.11 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 108.658 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -59.57 -42.31 92.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.476 0.655 . . . . 0.0 109.236 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -57.49 -24.26 54.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -0.759 . . . . 0.0 109.676 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.048 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -110.47 -4.83 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.22 110.1 0.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 22' ' ' VAL . 6.3 p -53.94 -18.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -41.51 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -116.74 14.74 15.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -78.25 121.32 24.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.073 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.1 m -104.24 160.11 27.12 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 108.81 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.42 -25.76 9.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.355 2.037 . . . . 0.0 110.066 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.27 -50.26 54.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 12.6 mttm -68.16 -40.71 82.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.151 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.03 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -63.88 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.07 . . . . 0.0 108.681 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.6 tp -54.2 -35.0 61.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 3.0 p30 -78.99 -28.93 43.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.048 ' CD1' HD11 ' A' ' 25' ' ' LEU . 6.2 mt -63.36 -31.83 73.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.495 -0.753 . . . . 0.0 109.129 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 41' ' ' VAL . 1.8 mtt -89.12 -40.95 12.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 52.25 25.37 3.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 109.051 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 19.5 t -80.93 146.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 109.582 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 17.6 p-10 -89.82 149.92 22.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.344 -0.847 . . . . 0.0 109.516 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 79.07 -3.76 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -93.41 130.3 39.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.304 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -102.59 160.42 14.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -77.97 -21.97 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -29.97 62.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.41 -25.32 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.55 -21.73 48.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 m -78.95 -43.02 25.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -67.81 -27.39 66.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -74.6 -38.77 62.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -67.97 -40.87 83.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -72.35 -31.68 65.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 60' ' ' LEU . 14.0 t80 -65.77 -43.68 88.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.328 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -57.48 -41.04 79.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 108.334 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.98 -34.54 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.01 59.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -88.09 -11.81 46.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 109.525 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.4 5.07 4.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.538 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -12.58 10.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.7 p -75.19 131.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.443 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.3 177.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -114.34 51.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 3' ' ' GLN . 6.4 mttp 43.66 52.38 6.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.408 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -164.48 107.17 0.86 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 7' ' ' ARG . 34.7 Cg_endo -77.18 155.34 33.12 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.377 2.051 . . . . 0.0 110.11 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -40.24 103.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 109.687 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.767 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.2 t -65.46 87.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.585 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 8.5 tp -112.26 -27.53 8.29 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 14.9 m95 -169.3 60.61 0.05 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -114.08 175.82 5.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 30.2 t-80 -47.81 -22.05 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.697 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.77 -50.75 10.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.982 -1.074 . . . . 0.0 109.574 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.692 ' CD1' HG12 ' A' ' 8' ' ' VAL . 10.4 mt -85.05 -58.28 2.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.987 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.499 ' HE1' HD11 ' A' ' 19' ' ' LEU . 52.9 t-80 -49.46 -22.08 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 2.7 m120 -73.4 -42.24 62.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.51 -36.63 84.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 109.352 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.063 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.1 t80 -69.62 -32.92 71.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD11 ' HE1' ' A' ' 15' ' ' HIS . 11.5 mt -70.38 -45.49 65.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.11 70.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -70.79 -40.36 72.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.229 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -63.56 -48.16 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.28 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -59.18 -44.11 92.18 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 109.326 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.54 -22.89 65.55 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 110.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 38' ' ' LEU . 2.6 mt -110.45 -1.69 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.03 108.45 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 p -53.13 -19.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -1.107 . . . . 0.0 109.557 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.61 -44.06 83.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -116.94 13.16 14.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -0.999 . . . . 0.0 110.159 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -81.19 109.01 15.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.878 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.9 m -99.67 160.49 27.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 108.949 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.13 -27.32 8.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.434 2.089 . . . . 0.0 110.022 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.48 -48.42 64.51 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.471 -0.768 . . . . 0.0 109.248 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -70.17 -42.72 72.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.858 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -66.61 -24.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.014 -1.053 . . . . 0.0 108.634 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.948 HD22 ' HB3' ' A' ' 46' ' ' ARG . 10.8 tp -56.16 -31.02 62.99 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.61 -32.14 57.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 25' ' ' LEU . 52.1 mt -57.87 -37.91 74.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.113 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.775 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 mmm -84.37 -47.95 10.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.769 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 49.24 25.09 1.12 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 108.804 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.946 ' HB ' HD12 ' A' ' 44' ' ' LEU . 11.9 t -78.55 159.54 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.527 -0.733 . . . . 0.0 109.81 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.2 p-10 -86.18 147.72 25.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 109.223 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 78.9 -6.39 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 109.603 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.946 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.7 mt -102.86 102.64 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.447 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 p -91.73 169.25 10.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.948 ' HB3' HD22 ' A' ' 36' ' ' LEU . 14.2 ptm180 -69.96 -18.6 63.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.852 . . . . 0.0 109.669 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -76.76 -24.26 52.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.747 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.37 -33.47 37.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 4.3 t -83.33 -30.28 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.178 -0.951 . . . . 0.0 108.775 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.88 43.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.128 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -80.14 -42.12 24.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.278 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -69.85 -30.6 68.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp -77.81 -35.19 51.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.03 -30.81 62.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -29.21 61.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -74.69 -44.29 50.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.259 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -58.79 -42.39 88.95 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.93 -37.81 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.13 60.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.07 -17.38 27.85 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -103.65 11.86 35.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.476 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 29.25 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 63' ' ' VAL . 3.5 p -117.62 62.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.538 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -44.91 127.29 6.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.558 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.26 88.01 4.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -155.49 67.86 0.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.65 105.2 56.49 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.322 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 35.1 Cg_endo -77.72 127.37 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.418 2.079 . . . . 0.0 110.351 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 46.5 mtt85 65.61 128.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.888 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.699 HG12 HD11 ' A' ' 14' ' ' LEU . 2.1 t -137.79 97.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 6.6 tp -106.53 -32.48 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 12.8 m95 -169.07 70.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.145 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 p -113.93 174.18 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -0.963 . . . . 0.0 109.767 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.15 9.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.221 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -67.41 -51.54 50.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.373 -0.829 . . . . 0.0 109.139 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.699 HD11 HG12 ' A' ' 8' ' ' VAL . 11.7 mt -64.57 -19.97 65.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.431 -0.793 . . . . 0.0 109.983 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.593 ' NE2' HD11 ' A' ' 19' ' ' LEU . 15.2 t60 -80.91 -22.19 39.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 110.03 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -79.46 -32.1 42.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.918 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -80.41 -35.86 34.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.946 ' O ' HG23 ' A' ' 22' ' ' VAL . 18.3 t80 -76.96 -23.37 52.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.539 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 ' NE2' ' A' ' 15' ' ' HIS . 12.8 mt -83.01 -35.77 25.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.666 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.58 -26.86 55.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.004 . . . . 0.0 109.274 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.03 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.03 -41.55 58.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.176 -0.953 . . . . 0.0 108.786 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.3 t -67.37 -47.9 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.847 . . . . 0.0 108.985 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -59.52 -41.88 90.99 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.502 0.667 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.91 -24.0 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.505 -0.747 . . . . 0.0 109.866 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 38' ' ' LEU . 3.4 mt -108.5 -7.5 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.96 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 109.46 0.27 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.03 -20.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -1.07 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.17 -41.21 64.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.818 . . . . 0.0 110.24 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.27 14.73 15.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.003 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -92.25 132.0 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.4 m -110.36 160.25 29.13 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.4 -25.52 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.367 2.045 . . . . 0.0 110.369 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 9.9 tmtt? -68.43 -52.93 27.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.301 -0.875 . . . . 0.0 109.309 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -66.21 -39.49 89.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.314 -0.866 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.053 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.92 -26.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.995 -1.065 . . . . 0.0 108.691 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.904 HD22 ' HB2' ' A' ' 46' ' ' ARG . 17.3 tp -52.78 -36.1 57.6 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.31 -34.82 68.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.053 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.9 mt -57.09 -37.27 71.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.529 -0.732 . . . . 0.0 109.125 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.7 mmm -76.56 -52.73 9.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.6 t30 51.24 24.63 2.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 108.951 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.005 ' HB ' HD12 ' A' ' 44' ' ' LEU . 66.4 t -79.91 153.31 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 5.6 p-10 -90.03 143.1 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.9 OUTLIER 82.46 -7.31 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.005 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.1 mt -91.38 143.46 26.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 109.53 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -118.31 163.74 16.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.904 ' HB2' HD22 ' A' ' 36' ' ' LEU . 59.7 ttp85 -73.76 -19.07 60.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -24.61 47.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.04 -44.77 65.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.5 t -83.24 -25.81 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.25 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -19.99 58.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.309 -0.869 . . . . 0.0 109.09 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -74.48 -48.03 29.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.565 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -60.67 -37.41 81.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.975 . . . . 0.0 109.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -64.72 -43.52 93.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -68.8 -25.68 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -71.9 -29.4 64.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -68.13 -48.15 66.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.212 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -54.16 -38.18 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.78 -40.04 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -14.55 62.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.86 -20.82 20.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.287 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -88.51 -66.19 0.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -94.16 62.31 3.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 109.422 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -57.27 177.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 151.14 17.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.53 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.513 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -171.69 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.674 ' HG3' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -65.32 134.38 95.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 36.2 Cg_endo -79.05 134.71 11.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.561 2.174 . . . . 0.0 110.812 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER 38.01 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 110.514 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.718 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.5 t -76.26 89.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 108.978 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 18.2 tp -102.19 -37.58 8.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.149 -0.97 . . . . 0.0 109.256 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 15.9 m95 -172.15 73.93 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.096 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -113.48 175.21 5.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -49.72 -24.75 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.24 -54.52 7.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.718 HD11 HG12 ' A' ' 8' ' ' VAL . 10.9 mt -60.44 -20.1 58.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.418 -0.801 . . . . 0.0 109.803 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.721 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -75.93 -28.65 58.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.836 . . . . 0.0 109.7 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -69.39 -42.74 74.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -72.22 -37.76 69.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.119 -0.988 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.949 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.9 t80 -73.66 -22.43 59.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.32 -0.863 . . . . 0.0 109.836 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.721 HD11 ' CE1' ' A' ' 15' ' ' HIS . 10.6 mt -83.2 -39.07 21.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.804 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.36 -23.78 50.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.053 -1.029 . . . . 0.0 109.189 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.85 -39.52 50.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.244 -0.91 . . . . 0.0 109.011 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 35' ' ' ILE . 17.4 t -71.36 -47.35 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 108.605 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.29 -40.67 86.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -56.7 -27.74 59.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.532 -0.73 . . . . 0.0 109.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.964 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.2 mt -105.19 -7.78 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.4 110.7 1.1 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -48.55 -23.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -1.131 . . . . 0.0 109.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.52 -45.88 71.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.76 . . . . 0.0 110.023 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -111.49 14.53 21.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.605 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.72 117.24 18.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 110.008 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -110.44 160.84 27.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.38 -26.86 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.28 1.986 . . . . 0.0 110.26 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 7.3 tmtt? -68.53 -50.96 48.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.1 mmtt -69.36 -42.58 75.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -63.34 -25.28 38.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.75 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.813 HD22 ' CG ' ' A' ' 46' ' ' ARG . 17.1 tp -52.48 -36.76 55.65 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.45 -33.12 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.25 -35.15 74.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.536 -0.727 . . . . 0.0 109.597 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.448 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.3 mmt -79.0 -48.08 15.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.371 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t30 53.36 23.54 3.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.022 ' HB ' HD12 ' A' ' 44' ' ' LEU . 18.8 t -86.77 158.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.08 148.78 24.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.187 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.7 ttmt 77.0 -2.95 2.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.022 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.5 mt -101.57 95.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -90.89 176.95 6.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.813 ' CG ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -72.75 -18.98 61.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -34.23 42.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -73.53 -38.49 65.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 109.574 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -82.97 -25.9 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.196 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -69.78 -22.14 63.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.415 -0.803 . . . . 0.0 109.308 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 m -74.55 -49.34 22.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 29.1 t-80 -55.45 -29.0 57.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp -75.16 -33.75 61.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -65.3 -30.54 71.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 109.307 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 52' ' ' HIS . 1.6 mtpp -72.59 -20.74 61.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -68.7 -42.3 77.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.78 -42.62 97.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 108.416 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -65.46 -31.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 -10.94 58.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 12.3 mt -76.17 5.54 6.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.554 -0.716 . . . . 0.0 109.657 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 5.4 ttmm 72.82 56.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 61' ' ' LYS . 3.7 ttpt 35.08 71.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.184 0.516 . . . . 0.0 110.252 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 61' ' ' LYS . 71.3 t -126.37 160.74 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.596 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.508 ' N ' HG12 ' A' ' 63' ' ' VAL . 45.7 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.482 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 1' ' ' THR . . . 178.71 158.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 65.86 65.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 95.11 2.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' HE3' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -123.06 101.33 38.78 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.191 -0.943 . . . . 0.0 110.218 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.41 113.74 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.174 1.916 . . . . 0.0 108.966 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.439 ' HD2' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 62.22 84.45 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.087 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.915 HG13 HD13 ' A' ' 14' ' ' LEU . 2.1 t -39.76 130.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.0 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.621 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 14.3 tp -117.54 -60.97 1.76 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.54 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.621 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 6.0 m95 179.48 72.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.594 -0.691 . . . . 0.0 109.387 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.518 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 73.2 p -83.45 162.83 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.131 -0.981 . . . . 0.0 109.44 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -55.24 -25.25 32.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -83.71 -46.41 12.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.915 HD13 HG13 ' A' ' 8' ' ' VAL . 67.7 mt -64.98 -19.56 66.04 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.551 -0.718 . . . . 0.0 109.742 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.621 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 70.2 t60 -79.51 -22.33 44.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -0.922 . . . . 0.0 109.297 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -71.31 -28.39 64.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.563 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -80.43 -38.68 29.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.021 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.8 t80 -75.7 -24.13 56.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 11.8 mt -75.84 -41.69 51.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.536 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.09 -24.65 59.51 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.13 -0.982 . . . . 0.0 109.347 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.27 -41.86 39.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -66.61 -45.49 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.931 . . . . 0.0 108.889 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -61.62 -45.28 94.74 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.547 0.689 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -62.6 -23.4 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.462 -0.774 . . . . 0.0 110.205 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.2 mt -107.89 -3.45 18.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 109.847 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.36 107.64 0.16 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 8.0 p -51.5 -21.01 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -1.12 . . . . 0.0 109.52 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.8 -45.07 91.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -116.75 13.81 15.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 27' ' ' VAL . . . -83.21 118.53 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.083 -1.01 . . . . 0.0 109.714 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -105.6 160.02 27.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 108.927 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.55 -26.21 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.406 2.07 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.85 -51.02 44.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 109.242 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' A' ' 31' ' ' VAL . 62.6 mttm -69.81 -41.42 75.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.085 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.994 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.65 -24.76 35.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.54 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 46' ' ' ARG . 27.2 tp -52.99 -38.84 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.22 -35.18 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.5 mt -58.09 -32.69 68.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 109.599 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.33 -43.37 67.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.469 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.84 26.98 8.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.951 . . . . 0.0 109.041 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.969 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.6 t -97.13 148.09 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.138 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.8 p-10 -84.33 148.35 26.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.87 -0.9 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.75 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.969 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -100.16 110.22 22.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.132 -0.98 . . . . 0.0 109.392 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -96.21 172.14 8.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.754 ' HB3' HD22 ' A' ' 36' ' ' LEU . 4.4 ptt180 -76.64 -17.89 58.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.923 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.78 -34.5 60.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -65.4 -38.76 90.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.14 -25.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.062 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.33 -28.02 63.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.845 . . . . 0.0 109.349 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -70.55 -50.51 36.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.853 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.34 -32.01 68.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.07 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.0 tp -78.23 -24.39 47.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.25 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.02 73.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.874 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 31.9 mmtt -56.51 -33.92 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.108 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CE2' HD11 ' A' ' 60' ' ' LEU . 8.9 t80 -69.18 -45.68 69.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 108.899 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.25 -38.01 62.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.017 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.8 t -65.79 -37.14 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.85 -12.12 60.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.691 HD11 ' CE2' ' A' ' 56' ' ' PHE . 7.9 mt -101.96 -4.12 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.52 -0.737 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 63' ' ' VAL . 1.1 ttmt -46.63 -57.35 4.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.217 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.514 -0.741 . . . . 0.0 109.238 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 63' ' ' VAL . 7.5 p -147.56 114.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.446 179.802 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.29 63.99 0.94 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' LYS . 6.6 tt0 61.81 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 5' ' ' LYS . 1.6 tptt -43.95 118.19 1.39 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.367 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.554 ' HD2' HG23 ' A' ' 8' ' ' VAL . 2.1 ttpm? -39.21 99.24 0.19 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.703 -0.623 . . . . 0.0 109.642 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 7' ' ' ARG . 37.1 Cg_endo -82.44 113.8 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.57 2.18 . . . . 0.0 110.878 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER 29.77 98.48 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.084 0.468 . . . . 0.0 110.942 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.728 HG13 ' HG ' ' A' ' 14' ' ' LEU . 3.0 t -50.38 89.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 10.5 tp -116.12 -27.12 7.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 22.1 m95 -172.57 66.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.011 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -113.69 173.27 6.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.813 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 26.4 p80 -50.59 -27.29 6.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.326 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.0 -54.49 9.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.728 ' HG ' HG13 ' A' ' 8' ' ' VAL . 11.6 mt -54.59 -24.53 21.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.924 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.4 t60 -72.43 -36.83 68.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 12' ' ' HIS . 20.3 m120 -71.37 -25.14 62.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.861 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -79.55 -41.68 26.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.987 ' O ' HG23 ' A' ' 22' ' ' VAL . 63.0 t80 -70.06 -23.57 63.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.924 HD11 ' CE1' ' A' ' 15' ' ' HIS . 23.2 mt -80.32 -43.84 20.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.962 . . . . 0.0 109.53 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -22.7 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.112 -0.993 . . . . 0.0 109.262 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.059 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.34 -43.94 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 0.0 108.707 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.0 t -64.01 -47.9 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.88 . . . . 0.0 108.915 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -59.52 -44.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.608 0.718 . . . . 0.0 109.137 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -58.14 -23.34 54.78 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.035 HD11 HD11 ' A' ' 38' ' ' LEU . 2.9 mt -110.16 -4.9 15.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.994 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.84 109.11 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.88 -19.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -1.068 . . . . 0.0 109.798 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 -45.45 75.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.51 14.03 15.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 109.897 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -72.1 105.4 3.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 34' ' ' LYS . 5.9 m -93.17 160.46 33.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.009 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 35.0 Cg_endo -76.86 -29.2 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.426 2.084 . . . . 0.0 110.068 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 6.7 tmtt? -65.84 -49.6 67.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.208 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.0 mtpt -67.36 -45.01 77.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.039 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -62.8 -23.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.698 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 46' ' ' ARG . 55.3 tp -53.81 -36.93 63.01 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -74.79 -31.43 61.74 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.059 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.7 mt -59.74 -32.76 70.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 41' ' ' VAL . 42.2 mmm -84.36 -49.99 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.817 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.9 t30 51.55 23.65 1.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 108.932 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.034 ' HB ' HD12 ' A' ' 44' ' ' LEU . 8.7 t -82.05 151.93 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.708 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.78 150.03 23.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.569 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 77.17 -2.35 2.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.661 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.034 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.9 mt -99.04 104.09 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -82.73 162.67 21.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HB3' HD22 ' A' ' 36' ' ' LEU . 23.2 ptt180 -69.6 -19.04 63.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.965 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -26.49 38.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.7 -41.53 71.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.24 -30.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.35 -20.01 62.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -75.79 -50.06 16.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.862 . . . . 0.0 109.227 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -57.11 -31.23 65.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.209 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.3 tp -79.31 -27.47 42.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.2 mt-30 -68.36 -25.86 65.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -71.08 -28.62 64.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 60' ' ' LEU . 8.9 t80 -81.84 -51.73 7.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 mtp85 -54.88 -40.02 69.3 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 54' ' ' GLN . 40.8 t -64.58 -42.67 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.58 -12.28 61.52 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.711 HD11 ' CE2' ' A' ' 56' ' ' PHE . 4.9 mt -102.77 -12.91 17.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.4 -0.813 . . . . 0.0 109.443 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -76.4 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.75 78.14 9.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.543 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 63' ' ' VAL . 12.0 p -162.36 116.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.462 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.59 5.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.443 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -79.36 105.75 10.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.917 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' LYS . 8.5 pttt -171.67 61.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.29 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 4' ' ' LYS . 15.4 mtmm 54.49 99.71 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.243 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' O ' ' CG ' ' A' ' 7' ' ' ARG . 35.7 Cg_endo -79.12 114.03 3.29 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.344 2.029 . . . . 0.0 110.59 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 38.28 54.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.654 . . . . 0.0 110.293 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.787 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.5 t -82.05 83.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.06 . . . . 0.0 109.123 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 13.1 tp -107.68 -29.22 9.26 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 108.774 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 6.9 m95 -176.3 69.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -112.57 175.35 5.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -49.64 -22.48 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.309 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -53.67 7.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HG ' HG13 ' A' ' 8' ' ' VAL . 10.5 mt -62.76 -20.19 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 110.101 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.75 ' CE1' HD11 ' A' ' 19' ' ' LEU . 6.5 t-80 -78.72 -22.57 46.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.778 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -75.29 -41.05 58.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.055 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.2 t80 -69.21 -22.2 63.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.439 -0.788 . . . . 0.0 109.723 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.75 HD11 ' CE1' ' A' ' 15' ' ' HIS . 20.0 mt -81.05 -44.38 18.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.98 59.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.954 -1.091 . . . . 0.0 109.165 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.981 ' CB ' HD13 ' A' ' 38' ' ' LEU . . . -77.29 -43.49 33.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 0.0 109.104 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -64.64 -43.69 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 108.969 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -57.92 -43.31 86.14 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.644 0.735 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -62.0 -23.11 66.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.316 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -111.04 -2.34 15.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.0 110.195 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 108.59 0.31 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.27 -18.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -1.069 . . . . 0.0 109.892 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -65.87 -47.28 75.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.785 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 mtp85 -117.08 13.85 14.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -63.07 119.23 9.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 34' ' ' LYS . 10.7 m -105.48 159.97 27.65 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.2 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.344 2.029 . . . . 0.0 110.036 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 1.4 tmtt? -70.16 -43.84 70.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.57 -46.32 63.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.328 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.972 ' HA ' HD12 ' A' ' 38' ' ' LEU . 2.9 mt -64.69 -25.7 38.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.277 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 46' ' ' ARG . 24.5 tp -52.29 -34.57 47.31 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.1 -34.69 59.51 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.981 HD13 ' CB ' ' A' ' 21' ' ' ALA . 4.0 mt -57.92 -33.87 69.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.694 -0.629 . . . . 0.0 109.665 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 41' ' ' VAL . 26.9 mtp -86.43 -47.4 9.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.85 23.89 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 44' ' ' LEU . 45.2 t -77.98 157.82 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 0.0 109.543 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 p30 -84.14 143.44 29.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 75.9 4.47 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.541 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 mt -111.75 100.59 9.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.505 ' C ' HD13 ' A' ' 36' ' ' LEU . 22.1 p -94.03 169.89 9.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.388 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -59.96 -23.27 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.269 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 44.3 tp10 -73.57 -32.62 64.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.339 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.25 -34.73 78.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.45 -30.35 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.888 . . . . 0.0 109.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.42 -20.12 60.16 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.361 -0.837 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -75.95 -48.48 21.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.119 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -58.6 -37.75 76.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.012 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.7 -39.43 80.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.29 -29.9 70.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.239 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -60.85 -36.55 79.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.82 -46.86 83.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 0.0 108.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -54.3 -36.57 63.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.59 -38.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 61' ' ' LYS . 12.8 mt -80.37 5.89 13.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.633 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 9.3 ttmm 87.67 76.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.412 0.625 . . . . 0.0 109.532 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' LYS . 7.6 tptp 42.41 59.88 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.76 . . . . 0.0 109.571 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 63' ' ' VAL . 58.6 t -120.37 56.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.356 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 41' ' ' VAL . 10.5 mt -58.58 -19.99 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 1.047 ' CD2' HD11 ' A' ' 19' ' ' LEU . 72.7 t60 -80.41 -30.26 37.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.691 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.55 -33.27 66.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD2' HD23 ' A' ' 14' ' ' LEU . 75.0 mttt -73.83 -42.62 60.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.4 t80 -67.28 -22.57 65.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.873 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.047 HD11 ' CD2' ' A' ' 15' ' ' HIS . 43.6 mt -81.53 -44.88 16.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.672 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.74 -19.96 60.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.123 -0.986 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.032 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.56 -38.87 33.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -0.953 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 18' ' ' PHE . 18.7 t -71.26 -47.14 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.57 -43.14 97.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.585 0.707 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -58.92 -22.84 60.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 38' ' ' LEU . 2.7 mt -112.54 -1.73 14.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.6 107.59 0.29 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.62 -19.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -1.091 . . . . 0.0 109.771 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.21 -43.34 70.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -116.8 14.24 15.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.027 . . . . 0.0 110.101 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.6 120.16 23.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.5 m -100.63 157.18 34.2 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 108.969 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.9 Cg_endo -77.23 -24.11 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.404 2.069 . . . . 0.0 110.144 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.12 -52.98 28.72 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.225 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.726 ' H ' HG23 ' A' ' 31' ' ' VAL . 20.2 mmtp -67.99 -41.83 81.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.153 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -64.53 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.608 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 46' ' ' ARG . 43.2 tp -53.5 -35.72 60.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.49 -33.72 67.16 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.032 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.4 mt -57.31 -38.48 74.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.425 -0.797 . . . . 0.0 109.045 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mmt -73.55 -51.47 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 t30 56.39 26.4 10.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 21.7 t -94.0 154.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 16.6 p30 -80.3 146.82 31.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.316 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 77.19 -2.23 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.6 mt -102.35 119.24 38.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 109.485 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.86 -179.99 3.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.504 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 36' ' ' LEU . 3.8 ptt-85 -77.07 -26.95 54.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 75.2 tt0 -72.53 -23.01 60.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.42 -36.46 58.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.45 -25.9 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 0.0 109.151 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.4 56.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.324 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -77.91 -46.15 22.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -63.66 -30.33 71.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.858 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.311 0.576 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 14' ' ' LEU . 9.7 mt -62.26 -19.16 62.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 109.811 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.562 ' CE1' HD11 ' A' ' 19' ' ' LEU . 13.7 t-160 -79.96 -23.83 41.39 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -71.7 -28.91 64.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -79.01 -47.95 15.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.133 -0.979 . . . . 0.0 109.139 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.997 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.2 t80 -69.86 -22.21 63.28 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 15' ' ' HIS . 12.4 mt -78.54 -39.45 37.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 109.74 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.88 -24.34 55.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.192 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.91 -43.66 34.71 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 108.737 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.7 t -65.38 -46.44 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 108.814 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.58 -44.79 95.81 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.522 0.677 . . . . 0.0 109.391 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -59.49 -23.09 62.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 0.0 109.918 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 38' ' ' LEU . 4.7 mt -107.25 -7.03 16.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.02 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.78 108.94 0.55 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.1 -18.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.46 -46.58 79.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 13.66 15.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.8 108.93 8.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 17.2 m -96.66 160.11 30.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 109.037 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.99 9.98 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.443 2.096 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -69.65 -48.81 58.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.347 -0.845 . . . . 0.0 109.302 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 66.8 mmtt -69.9 -42.89 72.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 109.18 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.993 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -65.9 -24.68 34.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.031 -1.043 . . . . 0.0 108.433 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 46' ' ' ARG . 19.0 tp -54.65 -32.6 59.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.21 -32.05 55.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 25' ' ' LEU . 5.1 mt -60.12 -36.45 77.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.592 -0.693 . . . . 0.0 109.598 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.46 -46.73 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.97 . . . . 0.0 109.739 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 t30 51.28 24.87 2.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 108.885 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.986 ' HB ' HD12 ' A' ' 44' ' ' LEU . 76.8 t -78.95 157.82 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.556 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.3 p-10 -90.34 146.26 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 ttmt 77.03 -2.25 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.1 mt -95.36 107.26 19.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 109.364 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -88.97 175.97 7.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HG3' HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -78.75 -24.95 44.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.765 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -22.97 54.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.583 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.93 -43.68 64.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.697 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG1' ' CE1' ' A' ' 18' ' ' PHE . 76.6 t -83.45 -26.59 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.19 -20.02 57.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 m -78.12 -45.61 22.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.73 -26.6 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 109.241 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.7 tp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.499 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.9 mt -62.03 -23.1 66.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.442 -0.786 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.891 ' CD2' HD11 ' A' ' 19' ' ' LEU . 3.9 t60 -71.62 -26.5 62.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.01 -37.61 72.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -72.85 -47.51 45.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 22' ' ' VAL . 62.9 t80 -68.93 -22.29 64.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.891 HD11 ' CD2' ' A' ' 15' ' ' HIS . 21.8 mt -82.15 -39.67 22.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.912 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.17 -22.57 44.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.112 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.35 -41.24 28.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 108.834 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 18' ' ' PHE . 28.3 t -70.59 -45.75 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.94 -43.72 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.15 -23.22 62.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.529 -0.732 . . . . 0.0 109.688 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mt -112.61 -0.57 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.817 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.18 107.16 0.19 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 9.5 p -52.28 -19.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -1.057 . . . . 0.0 109.921 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 -42.28 65.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -116.84 14.48 15.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -89.22 133.45 34.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.8 m -115.89 160.24 36.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.397 -0.814 . . . . 0.0 109.069 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.6 Cg_endo -76.18 -17.27 17.17 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.47 2.113 . . . . 0.0 110.253 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -71.54 -54.79 9.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.171 -0.956 . . . . 0.0 109.31 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -68.7 -38.47 80.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.218 -0.927 . . . . 0.0 108.838 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.003 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -63.43 -25.34 38.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.575 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 46' ' ' ARG . 23.1 tp -51.75 -36.2 46.38 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -73.34 -35.12 65.97 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.003 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.0 mt -58.01 -35.77 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.554 -0.716 . . . . 0.0 109.336 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.0 mmm -78.98 -51.28 9.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 57.94 25.75 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 44' ' ' LEU . 72.8 t -82.27 146.54 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.295 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.0 p30 -80.32 145.92 31.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.57 0.75 3.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.658 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 41' ' ' VAL . 4.0 mm? -103.11 137.55 41.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.65 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -118.46 173.85 6.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' HD22 ' A' ' 36' ' ' LEU . 1.4 ptt180 -77.85 -19.72 54.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.18 -43.21 53.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.51 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -61.65 -36.42 80.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.31 -25.22 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.18 -20.7 57.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -77.96 -45.73 23.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -62.45 -26.22 68.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.4 tp . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.401 0.619 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 14' ' ' LEU . 10.2 mt -62.56 -19.64 63.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.855 ' CE1' HD11 ' A' ' 19' ' ' LEU . 15.8 t-160 -80.69 -25.38 38.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.93 -34.23 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -0.927 . . . . 0.0 109.476 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -78.54 -40.61 34.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.208 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.982 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.8 t80 -74.07 -22.61 59.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.855 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.6 mt -82.48 -37.44 25.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.27 -24.94 51.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.106 -0.996 . . . . 0.0 109.296 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.853 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.93 -39.7 55.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.1 t -68.51 -47.37 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 108.879 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.57 -41.75 90.91 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.566 0.698 . . . . 0.0 109.187 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -56.09 -25.86 47.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 109.606 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.983 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.8 mt -109.32 -6.19 15.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 110.031 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 110.25 0.77 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.17 -19.0 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -1.073 . . . . 0.0 109.831 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.23 48.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -111.08 14.42 21.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 0.0 109.822 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.38 134.42 36.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.997 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -120.99 160.55 44.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 108.951 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.72 -24.7 11.47 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.371 2.048 . . . . 0.0 110.208 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.91 -53.82 18.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.362 -0.836 . . . . 0.0 109.062 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 33' ' ' LYS . 2.0 mmtp -67.59 -40.21 84.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.324 -0.86 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.015 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.1 -26.3 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.655 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.046 HD22 ' HB2' ' A' ' 46' ' ' ARG . 47.9 tp -52.51 -36.3 55.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.11 -34.22 63.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.3 mt -58.99 -34.41 71.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 109.406 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.444 ' HB3' HG23 ' A' ' 41' ' ' VAL . 64.1 mmm -80.85 -51.49 8.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.17 23.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 108.936 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.949 ' HB ' HD12 ' A' ' 44' ' ' LEU . 20.5 t -80.65 156.83 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.485 -0.759 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 26.5 p30 -88.07 146.54 25.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 76.06 1.78 3.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.949 HD12 ' HB ' ' A' ' 41' ' ' VAL . 14.2 mt -106.16 117.71 34.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.516 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.39 167.97 9.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 1.046 ' HB2' HD22 ' A' ' 36' ' ' LEU . 38.6 ttp180 -76.24 -21.47 56.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.27 -29.43 48.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -68.59 -42.18 78.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.409 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 -25.09 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.33 -20.51 62.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 m -80.79 -42.03 22.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.892 . . . . 0.0 109.507 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -75.4 -28.26 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.412 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.409 0.623 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 14' ' ' LEU . 11.4 mt -62.51 -20.26 64.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.022 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.718 ' CE1' HD11 ' A' ' 19' ' ' LEU . 17.3 t-160 -79.05 -22.39 45.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 109.921 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -77.34 -31.04 54.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -77.09 -42.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.3 t80 -73.36 -25.48 60.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.8 mt -82.2 -33.87 29.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.717 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 -22.96 45.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.134 -0.979 . . . . 0.0 109.359 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -78.46 -41.23 33.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.234 -0.916 . . . . 0.0 108.644 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.5 t -65.69 -47.97 84.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.15 -44.81 95.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.666 -0.646 . . . . 0.0 109.332 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -61.43 -22.93 65.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.771 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -108.16 -3.92 18.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.768 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.53 108.52 0.81 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 22' ' ' VAL . 11.4 p -54.56 -18.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -1.094 . . . . 0.0 109.738 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.82 -46.79 77.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.83 13.75 15.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.582 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.85 97.47 4.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.707 HG23 ' H ' ' A' ' 34' ' ' LYS . 33.1 m -90.48 159.88 40.45 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.279 -0.888 . . . . 0.0 108.923 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.99 -22.08 13.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.292 1.995 . . . . 0.0 109.936 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.11 -51.6 44.44 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.266 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.707 ' H ' HG23 ' A' ' 31' ' ' VAL . 23.1 mmtm -69.28 -44.39 71.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.154 -0.967 . . . . 0.0 108.951 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.977 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.9 mt -63.05 -23.49 33.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.08 -1.013 . . . . 0.0 108.606 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.757 HD22 ' HB2' ' A' ' 46' ' ' ARG . 29.4 tp -52.74 -39.37 62.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -36.49 68.86 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.012 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.6 mt -57.37 -29.38 64.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.532 -0.73 . . . . 0.0 109.254 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.0 mtp -83.25 -49.58 9.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 53.84 24.98 4.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.213 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.947 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.7 t -84.5 144.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -81.33 147.82 29.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 9.8 ttpt 78.05 -3.16 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.583 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.947 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.2 mt -99.47 109.56 22.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 p -89.27 169.89 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.757 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.27 -23.57 54.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -32.08 62.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -68.07 -35.61 78.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.462 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 32' ' ' PRO . 95.7 t -83.25 -25.74 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.99 -24.13 48.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.253 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.8 m -76.36 -44.27 37.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.334 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -62.74 -30.46 71.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.19 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.4 tp . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.276 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 14' ' ' LEU . 9.2 mt -82.33 -55.39 4.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.956 ' CD2' HD11 ' A' ' 19' ' ' LEU . 81.6 t60 -45.65 -25.19 0.44 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.687 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -68.19 -48.81 64.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 109.673 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -68.25 -35.15 77.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.994 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.7 t80 -69.95 -25.98 63.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.956 HD11 ' CD2' ' A' ' 15' ' ' HIS . 45.9 mt -77.7 -44.36 28.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -24.63 61.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 108.926 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.697 ' HA ' HD22 ' A' ' 38' ' ' LEU . . . -74.27 -40.57 62.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.994 HG23 ' O ' ' A' ' 18' ' ' PHE . 16.4 t -69.51 -46.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.0 108.906 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.33 -40.25 85.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.412 ' ND1' ' C ' ' A' ' 24' ' ' HIS . 8.4 t-80 -54.82 -27.54 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.518 -0.739 . . . . 0.0 109.354 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.978 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.5 mt -106.53 -9.03 16.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.99 111.39 2.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.9 -18.33 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -1.098 . . . . 0.0 110.088 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.58 -43.19 39.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.216 -0.928 . . . . 0.0 110.648 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -116.72 14.87 15.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 110.257 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -69.22 124.06 22.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.984 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 23.2 m -106.17 160.4 26.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 108.994 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.8 Cg_endo -76.59 -23.57 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.347 2.031 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -69.36 -52.72 24.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.401 -0.812 . . . . 0.0 109.382 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 14.2 mtpp -67.13 -38.97 86.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -0.86 . . . . 0.0 109.354 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.95 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -67.23 -24.72 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.999 -1.063 . . . . 0.0 108.863 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 46' ' ' ARG . 58.0 tp -54.09 -38.97 65.9 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -74.37 -35.85 63.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.978 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.3 mt -57.21 -28.79 63.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.589 -0.694 . . . . 0.0 109.343 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.8 mmm -82.54 -43.94 16.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 50.85 23.77 1.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.014 ' HB ' HD12 ' A' ' 44' ' ' LEU . 93.7 t -87.48 155.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.559 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.6 p-10 -90.1 140.71 29.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER 80.22 -8.48 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.528 -0.732 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.014 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.5 mt -84.2 125.37 32.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.96 -1.088 . . . . 0.0 109.152 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 p -109.34 158.91 17.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -78.17 -17.79 56.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.412 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -74.13 -22.91 59.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -80.47 -37.7 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.619 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.497 HG11 ' CE1' ' A' ' 18' ' ' PHE . 69.0 t -83.02 -24.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.35 -39.39 59.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -72.12 -38.5 69.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.516 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.7 t60 -70.04 -25.98 63.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.126 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.353 0.596 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 14' ' ' LEU . 10.2 mt -57.79 -19.58 29.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.883 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.875 ' NE2' HD11 ' A' ' 19' ' ' LEU . 4.7 t60 -75.8 -32.94 60.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -67.42 -30.36 70.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HD2' HD23 ' A' ' 14' ' ' LEU . 16.7 mttm -78.71 -38.12 39.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.955 ' O ' HG23 ' A' ' 22' ' ' VAL . 60.7 t80 -75.19 -23.22 57.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.676 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.875 HD11 ' NE2' ' A' ' 15' ' ' HIS . 4.5 mt -82.48 -36.54 26.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.66 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.31 -24.5 50.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.7 -43.32 38.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 108.768 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.5 t -67.16 -45.7 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -59.54 -43.54 93.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -58.61 -23.22 58.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.534 -0.728 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -112.83 -1.66 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.02 107.19 0.49 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 22' ' ' VAL . 8.1 p -54.41 -18.58 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -1.146 . . . . 0.0 109.748 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -46.79 74.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.949 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -116.8 14.01 15.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.0 109.919 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.567 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -70.05 125.61 27.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.772 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 34' ' ' LYS . 16.7 m -109.66 160.04 29.37 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.316 -0.865 . . . . 0.0 108.932 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.47 -19.25 15.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.41 2.074 . . . . 0.0 110.046 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -70.54 -55.13 9.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.397 -0.814 . . . . 0.0 109.03 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 31' ' ' VAL . 16.7 mttp -67.92 -39.47 83.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.951 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -68.0 -25.32 31.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.091 -1.043 . . . . 0.0 108.562 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 46' ' ' ARG . 25.8 tp -53.63 -38.33 63.96 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.1 -35.64 66.64 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.4 mt -57.66 -31.39 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.627 -0.67 . . . . 0.0 109.419 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.413 ' SD ' HD13 ' A' ' 44' ' ' LEU . 3.3 mtt -79.96 -53.24 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 55.17 27.0 8.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.202 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.97 ' HB ' HD12 ' A' ' 44' ' ' LEU . 24.5 t -88.31 157.52 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -90.27 140.87 29.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 81.84 -7.44 1.39 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 110.033 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.97 HD12 ' HB ' ' A' ' 41' ' ' VAL . 16.9 mt -90.58 136.99 32.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -114.0 164.26 14.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.554 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.853 ' HB2' HD22 ' A' ' 36' ' ' LEU . 32.7 ttp85 -78.73 -31.37 46.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.94 -22.87 63.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.418 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 3.9 m-20 -72.24 -36.52 69.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.12 -27.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.226 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.17 63.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.304 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.69 -50.26 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.378 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -54.39 -28.68 45.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 108.964 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 14' ' ' LEU . 8.4 mt -60.88 -19.26 59.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.926 ' NE2' HD11 ' A' ' 19' ' ' LEU . 4.0 t60 -77.33 -26.05 51.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.915 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.69 -43.69 53.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.75 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -78.39 -33.82 48.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 108.836 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.972 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.1 t80 -76.59 -23.19 53.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.35 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.926 HD11 ' NE2' ' A' ' 15' ' ' HIS . 13.7 mt -78.79 -37.77 40.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 109.628 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.81 50.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.142 -0.974 . . . . 0.0 108.902 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.41 -43.43 40.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.312 -0.867 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 18' ' ' PHE . 25.0 t -67.24 -45.76 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.733 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.96 -43.12 95.25 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.516 0.674 . . . . 0.0 109.262 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -58.28 -23.16 55.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.739 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.936 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -111.39 -4.49 14.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.152 -0.967 . . . . 0.0 110.067 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 110.05 1.08 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 22' ' ' VAL . 13.7 p -54.07 -18.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -1.116 . . . . 0.0 109.909 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 29' ' ' ARG . 8.7 pt-20 -80.16 -37.41 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.75 14.5 15.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.176 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.163 -0.961 . . . . 0.0 110.091 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.7 m -119.74 160.53 42.03 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.365 -0.835 . . . . 0.0 108.936 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.854 ' HD3' HD22 ' A' ' 53' ' ' LEU . 33.9 Cg_endo -75.64 -24.21 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.409 2.073 . . . . 0.0 110.005 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.1 -52.42 28.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.371 -0.831 . . . . 0.0 109.298 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 31' ' ' VAL . 13.4 mttt -69.18 -38.89 78.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.005 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -67.8 -24.78 31.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.082 -1.011 . . . . 0.0 108.61 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.007 HD22 ' HB3' ' A' ' 46' ' ' ARG . 20.3 tp -53.34 -37.92 62.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.99 -34.47 64.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.005 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -59.24 -31.64 69.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.442 -0.786 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.681 ' HB3' HG23 ' A' ' 41' ' ' VAL . 83.0 mmm -85.09 -50.26 7.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.7 t30 54.48 25.46 6.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.21 -0.932 . . . . 0.0 109.104 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.878 ' HB ' HD12 ' A' ' 44' ' ' LEU . 7.8 t -78.77 158.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.54 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 22.4 p30 -89.67 144.66 25.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 76.37 -0.5 3.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.878 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.4 mt -101.81 115.56 30.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 109.506 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -99.26 168.23 10.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 1.007 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.75 -18.23 60.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -32.94 61.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.481 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.24 -25.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.134 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 32' ' ' PRO . . . -77.7 -20.85 52.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.281 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -76.63 -43.76 37.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 109.297 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.8 t60 -67.07 -30.75 70.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.854 HD22 ' HD3' ' A' ' 32' ' ' PRO . 5.8 tp . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.435 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' CG ' ' HE3' ' A' ' 17' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 14' ' ' LEU . 11.9 mt -58.51 -20.08 42.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.58 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -78.58 -32.82 47.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.41 -38.25 65.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.763 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.409 ' HE3' ' CG ' ' A' ' 13' ' ' GLU . 74.2 mttt -74.33 -35.31 63.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.7 t80 -72.41 -26.88 62.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.883 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 19' ' ' LEU . 12.6 mt -80.54 -39.85 27.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -23.68 51.34 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.127 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.43 -41.8 38.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.867 . . . . 0.0 108.967 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -69.6 -45.11 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 108.658 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -59.57 -42.31 92.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.476 0.655 . . . . 0.0 109.236 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -57.49 -24.26 54.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -0.759 . . . . 0.0 109.676 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.048 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -110.47 -4.83 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.22 110.1 0.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 22' ' ' VAL . 6.3 p -53.94 -18.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -41.51 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -116.74 14.74 15.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -78.25 121.32 24.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.073 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.1 m -104.24 160.11 27.12 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 108.81 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.42 -25.76 9.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.355 2.037 . . . . 0.0 110.066 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.27 -50.26 54.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 12.6 mttm -68.16 -40.71 82.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.151 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.03 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -63.88 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.07 . . . . 0.0 108.681 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.6 tp -54.2 -35.0 61.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 3.0 p30 -78.99 -28.93 43.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.048 ' CD1' HD11 ' A' ' 25' ' ' LEU . 6.2 mt -63.36 -31.83 73.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.495 -0.753 . . . . 0.0 109.129 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 41' ' ' VAL . 1.8 mtt -89.12 -40.95 12.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 52.25 25.37 3.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 109.051 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 19.5 t -80.93 146.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 109.582 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 17.6 p-10 -89.82 149.92 22.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.344 -0.847 . . . . 0.0 109.516 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 79.07 -3.76 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -93.41 130.3 39.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.304 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -102.59 160.42 14.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -77.97 -21.97 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -29.97 62.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.41 -25.32 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.55 -21.73 48.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 m -78.95 -43.02 25.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -67.81 -27.39 66.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.33 0.586 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 14' ' ' LEU . 10.4 mt -85.05 -58.28 2.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.987 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.499 ' HE1' HD11 ' A' ' 19' ' ' LEU . 52.9 t-80 -49.46 -22.08 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.4 -42.24 62.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.51 -36.63 84.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 109.352 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.063 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.1 t80 -69.62 -32.92 71.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD11 ' HE1' ' A' ' 15' ' ' HIS . 11.5 mt -70.38 -45.49 65.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.11 70.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -70.79 -40.36 72.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.229 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -63.56 -48.16 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.28 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -59.18 -44.11 92.18 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 109.326 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.54 -22.89 65.55 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 110.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 38' ' ' LEU . 2.6 mt -110.45 -1.69 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.03 108.45 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 p -53.13 -19.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -1.107 . . . . 0.0 109.557 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.61 -44.06 83.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -116.94 13.16 14.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -0.999 . . . . 0.0 110.159 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -81.19 109.01 15.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.878 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.9 m -99.67 160.49 27.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 108.949 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.13 -27.32 8.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.434 2.089 . . . . 0.0 110.022 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.48 -48.42 64.51 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.471 -0.768 . . . . 0.0 109.248 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -70.17 -42.72 72.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.858 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -66.61 -24.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.014 -1.053 . . . . 0.0 108.634 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.948 HD22 ' HB3' ' A' ' 46' ' ' ARG . 10.8 tp -56.16 -31.02 62.99 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.61 -32.14 57.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 25' ' ' LEU . 52.1 mt -57.87 -37.91 74.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.113 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.775 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 mmm -84.37 -47.95 10.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.769 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 49.24 25.09 1.12 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 108.804 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.946 ' HB ' HD12 ' A' ' 44' ' ' LEU . 11.9 t -78.55 159.54 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.527 -0.733 . . . . 0.0 109.81 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.2 p-10 -86.18 147.72 25.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 109.223 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 78.9 -6.39 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 109.603 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.946 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.7 mt -102.86 102.64 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.447 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 p -91.73 169.25 10.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.948 ' HB3' HD22 ' A' ' 36' ' ' LEU . 14.2 ptm180 -69.96 -18.6 63.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.852 . . . . 0.0 109.669 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -76.76 -24.26 52.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.747 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.37 -33.47 37.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 4.3 t -83.33 -30.28 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.178 -0.951 . . . . 0.0 108.775 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.88 43.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.128 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -80.14 -42.12 24.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.278 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 15' ' ' HIS . 55.7 t-80 -69.85 -30.6 68.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.7 mt -64.57 -19.97 65.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.431 -0.793 . . . . 0.0 109.983 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.593 ' NE2' HD11 ' A' ' 19' ' ' LEU . 15.2 t60 -80.91 -22.19 39.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 110.03 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.46 -32.1 42.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.918 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -80.41 -35.86 34.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.946 ' O ' HG23 ' A' ' 22' ' ' VAL . 18.3 t80 -76.96 -23.37 52.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.539 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 ' NE2' ' A' ' 15' ' ' HIS . 12.8 mt -83.01 -35.77 25.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.666 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.58 -26.86 55.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.004 . . . . 0.0 109.274 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.03 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.03 -41.55 58.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.176 -0.953 . . . . 0.0 108.786 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.3 t -67.37 -47.9 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.847 . . . . 0.0 108.985 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -59.52 -41.88 90.99 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.502 0.667 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.475 ' O ' ' CD2' ' A' ' 24' ' ' HIS . 21.1 t-160 -58.91 -24.0 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.505 -0.747 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 38' ' ' LEU . 3.4 mt -108.5 -7.5 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.96 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 109.46 0.27 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.03 -20.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -1.07 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.17 -41.21 64.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.818 . . . . 0.0 110.24 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.27 14.73 15.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.003 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -92.25 132.0 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.4 m -110.36 160.25 29.13 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.4 -25.52 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.367 2.045 . . . . 0.0 110.369 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 9.9 tmtt? -68.43 -52.93 27.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.301 -0.875 . . . . 0.0 109.309 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -66.21 -39.49 89.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.314 -0.866 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.053 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.92 -26.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.995 -1.065 . . . . 0.0 108.691 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.904 HD22 ' HB2' ' A' ' 46' ' ' ARG . 17.3 tp -52.78 -36.1 57.6 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.31 -34.82 68.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.053 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.9 mt -57.09 -37.27 71.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.529 -0.732 . . . . 0.0 109.125 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.7 mmm -76.56 -52.73 9.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 51.24 24.63 2.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 108.951 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.005 ' HB ' HD12 ' A' ' 44' ' ' LEU . 66.4 t -79.91 153.31 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 5.6 p-10 -90.03 143.1 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.9 OUTLIER 82.46 -7.31 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.005 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.1 mt -91.38 143.46 26.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 109.53 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -118.31 163.74 16.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.904 ' HB2' HD22 ' A' ' 36' ' ' LEU . 59.7 ttp85 -73.76 -19.07 60.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -24.61 47.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.04 -44.77 65.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.5 t -83.24 -25.81 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.25 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -19.99 58.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.309 -0.869 . . . . 0.0 109.09 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -74.48 -48.03 29.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.565 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -60.67 -37.41 81.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.975 . . . . 0.0 109.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 14' ' ' LEU . 10.9 mt -60.44 -20.1 58.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.418 -0.801 . . . . 0.0 109.803 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.721 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -75.93 -28.65 58.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.836 . . . . 0.0 109.7 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -69.39 -42.74 74.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -72.22 -37.76 69.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.119 -0.988 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.949 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.9 t80 -73.66 -22.43 59.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.32 -0.863 . . . . 0.0 109.836 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.721 HD11 ' CE1' ' A' ' 15' ' ' HIS . 10.6 mt -83.2 -39.07 21.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.804 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.36 -23.78 50.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.053 -1.029 . . . . 0.0 109.189 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.85 -39.52 50.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.244 -0.91 . . . . 0.0 109.011 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 35' ' ' ILE . 17.4 t -71.36 -47.35 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 108.605 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.29 -40.67 86.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -56.7 -27.74 59.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.532 -0.73 . . . . 0.0 109.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.964 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.2 mt -105.19 -7.78 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.4 110.7 1.1 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -48.55 -23.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -1.131 . . . . 0.0 109.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.52 -45.88 71.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.76 . . . . 0.0 110.023 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -111.49 14.53 21.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.605 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.72 117.24 18.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 110.008 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -110.44 160.84 27.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.38 -26.86 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.28 1.986 . . . . 0.0 110.26 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 7.3 tmtt? -68.53 -50.96 48.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.1 mmtt -69.36 -42.58 75.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -63.34 -25.28 38.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.75 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.813 HD22 ' CG ' ' A' ' 46' ' ' ARG . 17.1 tp -52.48 -36.76 55.65 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.45 -33.12 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.25 -35.15 74.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.536 -0.727 . . . . 0.0 109.597 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.448 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.3 mmt -79.0 -48.08 15.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.371 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t30 53.36 23.54 3.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.022 ' HB ' HD12 ' A' ' 44' ' ' LEU . 18.8 t -86.77 158.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.08 148.78 24.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.187 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.7 ttmt 77.0 -2.95 2.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.022 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.5 mt -101.57 95.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -90.89 176.95 6.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.813 ' CG ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -72.75 -18.98 61.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -34.23 42.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -73.53 -38.49 65.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 109.574 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -82.97 -25.9 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.196 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -69.78 -22.14 63.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.415 -0.803 . . . . 0.0 109.308 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 m -74.55 -49.34 22.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.425 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 6.5 t60 -55.45 -29.0 57.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.835 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.459 0.647 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 14' ' ' LEU . 67.7 mt -64.98 -19.56 66.04 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.551 -0.718 . . . . 0.0 109.742 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.621 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 70.2 t60 -79.51 -22.33 44.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -0.922 . . . . 0.0 109.297 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -71.31 -28.39 64.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.563 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -80.43 -38.68 29.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.021 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.8 t80 -75.7 -24.13 56.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 11.8 mt -75.84 -41.69 51.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.536 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.09 -24.65 59.51 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.13 -0.982 . . . . 0.0 109.347 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.27 -41.86 39.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -66.61 -45.49 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.931 . . . . 0.0 108.889 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -61.62 -45.28 94.74 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.547 0.689 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -62.6 -23.4 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.462 -0.774 . . . . 0.0 110.205 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.2 mt -107.89 -3.45 18.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 109.847 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.36 107.64 0.16 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 8.0 p -51.5 -21.01 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -1.12 . . . . 0.0 109.52 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.8 -45.07 91.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -116.75 13.81 15.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 27' ' ' VAL . . . -83.21 118.53 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.083 -1.01 . . . . 0.0 109.714 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -105.6 160.02 27.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 108.927 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.55 -26.21 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.406 2.07 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.85 -51.02 44.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 109.242 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' A' ' 31' ' ' VAL . 62.6 mttm -69.81 -41.42 75.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.085 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.994 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.65 -24.76 35.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.54 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 46' ' ' ARG . 27.2 tp -52.99 -38.84 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.22 -35.18 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.5 mt -58.09 -32.69 68.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 109.599 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.33 -43.37 67.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.469 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.84 26.98 8.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.951 . . . . 0.0 109.041 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.969 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.6 t -97.13 148.09 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.138 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.8 p-10 -84.33 148.35 26.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.87 -0.9 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.75 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.969 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -100.16 110.22 22.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.132 -0.98 . . . . 0.0 109.392 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -96.21 172.14 8.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.754 ' HB3' HD22 ' A' ' 36' ' ' LEU . 4.4 ptt180 -76.64 -17.89 58.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.923 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.78 -34.5 60.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -65.4 -38.76 90.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.14 -25.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.062 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.33 -28.02 63.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.845 . . . . 0.0 109.349 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -70.55 -50.51 36.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.853 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.34 -32.01 68.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.07 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.0 tp . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.25 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 14' ' ' LEU . 11.6 mt -54.59 -24.53 21.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.924 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.4 t60 -72.43 -36.83 68.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -71.37 -25.14 62.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.861 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -79.55 -41.68 26.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.987 ' O ' HG23 ' A' ' 22' ' ' VAL . 63.0 t80 -70.06 -23.57 63.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.924 HD11 ' CE1' ' A' ' 15' ' ' HIS . 23.2 mt -80.32 -43.84 20.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.962 . . . . 0.0 109.53 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -22.7 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.112 -0.993 . . . . 0.0 109.262 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.059 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.34 -43.94 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 0.0 108.707 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.0 t -64.01 -47.9 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.88 . . . . 0.0 108.915 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -59.52 -44.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.608 0.718 . . . . 0.0 109.137 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -58.14 -23.34 54.78 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.035 HD11 HD11 ' A' ' 38' ' ' LEU . 2.9 mt -110.16 -4.9 15.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.994 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.84 109.11 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.88 -19.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -1.068 . . . . 0.0 109.798 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 -45.45 75.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.51 14.03 15.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 109.897 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -72.1 105.4 3.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 34' ' ' LYS . 5.9 m -93.17 160.46 33.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.009 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 35.0 Cg_endo -76.86 -29.2 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.426 2.084 . . . . 0.0 110.068 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 6.7 tmtt? -65.84 -49.6 67.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.208 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.0 mtpt -67.36 -45.01 77.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.039 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -62.8 -23.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.698 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 46' ' ' ARG . 55.3 tp -53.81 -36.93 63.01 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -74.79 -31.43 61.74 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.059 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.7 mt -59.74 -32.76 70.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 41' ' ' VAL . 42.2 mmm -84.36 -49.99 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.817 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.55 23.65 1.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 108.932 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.034 ' HB ' HD12 ' A' ' 44' ' ' LEU . 8.7 t -82.05 151.93 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.708 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.78 150.03 23.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.569 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 77.17 -2.35 2.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.661 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.034 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.9 mt -99.04 104.09 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -82.73 162.67 21.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HB3' HD22 ' A' ' 36' ' ' LEU . 23.2 ptt180 -69.6 -19.04 63.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.965 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -26.49 38.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -41.53 71.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.24 -30.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.35 -20.01 62.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -75.79 -50.06 16.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.862 . . . . 0.0 109.227 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -57.11 -31.23 65.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.209 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.3 tp . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' CE ' ' A' ' 39' ' ' MET . 10.5 mt -62.76 -20.19 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 110.101 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.857 ' CD2' HD11 ' A' ' 19' ' ' LEU . 27.7 t60 -78.72 -22.57 46.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.778 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -75.29 -41.05 58.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.055 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.2 t80 -69.21 -22.2 63.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.439 -0.788 . . . . 0.0 109.723 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 15' ' ' HIS . 20.0 mt -81.05 -44.38 18.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.98 59.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.954 -1.091 . . . . 0.0 109.165 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.981 ' CB ' HD13 ' A' ' 38' ' ' LEU . . . -77.29 -43.49 33.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 0.0 109.104 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -64.64 -43.69 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 108.969 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -57.92 -43.31 86.14 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.644 0.735 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' HIS . 14.4 t60 -62.0 -23.11 66.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.316 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -111.04 -2.34 15.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.0 110.195 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 108.59 0.31 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.27 -18.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -1.069 . . . . 0.0 109.892 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -65.87 -47.28 75.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.785 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 2.6 mtp85 -117.08 13.85 14.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -63.07 119.23 9.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 34' ' ' LYS . 10.7 m -105.48 159.97 27.65 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.2 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.344 2.029 . . . . 0.0 110.036 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 1.4 tmtt? -70.16 -43.84 70.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.57 -46.32 63.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.328 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.972 ' HA ' HD12 ' A' ' 38' ' ' LEU . 2.9 mt -64.69 -25.7 38.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.277 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 46' ' ' ARG . 24.5 tp -52.29 -34.57 47.31 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.1 -34.69 59.51 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.981 HD13 ' CB ' ' A' ' 21' ' ' ALA . 4.0 mt -57.92 -33.87 69.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.694 -0.629 . . . . 0.0 109.665 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 41' ' ' VAL . 26.9 mtp -86.43 -47.4 9.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.85 23.89 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 44' ' ' LEU . 45.2 t -77.98 157.82 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 0.0 109.543 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 p30 -84.14 143.44 29.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 75.9 4.47 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.541 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 mt -111.75 100.59 9.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.505 ' C ' HD13 ' A' ' 36' ' ' LEU . 22.1 p -94.03 169.89 9.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.388 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -59.96 -23.27 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.269 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 44.3 tp10 -73.57 -32.62 64.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.339 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.25 -34.73 78.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.45 -30.35 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.888 . . . . 0.0 109.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.42 -20.12 60.16 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.361 -0.837 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -75.95 -48.48 21.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.119 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -58.6 -37.75 76.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.012 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.285 0.564 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 1' ' ' THR . . . 176.81 167.06 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -50.06 -179.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 5.4 tttt -155.58 55.2 0.62 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.93 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.576 ' CG ' HG22 ' A' ' 8' ' ' VAL . 9.7 ptpt -85.9 135.77 37.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 109.299 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 36.2 Cg_endo -78.69 136.2 13.43 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.487 2.125 . . . . 0.0 110.541 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 38.6 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.707 . . . . 0.0 110.062 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG22 ' CG ' ' A' ' 5' ' ' LYS . 12.0 t -67.92 125.19 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.32 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -91.26 -53.54 4.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -160.86 79.74 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.454 ' OG1' ' CG1' ' A' ' 8' ' ' VAL . 33.1 p -113.34 175.45 5.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.482 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -56.93 -20.5 23.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.74 -59.71 2.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 41' ' ' VAL . 10.5 mt -58.58 -19.99 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 1.047 ' CD2' HD11 ' A' ' 19' ' ' LEU . 72.7 t60 -80.41 -30.26 37.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.691 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.55 -33.27 66.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' HD2' HD23 ' A' ' 14' ' ' LEU . 75.0 mttt -73.83 -42.62 60.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 22' ' ' VAL . 49.4 t80 -67.28 -22.57 65.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.873 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.047 HD11 ' CD2' ' A' ' 15' ' ' HIS . 43.6 mt -81.53 -44.88 16.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.99 -1.069 . . . . 0.0 109.672 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.74 -19.96 60.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.123 -0.986 . . . . 0.0 109.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.032 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.56 -38.87 33.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -0.953 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 18' ' ' PHE . 18.7 t -71.26 -47.14 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.57 -43.14 97.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.585 0.707 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -58.92 -22.84 60.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 38' ' ' LEU . 2.7 mt -112.54 -1.73 14.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.6 107.59 0.29 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -52.62 -19.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -1.091 . . . . 0.0 109.771 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.21 -43.34 70.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -116.8 14.24 15.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.057 -1.027 . . . . 0.0 110.101 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.6 120.16 23.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.5 m -100.63 157.18 34.2 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 108.969 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.9 Cg_endo -77.23 -24.11 9.72 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.404 2.069 . . . . 0.0 110.144 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.12 -52.98 28.72 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.225 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.726 ' H ' HG23 ' A' ' 31' ' ' VAL . 20.2 mmtp -67.99 -41.83 81.7 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.153 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -64.53 -24.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.608 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 46' ' ' ARG . 43.2 tp -53.5 -35.72 60.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.49 -33.72 67.16 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.032 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.4 mt -57.31 -38.48 74.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.425 -0.797 . . . . 0.0 109.045 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mmt -73.55 -51.47 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.3 t30 56.39 26.4 10.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 21.7 t -94.0 154.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 16.6 p30 -80.3 146.82 31.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.316 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 77.19 -2.23 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.6 mt -102.35 119.24 38.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 109.485 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.86 -179.99 3.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.504 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 36' ' ' LEU . 3.8 ptt-85 -77.07 -26.95 54.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 75.2 tt0 -72.53 -23.01 60.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.42 -36.46 58.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.45 -25.9 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 0.0 109.151 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.02 -20.4 56.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.324 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -77.91 -46.15 22.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -63.66 -30.33 71.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -71.55 -48.39 48.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -68.56 -19.26 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -79.91 -28.07 39.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.832 ' CE2' HD11 ' A' ' 60' ' ' LEU . 22.0 t80 -71.01 -46.41 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.326 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.44 -40.42 71.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.6 t -64.7 -38.7 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.567 ' O ' HG13 ' A' ' 63' ' ' VAL . . . -74.44 -12.22 60.44 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.832 HD11 ' CE2' ' A' ' 56' ' ' PHE . 5.7 mt -91.07 -27.27 18.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -61.16 -81.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -87.29 103.91 15.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.583 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -128.93 106.73 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.897 . . . . 0.0 109.441 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.419 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.5 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 1' ' ' THR . . . 66.18 -178.42 0.2 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 152.19 29.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 3.9 mmtt -120.62 76.02 1.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.855 ' HG2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER 60.88 98.65 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' ARG . 36.6 Cg_endo -80.83 120.47 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.666 2.244 . . . . 0.0 110.262 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 6' ' ' PRO . 4.4 mtt180 43.58 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.855 HG22 ' HG2' ' A' ' 5' ' ' LYS . 58.3 t -51.53 117.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.963 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 7.0 tp -91.48 -38.55 12.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 108.809 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 7.4 m95 -169.85 76.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.074 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.724 HG23 HG13 ' A' ' 8' ' ' VAL . 51.6 p -111.06 176.09 5.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 109.588 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -57.97 -20.28 36.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.688 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -59.46 2.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.754 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.795 HD12 HG12 ' A' ' 8' ' ' VAL . 9.7 mt -62.26 -19.16 62.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 109.811 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.562 ' CE1' HD11 ' A' ' 19' ' ' LEU . 13.7 t-160 -79.96 -23.83 41.39 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -71.7 -28.91 64.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -79.01 -47.95 15.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.133 -0.979 . . . . 0.0 109.139 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.997 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.2 t80 -69.86 -22.21 63.28 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 15' ' ' HIS . 12.4 mt -78.54 -39.45 37.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 109.74 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.88 -24.34 55.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.192 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.91 -43.66 34.71 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 108.737 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.7 t -65.38 -46.44 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 108.814 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.58 -44.79 95.81 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.522 0.677 . . . . 0.0 109.391 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -59.49 -23.09 62.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 0.0 109.918 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 38' ' ' LEU . 4.7 mt -107.25 -7.03 16.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.02 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.78 108.94 0.55 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.1 -18.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.46 -46.58 79.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 13.66 15.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.8 108.93 8.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 17.2 m -96.66 160.11 30.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 109.037 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.99 9.98 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.443 2.096 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -69.65 -48.81 58.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.347 -0.845 . . . . 0.0 109.302 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 66.8 mmtt -69.9 -42.89 72.78 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 109.18 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.993 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -65.9 -24.68 34.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.031 -1.043 . . . . 0.0 108.433 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 46' ' ' ARG . 19.0 tp -54.65 -32.6 59.39 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.21 -32.05 55.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 25' ' ' LEU . 5.1 mt -60.12 -36.45 77.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.592 -0.693 . . . . 0.0 109.598 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.46 -46.73 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.97 . . . . 0.0 109.739 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 t30 51.28 24.87 2.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 108.885 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.986 ' HB ' HD12 ' A' ' 44' ' ' LEU . 76.8 t -78.95 157.82 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.556 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.3 p-10 -90.34 146.26 24.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 ttmt 77.03 -2.25 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.1 mt -95.36 107.26 19.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 109.364 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -88.97 175.97 7.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HG3' HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -78.75 -24.95 44.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.765 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.36 -22.97 54.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.583 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.93 -43.68 64.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.697 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG1' ' CE1' ' A' ' 18' ' ' PHE . 76.6 t -83.45 -26.59 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.19 -20.02 57.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 m -78.12 -45.61 22.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.73 -26.6 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 109.241 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.7 tp -81.05 -22.3 39.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 -29.28 42.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.683 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.73 -24.8 33.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.678 ' CE2' HD11 ' A' ' 60' ' ' LEU . 25.1 t80 -80.65 -48.64 12.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.232 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -40.49 75.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 42.7 t -65.8 -30.79 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.25 -11.85 57.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.678 HD11 ' CE2' ' A' ' 56' ' ' PHE . 11.3 mt -97.82 4.42 49.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 7.6 pttt -95.76 -12.34 25.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.671 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.494 ' HD3' ' HG2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -130.34 -33.05 1.72 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.764 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.574 HG11 HD23 ' A' ' 60' ' ' LEU . 8.6 p -53.39 155.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.326 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.423 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 3' ' ' GLN . . . -96.84 136.2 37.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 1.2 mp0 66.47 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 174.22 1.4 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 57.32 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' ARG . 34.8 Cg_endo -76.85 150.82 30.86 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.449 2.099 . . . . 0.0 110.391 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 6' ' ' PRO . 2.0 ptm180 -42.62 110.36 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.602 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.86 HG12 HD11 ' A' ' 14' ' ' LEU . 2.5 t -95.49 106.58 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 109.218 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.578 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 14.8 tp -107.09 -51.4 2.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.322 -0.861 . . . . 0.0 109.306 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 34.5 m95 -164.17 74.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.2 p -113.78 174.88 5.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.51 -30.89 5.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -51.52 47.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.166 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD11 HG12 ' A' ' 8' ' ' VAL . 11.9 mt -62.03 -23.1 66.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.442 -0.786 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.891 ' CD2' HD11 ' A' ' 19' ' ' LEU . 3.9 t60 -71.62 -26.5 62.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.508 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.01 -37.61 72.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -72.85 -47.51 45.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 22' ' ' VAL . 62.9 t80 -68.93 -22.29 64.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.39 -0.819 . . . . 0.0 109.678 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.891 HD11 ' CD2' ' A' ' 15' ' ' HIS . 21.8 mt -82.15 -39.67 22.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.032 -1.042 . . . . 0.0 109.912 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.17 -22.57 44.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.089 -1.007 . . . . 0.0 109.112 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -79.35 -41.24 28.31 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 108.834 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 18' ' ' PHE . 28.3 t -70.59 -45.75 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -59.94 -43.72 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.15 -23.22 62.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.529 -0.732 . . . . 0.0 109.688 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.5 mt -112.61 -0.57 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.817 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.18 107.16 0.19 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 22' ' ' VAL . 9.5 p -52.28 -19.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -1.057 . . . . 0.0 109.921 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 -42.28 65.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -116.84 14.48 15.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -89.22 133.45 34.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.8 m -115.89 160.24 36.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.397 -0.814 . . . . 0.0 109.069 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.6 Cg_endo -76.18 -17.27 17.17 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.47 2.113 . . . . 0.0 110.253 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -71.54 -54.79 9.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.171 -0.956 . . . . 0.0 109.31 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -68.7 -38.47 80.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.218 -0.927 . . . . 0.0 108.838 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.003 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -63.43 -25.34 38.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.575 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 46' ' ' ARG . 23.1 tp -51.75 -36.2 46.38 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -73.34 -35.12 65.97 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.003 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.0 mt -58.01 -35.77 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.554 -0.716 . . . . 0.0 109.336 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.0 mmm -78.98 -51.28 9.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 57.94 25.75 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 44' ' ' LEU . 72.8 t -82.27 146.54 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.295 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.0 p30 -80.32 145.92 31.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.57 0.75 3.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.658 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 41' ' ' VAL . 4.0 mm? -103.11 137.55 41.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.65 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -118.46 173.85 6.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' HD22 ' A' ' 36' ' ' LEU . 1.4 ptt180 -77.85 -19.72 54.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.18 -43.21 53.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.51 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -61.65 -36.42 80.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.31 -25.22 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.18 -20.7 57.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -77.96 -45.73 23.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -62.45 -26.22 68.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.4 tp -76.19 -29.23 57.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -77.29 -26.43 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.44 -38.49 34.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.701 ' CE2' HD11 ' A' ' 60' ' ' LEU . 11.3 t80 -64.82 -43.87 91.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.396 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -58.1 -40.86 82.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.973 . . . . 0.0 108.38 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 56.1 t -65.39 -30.79 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.552 ' O ' HG12 ' A' ' 63' ' ' VAL . . . -84.01 -11.75 56.3 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD11 ' CE2' ' A' ' 56' ' ' PHE . 7.7 mt -91.01 4.52 51.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.486 -0.759 . . . . 0.0 109.936 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 13.9 pttp -98.12 -22.92 15.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 0.0 109.545 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 68.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.5 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 59' ' ' ALA . 22.0 m -88.42 149.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.402 ' OXT' ' O ' ' A' ' 63' ' ' VAL . 11.0 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.39 120.01 13.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.463 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -130.04 75.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -139.1 75.18 1.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 61.45 132.42 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 109.49 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.468 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 35.6 Cg_endo -78.25 130.05 9.91 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.444 2.096 . . . . 0.0 110.362 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' PRO . 9.1 ptp180 -43.77 131.65 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.901 . . . . 0.0 109.709 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 8' ' ' VAL . 2.6 t -129.7 83.02 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.19 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 7.4 tp -108.78 -27.49 9.74 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.125 -0.984 . . . . 0.0 108.657 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 3.0 m95 -174.1 67.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.8 p -113.53 175.8 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.855 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -50.42 -28.37 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.784 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.77 -55.31 7.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.408 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 8' ' ' VAL . 10.2 mt -62.56 -19.64 63.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.855 ' CE1' HD11 ' A' ' 19' ' ' LEU . 15.8 t-160 -80.69 -25.38 38.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -72.93 -34.23 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -0.927 . . . . 0.0 109.476 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -78.54 -40.61 34.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.208 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.982 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.8 t80 -74.07 -22.61 59.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.855 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.6 mt -82.48 -37.44 25.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.27 -24.94 51.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.106 -0.996 . . . . 0.0 109.296 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.853 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.93 -39.7 55.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.1 t -68.51 -47.37 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 108.879 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.57 -41.75 90.91 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.566 0.698 . . . . 0.0 109.187 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -56.09 -25.86 47.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 109.606 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.983 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.8 mt -109.32 -6.19 15.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 110.031 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.95 110.25 0.77 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.17 -19.0 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -1.073 . . . . 0.0 109.831 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.23 48.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -111.08 14.42 21.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 0.0 109.822 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.38 134.42 36.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.997 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -120.99 160.55 44.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 108.951 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.72 -24.7 11.47 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.371 2.048 . . . . 0.0 110.208 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.91 -53.82 18.91 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.362 -0.836 . . . . 0.0 109.062 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 33' ' ' LYS . 2.0 mmtp -67.59 -40.21 84.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.324 -0.86 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.015 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.1 -26.3 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.655 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.046 HD22 ' HB2' ' A' ' 46' ' ' ARG . 47.9 tp -52.51 -36.3 55.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.11 -34.22 63.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.3 mt -58.99 -34.41 71.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 109.406 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.444 ' HB3' HG23 ' A' ' 41' ' ' VAL . 64.1 mmm -80.85 -51.49 8.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.6 t30 51.17 23.62 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 108.936 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.949 ' HB ' HD12 ' A' ' 44' ' ' LEU . 20.5 t -80.65 156.83 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.485 -0.759 . . . . 0.0 109.483 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 26.5 p30 -88.07 146.54 25.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 76.06 1.78 3.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.949 HD12 ' HB ' ' A' ' 41' ' ' VAL . 14.2 mt -106.16 117.71 34.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.516 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -101.39 167.97 9.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 1.046 ' HB2' HD22 ' A' ' 36' ' ' LEU . 38.6 ttp180 -76.24 -21.47 56.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -78.27 -29.43 48.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -68.59 -42.18 78.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.409 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.19 -25.09 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.33 -20.51 62.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 m -80.79 -42.03 22.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.892 . . . . 0.0 109.507 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -75.4 -28.26 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -80.84 -22.96 39.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.412 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -79.56 -38.11 34.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.39 -26.52 55.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' HD11 ' A' ' 60' ' ' LEU . 13.0 t80 -77.67 -46.62 21.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.403 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -58.02 -42.06 84.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.93 -37.87 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.25 60.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.62 HD11 ' CE2' ' A' ' 56' ' ' PHE . 11.4 mt -98.29 -15.41 19.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.6 -29.53 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -74.38 -61.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 63' ' ' VAL . 7.3 p -48.95 127.59 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.504 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.33 0.586 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 1' ' ' THR . . . 165.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -110.42 124.81 52.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.401 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 136.79 19.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.775 ' HD2' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -136.74 99.91 10.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.331 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 7' ' ' ARG . 34.9 Cg_endo -76.96 115.22 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.526 2.15 . . . . 0.0 110.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER 45.22 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 8' ' ' VAL . 2.2 t -88.15 87.84 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.117 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 13.0 tp -108.81 -24.56 11.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.26 -0.9 . . . . 0.0 109.004 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 13.2 m95 -171.74 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 108.883 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.3 p -113.54 175.42 5.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -47.74 -29.24 2.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 109.593 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.59 -53.65 15.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 8' ' ' VAL . 11.4 mt -62.51 -20.26 64.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.022 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.718 ' CE1' HD11 ' A' ' 19' ' ' LEU . 17.3 t-160 -79.05 -22.39 45.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 109.921 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -77.34 -31.04 54.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -77.09 -42.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.3 t80 -73.36 -25.48 60.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 15' ' ' HIS . 11.8 mt -82.2 -33.87 29.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.717 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 -22.96 45.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.134 -0.979 . . . . 0.0 109.359 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -78.46 -41.23 33.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.234 -0.916 . . . . 0.0 108.644 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.5 t -65.69 -47.97 84.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.15 -44.81 95.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.666 -0.646 . . . . 0.0 109.332 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -61.43 -22.93 65.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.771 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -108.16 -3.92 18.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.768 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.53 108.52 0.81 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 22' ' ' VAL . 11.4 p -54.56 -18.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -1.094 . . . . 0.0 109.738 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.82 -46.79 77.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.83 13.75 15.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.582 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.85 97.47 4.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.707 HG23 ' H ' ' A' ' 34' ' ' LYS . 33.1 m -90.48 159.88 40.45 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.279 -0.888 . . . . 0.0 108.923 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.99 -22.08 13.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.292 1.995 . . . . 0.0 109.936 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -68.11 -51.6 44.44 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.266 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.707 ' H ' HG23 ' A' ' 31' ' ' VAL . 23.1 mmtm -69.28 -44.39 71.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.154 -0.967 . . . . 0.0 108.951 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.977 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.9 mt -63.05 -23.49 33.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.08 -1.013 . . . . 0.0 108.606 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.757 HD22 ' HB2' ' A' ' 46' ' ' ARG . 29.4 tp -52.74 -39.37 62.07 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -36.49 68.86 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.012 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.6 mt -57.37 -29.38 64.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.532 -0.73 . . . . 0.0 109.254 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.0 mtp -83.25 -49.58 9.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 53.84 24.98 4.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.213 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.947 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.7 t -84.5 144.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 109.428 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -81.33 147.82 29.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 9.8 ttpt 78.05 -3.16 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.583 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.947 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.2 mt -99.47 109.56 22.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 p -89.27 169.89 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.344 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.757 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.27 -23.57 54.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -32.08 62.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -68.07 -35.61 78.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.462 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 32' ' ' PRO . 95.7 t -83.25 -25.74 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.99 -24.13 48.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.439 -0.788 . . . . 0.0 109.253 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.8 m -76.36 -44.27 37.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.334 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -62.74 -30.46 71.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.19 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.4 tp -75.19 -23.79 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 8.7 mm100 -68.75 -32.88 72.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.842 . . . . 0.0 109.565 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -76.43 -29.38 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HD11 ' A' ' 60' ' ' LEU . 9.7 t80 -74.36 -41.53 60.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.2 -0.938 . . . . 0.0 109.264 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -64.02 -45.49 88.7 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 92.7 t -65.28 -31.33 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.919 ' O ' HG12 ' A' ' 63' ' ' VAL . . . -82.65 -12.41 57.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.695 HD11 ' CE2' ' A' ' 56' ' ' PHE . 12.3 mt -92.31 4.34 53.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.546 -0.721 . . . . 0.0 109.493 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.3 pttt -81.47 -11.28 59.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -137.92 -48.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.919 HG12 ' O ' ' A' ' 59' ' ' ALA . 4.3 p -68.99 170.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.498 ' H ' HG22 ' A' ' 63' ' ' VAL . 52.3 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.485 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.38 71.36 0.87 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.372 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' LYS . 3.7 mt-30 -84.71 159.96 20.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' GLN . 22.3 mttt -52.83 -173.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -75.81 121.02 84.24 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.173 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 8' ' ' VAL . 36.2 Cg_endo -77.55 154.57 31.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.409 2.072 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -43.68 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.341 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 14' ' ' LEU . 41.1 t -82.66 117.37 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 109.781 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.603 ' O ' ' CD2' ' A' ' 10' ' ' TRP . 22.2 tp -93.44 -60.44 1.78 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 11.4 m95 -150.26 76.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' HIS . 22.8 p -113.76 175.82 5.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.11 -0.994 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 2.0 m170 -53.82 -21.14 6.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.22 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.62 -58.2 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.667 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD12 ' HB ' ' A' ' 8' ' ' VAL . 9.2 mt -82.33 -55.39 4.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.956 ' CD2' HD11 ' A' ' 19' ' ' LEU . 81.6 t60 -45.65 -25.19 0.44 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.687 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 10.6 m-20 -68.19 -48.81 64.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 109.673 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -68.25 -35.15 77.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.362 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.994 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.7 t80 -69.95 -25.98 63.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.956 HD11 ' CD2' ' A' ' 15' ' ' HIS . 45.9 mt -77.7 -44.36 28.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -24.63 61.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 108.926 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.697 ' HA ' HD22 ' A' ' 38' ' ' LEU . . . -74.27 -40.57 62.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.994 HG23 ' O ' ' A' ' 18' ' ' PHE . 16.4 t -69.51 -46.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.368 -0.833 . . . . 0.0 108.906 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.33 -40.25 85.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.412 ' ND1' ' C ' ' A' ' 24' ' ' HIS . 8.4 t-80 -54.82 -27.54 42.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.518 -0.739 . . . . 0.0 109.354 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.978 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.5 mt -106.53 -9.03 16.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.99 111.39 2.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.9 -18.33 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -1.098 . . . . 0.0 110.088 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -76.58 -43.19 39.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.216 -0.928 . . . . 0.0 110.648 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -116.72 14.87 15.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 110.257 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -69.22 124.06 22.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.984 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 23.2 m -106.17 160.4 26.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 108.994 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.8 Cg_endo -76.59 -23.57 11.15 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.347 2.031 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -69.36 -52.72 24.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.401 -0.812 . . . . 0.0 109.382 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 14.2 mtpp -67.13 -38.97 86.48 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.324 -0.86 . . . . 0.0 109.354 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.95 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.7 mt -67.23 -24.72 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.999 -1.063 . . . . 0.0 108.863 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 46' ' ' ARG . 58.0 tp -54.09 -38.97 65.9 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -74.37 -35.85 63.54 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.978 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.3 mt -57.21 -28.79 63.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.589 -0.694 . . . . 0.0 109.343 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.8 mmm -82.54 -43.94 16.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.408 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 50.85 23.77 1.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.052 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.014 ' HB ' HD12 ' A' ' 44' ' ' LEU . 93.7 t -87.48 155.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.559 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.6 p-10 -90.1 140.71 29.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER 80.22 -8.48 1.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.528 -0.732 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.014 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.5 mt -84.2 125.37 32.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.96 -1.088 . . . . 0.0 109.152 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.3 p -109.34 158.91 17.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -78.17 -17.79 56.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.412 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -74.13 -22.91 59.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.484 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -80.47 -37.7 31.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.619 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.543 HG22 ' CZ2' ' A' ' 10' ' ' TRP . 69.0 t -83.02 -24.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.35 -39.39 59.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -72.12 -38.5 69.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.516 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.7 t60 -70.04 -25.98 63.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.126 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.56 -47.61 46.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -26.9 61.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.507 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -83.27 -23.3 32.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.671 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 32.7 t80 -73.34 -41.78 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.29 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.685 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -61.95 -43.62 98.47 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.97 -34.47 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -11.8 59.79 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 57' ' ' ARG . 9.7 mt -79.2 5.16 12.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.475 -0.765 . . . . 0.0 109.62 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -93.41 -27.17 16.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.97 59.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.743 ' O ' HG13 ' A' ' 63' ' ' VAL . 11.4 p -121.42 75.55 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.459 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 3' ' ' GLN . . . -134.96 83.98 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 71.71 139.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 109.605 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' LYS . 4.0 mtpp -129.05 73.65 1.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.963 ' HG2' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER 50.96 99.37 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.53 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 7' ' ' ARG . 36.4 Cg_endo -79.47 114.68 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.561 2.174 . . . . 0.0 110.432 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' PRO . 14.2 mtt180 52.51 105.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.822 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.963 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.8 t -90.54 114.31 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.103 -0.998 . . . . 0.0 109.635 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.592 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 16.6 tp -106.04 -35.96 7.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.163 -0.96 . . . . 0.0 108.889 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 8.3 m95 -170.82 70.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.54 HG21 ' HE2' ' A' ' 5' ' ' LYS . 40.8 p -113.75 175.92 5.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -54.13 -22.84 12.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -78.13 -61.34 2.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.439 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.607 HD12 HG12 ' A' ' 8' ' ' VAL . 10.2 mt -57.79 -19.58 29.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.883 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.875 ' NE2' HD11 ' A' ' 19' ' ' LEU . 4.7 t60 -75.8 -32.94 60.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -67.42 -30.36 70.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.73 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HD2' HD23 ' A' ' 14' ' ' LEU . 16.7 mttm -78.71 -38.12 39.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.955 ' O ' HG23 ' A' ' 22' ' ' VAL . 60.7 t80 -75.19 -23.22 57.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.676 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.875 HD11 ' NE2' ' A' ' 15' ' ' HIS . 4.5 mt -82.48 -36.54 26.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.66 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.31 -24.5 50.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.7 -43.32 38.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 108.768 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.5 t -67.16 -45.7 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -59.54 -43.54 93.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -58.61 -23.22 58.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.534 -0.728 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.889 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -112.83 -1.66 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.02 107.19 0.49 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 22' ' ' VAL . 8.1 p -54.41 -18.58 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -1.146 . . . . 0.0 109.748 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -46.79 74.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.949 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -116.8 14.01 15.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.194 -0.941 . . . . 0.0 109.919 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.567 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -70.05 125.61 27.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.772 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 34' ' ' LYS . 16.7 m -109.66 160.04 29.37 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.316 -0.865 . . . . 0.0 108.932 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.47 -19.25 15.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.41 2.074 . . . . 0.0 110.046 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -70.54 -55.13 9.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.397 -0.814 . . . . 0.0 109.03 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 31' ' ' VAL . 16.7 mttp -67.92 -39.47 83.52 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.951 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -68.0 -25.32 31.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.091 -1.043 . . . . 0.0 108.562 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 46' ' ' ARG . 25.8 tp -53.63 -38.33 63.96 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.1 -35.64 66.64 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.4 mt -57.66 -31.39 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.627 -0.67 . . . . 0.0 109.419 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.413 ' SD ' HD13 ' A' ' 44' ' ' LEU . 3.3 mtt -79.96 -53.24 6.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 55.17 27.0 8.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.202 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.97 ' HB ' HD12 ' A' ' 44' ' ' LEU . 24.5 t -88.31 157.52 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.498 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -90.27 140.87 29.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 81.84 -7.44 1.39 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 110.033 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.97 HD12 ' HB ' ' A' ' 41' ' ' VAL . 16.9 mt -90.58 136.99 32.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.418 ' OG1' ' OD1' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -114.0 164.26 14.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.554 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.853 ' HB2' HD22 ' A' ' 36' ' ' LEU . 32.7 ttp85 -78.73 -31.37 46.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.94 -22.87 63.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.418 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 3.9 m-20 -72.24 -36.52 69.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.12 -27.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.16 -0.962 . . . . 0.0 109.226 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.93 -20.17 63.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.304 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m -72.69 -50.26 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.378 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -54.39 -28.68 45.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.301 -0.874 . . . . 0.0 108.964 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.87 -35.33 64.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -63.41 -35.69 81.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -56.82 -32.81 66.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.146 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.897 ' CE2' HD11 ' A' ' 60' ' ' LEU . 47.8 t80 -69.29 -49.07 59.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.156 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -53.04 -38.12 62.16 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.45 -41.38 92.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.45 -12.43 61.39 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.897 HD11 ' CE2' ' A' ' 56' ' ' PHE . 12.4 mt -91.37 -13.6 32.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.465 -0.772 . . . . 0.0 109.41 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 62' ' ' LYS . 66.4 tttt -68.56 -35.0 76.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.58 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -45.02 -26.99 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.396 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 60' ' ' LEU . 7.3 p -59.83 142.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.99 -176.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.65 134.34 47.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 4.3 mmpt? -52.72 -179.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -109.62 100.55 42.67 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.385 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 4' ' ' LYS . 34.6 Cg_endo -77.5 152.91 30.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.394 2.063 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.453 ' NH2' HD13 ' A' ' 9' ' ' LEU . 4.0 mmm-85 -43.07 100.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.917 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 8' ' ' VAL . 2.2 t -86.95 89.92 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.96 . . . . 0.0 109.072 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 5.4 tp -99.91 -41.71 7.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.141 -0.974 . . . . 0.0 108.466 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.681 ' HZ2' HG13 ' A' ' 49' ' ' VAL . 5.7 m95 -168.0 70.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p -103.95 175.78 5.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 109.815 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.97 -27.78 5.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.63 -56.55 4.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.649 HD11 HG12 ' A' ' 8' ' ' VAL . 8.4 mt -60.88 -19.26 59.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.348 -0.845 . . . . 0.0 110.092 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.926 ' NE2' HD11 ' A' ' 19' ' ' LEU . 4.0 t60 -77.33 -26.05 51.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.915 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.69 -43.69 53.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.75 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -78.39 -33.82 48.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 108.836 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.972 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.1 t80 -76.59 -23.19 53.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.35 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.926 HD11 ' NE2' ' A' ' 15' ' ' HIS . 13.7 mt -78.79 -37.77 40.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.025 -1.047 . . . . 0.0 109.628 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.81 50.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.142 -0.974 . . . . 0.0 108.902 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.812 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.41 -43.43 40.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.312 -0.867 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 18' ' ' PHE . 25.0 t -67.24 -45.76 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.733 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -59.96 -43.12 95.25 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.516 0.674 . . . . 0.0 109.262 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -58.28 -23.16 55.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.739 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.936 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -111.39 -4.49 14.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.152 -0.967 . . . . 0.0 110.067 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.37 110.05 1.08 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 22' ' ' VAL . 13.7 p -54.07 -18.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -1.116 . . . . 0.0 109.909 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 29' ' ' ARG . 8.7 pt-20 -80.16 -37.41 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.75 14.5 15.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.176 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.32 135.27 36.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.163 -0.961 . . . . 0.0 110.091 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.7 m -119.74 160.53 42.03 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.365 -0.835 . . . . 0.0 108.936 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.854 ' HD3' HD22 ' A' ' 53' ' ' LEU . 33.9 Cg_endo -75.64 -24.21 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.409 2.073 . . . . 0.0 110.005 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.1 -52.42 28.48 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.371 -0.831 . . . . 0.0 109.298 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 31' ' ' VAL . 13.4 mttt -69.18 -38.89 78.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.005 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -67.8 -24.78 31.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.082 -1.011 . . . . 0.0 108.61 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.007 HD22 ' HB3' ' A' ' 46' ' ' ARG . 20.3 tp -53.34 -37.92 62.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.99 -34.47 64.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.005 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.6 mt -59.24 -31.64 69.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.442 -0.786 . . . . 0.0 109.579 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.681 ' HB3' HG23 ' A' ' 41' ' ' VAL . 83.0 mmm -85.09 -50.26 7.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.7 t30 54.48 25.46 6.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.21 -0.932 . . . . 0.0 109.104 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.878 ' HB ' HD12 ' A' ' 44' ' ' LEU . 7.8 t -78.77 158.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.54 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 22.4 p30 -89.67 144.66 25.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 76.37 -0.5 3.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.878 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.4 mt -101.81 115.56 30.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 109.506 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -99.26 168.23 10.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.414 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 1.007 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.75 -18.23 60.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -32.94 61.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.481 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 ' HZ2' ' A' ' 10' ' ' TRP . 5.0 t -83.24 -25.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.134 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 32' ' ' PRO . . . -77.7 -20.85 52.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.281 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -76.63 -43.76 37.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 109.297 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.8 t60 -67.07 -30.75 70.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.854 HD22 ' HD3' ' A' ' 32' ' ' PRO . 5.8 tp -75.25 -41.57 57.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.435 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.71 -30.95 70.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -67.76 -27.46 66.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -72.61 -37.75 67.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 109.102 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 60' ' ' LEU . 6.8 mtp180 -63.95 -43.53 95.54 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 61' ' ' LYS . 42.8 t -64.39 -34.06 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.23 -12.34 59.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 57' ' ' ARG . 9.8 mt -80.2 -27.31 38.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.447 -0.783 . . . . 0.0 109.577 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 58' ' ' VAL . 1.4 ptmt -79.44 -0.74 34.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.385 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -111.21 6.75 20.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 63' ' ' VAL . 9.3 p -158.87 123.55 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 109.451 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.478 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.652 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 13.9 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 1' ' ' THR . . . 72.31 60.98 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.13 55.49 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -178.24 48.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' LYS . 26.5 tttt 56.32 109.69 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.657 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 7' ' ' ARG . 35.4 Cg_endo -76.91 155.4 34.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.474 2.116 . . . . 0.0 110.317 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 6' ' ' PRO . 7.6 ptm180 -40.59 116.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.814 . . . . 0.0 109.729 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 8' ' ' VAL . 2.3 t -94.08 93.28 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 109.326 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.544 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 11.5 tp -108.3 -32.03 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.544 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 14.9 m95 -168.97 68.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.873 . . . . 0.0 109.185 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.93 174.22 6.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -48.99 -29.21 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.213 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' CG ' ' HE3' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -69.11 -54.06 16.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.1 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.555 HD11 HG12 ' A' ' 8' ' ' VAL . 11.9 mt -58.51 -20.08 42.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.58 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -78.58 -32.82 47.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.41 -38.25 65.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.763 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.409 ' HE3' ' CG ' ' A' ' 13' ' ' GLU . 74.2 mttt -74.33 -35.31 63.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.7 t80 -72.41 -26.88 62.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.883 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 19' ' ' LEU . 12.6 mt -80.54 -39.85 27.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -23.68 51.34 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.068 -1.02 . . . . 0.0 109.127 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.43 -41.8 38.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.867 . . . . 0.0 108.967 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -69.6 -45.11 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 108.658 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -59.57 -42.31 92.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.476 0.655 . . . . 0.0 109.236 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -57.49 -24.26 54.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -0.759 . . . . 0.0 109.676 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.048 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.9 mt -110.47 -4.83 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.22 110.1 0.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 22' ' ' VAL . 6.3 p -53.94 -18.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -41.51 53.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -116.74 14.74 15.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.142 -0.973 . . . . 0.0 109.818 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -78.25 121.32 24.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 110.073 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG23 ' H ' ' A' ' 34' ' ' LYS . 19.1 m -104.24 160.11 27.12 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 108.81 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.42 -25.76 9.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.355 2.037 . . . . 0.0 110.066 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.27 -50.26 54.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.319 -0.863 . . . . 0.0 109.517 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' H ' HG23 ' A' ' 31' ' ' VAL . 12.6 mttm -68.16 -40.71 82.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.151 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.03 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.6 mt -63.88 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.07 . . . . 0.0 108.681 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 23.6 tp -54.2 -35.0 61.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 3.0 p30 -78.99 -28.93 43.53 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.048 ' CD1' HD11 ' A' ' 25' ' ' LEU . 6.2 mt -63.36 -31.83 73.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.495 -0.753 . . . . 0.0 109.129 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 41' ' ' VAL . 1.8 mtt -89.12 -40.95 12.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.462 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 52.25 25.37 3.32 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 109.051 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 44' ' ' LEU . 19.5 t -80.93 146.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 109.582 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 17.6 p-10 -89.82 149.92 22.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.344 -0.847 . . . . 0.0 109.516 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 79.07 -3.76 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -93.41 130.3 39.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.304 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -102.59 160.42 14.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -77.97 -21.97 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -29.97 62.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -69.83 -37.88 76.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.41 -25.32 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.55 -21.73 48.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.9 m -78.95 -43.02 25.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -67.81 -27.39 66.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -74.6 -38.77 62.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -67.97 -40.87 83.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.417 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -72.35 -31.68 65.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 60' ' ' LEU . 14.0 t80 -65.77 -43.68 88.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.328 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -57.48 -41.04 79.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 108.334 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.98 -34.54 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.01 59.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -88.09 -11.81 46.0 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 109.525 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.4 5.07 4.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.538 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -12.58 10.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.7 p -75.19 131.97 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.443 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.3 177.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -114.34 51.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 3' ' ' GLN . 6.4 mttp 43.66 52.38 6.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.408 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -164.48 107.17 0.86 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.401 -0.812 . . . . 0.0 109.447 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 7' ' ' ARG . 34.7 Cg_endo -77.18 155.34 33.12 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.377 2.051 . . . . 0.0 110.11 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -40.24 103.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 109.687 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 8' ' ' VAL . 2.2 t -65.46 87.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.585 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 8.5 tp -112.26 -27.53 8.29 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 14.9 m95 -169.3 60.61 0.05 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -114.08 175.82 5.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 30.2 t-80 -47.81 -22.05 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.697 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.77 -50.75 10.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.982 -1.074 . . . . 0.0 109.574 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.692 ' CD1' HG12 ' A' ' 8' ' ' VAL . 10.4 mt -85.05 -58.28 2.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.987 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.499 ' HE1' HD11 ' A' ' 19' ' ' LEU . 52.9 t-80 -49.46 -22.08 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 2.7 m120 -73.4 -42.24 62.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -64.51 -36.63 84.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 109.352 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.063 ' O ' HG23 ' A' ' 22' ' ' VAL . 47.1 t80 -69.62 -32.92 71.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD11 ' HE1' ' A' ' 15' ' ' HIS . 11.5 mt -70.38 -45.49 65.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.71 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.11 70.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -70.79 -40.36 72.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.229 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -63.56 -48.16 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.28 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -59.18 -44.11 92.18 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 109.326 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.54 -22.89 65.55 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 110.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 38' ' ' LEU . 2.6 mt -110.45 -1.69 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.045 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.03 108.45 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 p -53.13 -19.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -1.107 . . . . 0.0 109.557 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.61 -44.06 83.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -116.94 13.16 14.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -0.999 . . . . 0.0 110.159 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -81.19 109.01 15.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.878 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.9 m -99.67 160.49 27.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 108.949 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.4 Cg_endo -76.13 -27.32 8.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.434 2.089 . . . . 0.0 110.022 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -68.48 -48.42 64.51 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.471 -0.768 . . . . 0.0 109.248 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -70.17 -42.72 72.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.978 . . . . 0.0 109.227 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.858 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -66.61 -24.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.014 -1.053 . . . . 0.0 108.634 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.948 HD22 ' HB3' ' A' ' 46' ' ' ARG . 10.8 tp -56.16 -31.02 62.99 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.61 -32.14 57.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.009 HD11 HD11 ' A' ' 25' ' ' LEU . 52.1 mt -57.87 -37.91 74.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.113 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.775 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 mmm -84.37 -47.95 10.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.769 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 49.24 25.09 1.12 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.123 -0.986 . . . . 0.0 108.804 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.946 ' HB ' HD12 ' A' ' 44' ' ' LEU . 11.9 t -78.55 159.54 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.527 -0.733 . . . . 0.0 109.81 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.2 p-10 -86.18 147.72 25.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 109.223 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 78.9 -6.39 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 109.603 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.946 HD12 ' HB ' ' A' ' 41' ' ' VAL . 11.7 mt -102.86 102.64 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.447 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 p -91.73 169.25 10.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.105 -0.997 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.948 ' HB3' HD22 ' A' ' 36' ' ' LEU . 14.2 ptm180 -69.96 -18.6 63.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -0.852 . . . . 0.0 109.669 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -76.76 -24.26 52.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.747 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.37 -33.47 37.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 4.3 t -83.33 -30.28 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.178 -0.951 . . . . 0.0 108.775 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.88 43.87 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.128 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -80.14 -42.12 24.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.278 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 15' ' ' HIS . 55.7 t-80 -69.85 -30.6 68.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp -77.81 -35.19 51.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -74.03 -30.81 62.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -29.21 61.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -74.69 -44.29 50.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.259 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -58.79 -42.39 88.95 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.93 -37.81 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.13 60.22 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.07 -17.38 27.85 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -103.65 11.86 35.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.476 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.79 29.25 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 63' ' ' VAL . 3.5 p -117.62 62.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.538 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -44.91 127.29 6.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.558 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.26 88.01 4.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -155.49 67.86 0.65 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -108.65 105.2 56.49 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.322 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 35.1 Cg_endo -77.72 127.37 8.71 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.418 2.079 . . . . 0.0 110.351 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 46.5 mtt85 65.61 128.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.888 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.699 HG12 HD11 ' A' ' 14' ' ' LEU . 2.1 t -137.79 97.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 6.6 tp -106.53 -32.48 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 12.8 m95 -169.07 70.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.145 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.5 p -113.93 174.18 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -0.963 . . . . 0.0 109.767 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.15 9.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.221 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -67.41 -51.54 50.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.373 -0.829 . . . . 0.0 109.139 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.699 HD11 HG12 ' A' ' 8' ' ' VAL . 11.7 mt -64.57 -19.97 65.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.431 -0.793 . . . . 0.0 109.983 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.593 ' NE2' HD11 ' A' ' 19' ' ' LEU . 15.2 t60 -80.91 -22.19 39.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 110.03 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.46 -32.1 42.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.918 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -80.41 -35.86 34.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.946 ' O ' HG23 ' A' ' 22' ' ' VAL . 18.3 t80 -76.96 -23.37 52.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.539 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD11 ' NE2' ' A' ' 15' ' ' HIS . 12.8 mt -83.01 -35.77 25.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.666 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.58 -26.86 55.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.093 -1.004 . . . . 0.0 109.274 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.03 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -75.03 -41.55 58.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.176 -0.953 . . . . 0.0 108.786 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 18' ' ' PHE . 17.3 t -67.37 -47.9 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.847 . . . . 0.0 108.985 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -59.52 -41.88 90.99 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.502 0.667 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.475 ' O ' ' CD2' ' A' ' 24' ' ' HIS . 21.1 t-160 -58.91 -24.0 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.505 -0.747 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 38' ' ' LEU . 3.4 mt -108.5 -7.5 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.96 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 109.46 0.27 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.03 -20.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -1.07 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.17 -41.21 64.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.818 . . . . 0.0 110.24 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.27 14.73 15.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.09 -1.006 . . . . 0.0 110.003 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . . . -92.25 132.0 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.157 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 34' ' ' LYS . 2.4 m -110.36 160.25 29.13 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.4 -25.52 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.367 2.045 . . . . 0.0 110.369 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 9.9 tmtt? -68.43 -52.93 27.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.301 -0.875 . . . . 0.0 109.309 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -66.21 -39.49 89.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.314 -0.866 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.053 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.92 -26.8 39.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.995 -1.065 . . . . 0.0 108.691 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.904 HD22 ' HB2' ' A' ' 46' ' ' ARG . 17.3 tp -52.78 -36.1 57.6 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.31 -34.82 68.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.053 HD12 ' HA ' ' A' ' 35' ' ' ILE . 4.9 mt -57.09 -37.27 71.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.529 -0.732 . . . . 0.0 109.125 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.7 mmm -76.56 -52.73 9.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 51.24 24.63 2.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 108.951 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.005 ' HB ' HD12 ' A' ' 44' ' ' LEU . 66.4 t -79.91 153.31 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.617 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 5.6 p-10 -90.03 143.1 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.9 OUTLIER 82.46 -7.31 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.005 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.1 mt -91.38 143.46 26.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 109.53 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -118.31 163.74 16.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.904 ' HB2' HD22 ' A' ' 36' ' ' LEU . 59.7 ttp85 -73.76 -19.07 60.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.21 -24.61 47.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.04 -44.77 65.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.5 t -83.24 -25.81 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.25 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -19.99 58.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.309 -0.869 . . . . 0.0 109.09 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -74.48 -48.03 29.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.851 . . . . 0.0 109.565 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -60.67 -37.41 81.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.975 . . . . 0.0 109.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 tp -64.72 -43.52 93.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -68.8 -25.68 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -71.9 -29.4 64.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -68.13 -48.15 66.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.212 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -54.16 -38.18 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.78 -40.04 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -14.55 62.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.86 -20.82 20.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.287 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -88.51 -66.19 0.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -94.16 62.31 3.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 109.422 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -57.27 177.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.78 151.14 17.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.53 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.513 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -171.69 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.674 ' HG3' HG23 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -65.32 134.38 95.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.273 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 36.2 Cg_endo -79.05 134.71 11.85 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.561 2.174 . . . . 0.0 110.812 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER 38.01 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 110.514 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 8' ' ' VAL . 2.5 t -76.26 89.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 108.978 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 18.2 tp -102.19 -37.58 8.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.149 -0.97 . . . . 0.0 109.256 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 15.9 m95 -172.15 73.93 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.096 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -113.48 175.21 5.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -49.72 -24.75 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.24 -54.52 7.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.718 HD11 HG12 ' A' ' 8' ' ' VAL . 10.9 mt -60.44 -20.1 58.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.418 -0.801 . . . . 0.0 109.803 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.721 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -75.93 -28.65 58.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.836 . . . . 0.0 109.7 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -69.39 -42.74 74.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.839 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -72.22 -37.76 69.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.119 -0.988 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.949 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.9 t80 -73.66 -22.43 59.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.32 -0.863 . . . . 0.0 109.836 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.721 HD11 ' CE1' ' A' ' 15' ' ' HIS . 10.6 mt -83.2 -39.07 21.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.804 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.36 -23.78 50.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.053 -1.029 . . . . 0.0 109.189 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.748 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.85 -39.52 50.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.244 -0.91 . . . . 0.0 109.011 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 35' ' ' ILE . 17.4 t -71.36 -47.35 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 108.605 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.29 -40.67 86.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -56.7 -27.74 59.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.532 -0.73 . . . . 0.0 109.536 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.964 HD11 ' CD1' ' A' ' 38' ' ' LEU . 3.2 mt -105.19 -7.78 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.4 110.7 1.1 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -48.55 -23.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -1.131 . . . . 0.0 109.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.52 -45.88 71.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.76 . . . . 0.0 110.023 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 mtt85 -111.49 14.53 21.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.605 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -76.72 117.24 18.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 110.008 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -110.44 160.84 27.01 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 33.6 Cg_endo -75.38 -26.86 9.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.28 1.986 . . . . 0.0 110.26 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 7.3 tmtt? -68.53 -50.96 48.07 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.1 mmtt -69.36 -42.58 75.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.204 -0.935 . . . . 0.0 109.083 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.001 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -63.34 -25.28 38.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.75 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.813 HD22 ' CG ' ' A' ' 46' ' ' ARG . 17.1 tp -52.48 -36.76 55.65 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.45 -33.12 62.84 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.001 HD12 ' HA ' ' A' ' 35' ' ' ILE . 5.1 mt -60.25 -35.15 74.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.536 -0.727 . . . . 0.0 109.597 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.448 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.3 mmt -79.0 -48.08 15.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.371 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t30 53.36 23.54 3.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.022 ' HB ' HD12 ' A' ' 44' ' ' LEU . 18.8 t -86.77 158.78 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.08 148.78 24.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.861 . . . . 0.0 109.187 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.7 ttmt 77.0 -2.95 2.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.022 HD12 ' HB ' ' A' ' 41' ' ' VAL . 13.5 mt -101.57 95.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -90.89 176.95 6.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.813 ' CG ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -72.75 -18.98 61.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -34.23 42.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -73.53 -38.49 65.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 109.574 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -82.97 -25.9 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.956 . . . . 0.0 109.196 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 46' ' ' ARG . . . -69.78 -22.14 63.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.415 -0.803 . . . . 0.0 109.308 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 m -74.55 -49.34 22.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 6.5 t60 -55.45 -29.0 57.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.113 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp -75.16 -33.75 61.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -65.3 -30.54 71.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 109.307 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 52' ' ' HIS . 1.6 mtpp -72.59 -20.74 61.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -68.7 -42.3 77.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.78 -42.62 97.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 108.416 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.2 t -65.46 -31.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 -10.94 58.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 12.3 mt -76.17 5.54 6.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.554 -0.716 . . . . 0.0 109.657 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' VAL . 5.4 ttmm 72.82 56.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.612 -0.68 . . . . 0.0 109.631 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 61' ' ' LYS . 3.7 ttpt 35.08 71.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.184 0.516 . . . . 0.0 110.252 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 61' ' ' LYS . 71.3 t -126.37 160.74 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 109.596 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.508 ' N ' HG12 ' A' ' 63' ' ' VAL . 45.7 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.482 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 1' ' ' THR . . . 178.71 158.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 65.86 65.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 95.11 2.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' HE3' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -123.06 101.33 38.78 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.191 -0.943 . . . . 0.0 110.218 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.41 113.74 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.174 1.916 . . . . 0.0 108.966 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.439 ' HD2' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 62.22 84.45 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.087 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.915 HG13 HD13 ' A' ' 14' ' ' LEU . 2.1 t -39.76 130.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.489 -0.757 . . . . 0.0 110.0 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.621 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 14.3 tp -117.54 -60.97 1.76 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.54 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.621 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 6.0 m95 179.48 72.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.594 -0.691 . . . . 0.0 109.387 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.518 ' CG2' ' HE3' ' A' ' 5' ' ' LYS . 73.2 p -83.45 162.83 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.131 -0.981 . . . . 0.0 109.44 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -55.24 -25.25 32.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -83.71 -46.41 12.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.743 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.915 HD13 HG13 ' A' ' 8' ' ' VAL . 67.7 mt -64.98 -19.56 66.04 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.551 -0.718 . . . . 0.0 109.742 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.621 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 70.2 t60 -79.51 -22.33 44.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.224 -0.922 . . . . 0.0 109.297 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -71.31 -28.39 64.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.563 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -80.43 -38.68 29.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.021 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.8 t80 -75.7 -24.13 56.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 15' ' ' HIS . 11.8 mt -75.84 -41.69 51.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.536 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.09 -24.65 59.51 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.13 -0.982 . . . . 0.0 109.347 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -77.27 -41.86 39.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 18' ' ' PHE . 19.7 t -66.61 -45.49 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.931 . . . . 0.0 108.889 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -61.62 -45.28 94.74 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.547 0.689 . . . . 0.0 109.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -62.6 -23.4 67.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.462 -0.774 . . . . 0.0 110.205 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.2 mt -107.89 -3.45 18.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 109.847 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.36 107.64 0.16 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 8.0 p -51.5 -21.01 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -1.12 . . . . 0.0 109.52 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.8 -45.07 91.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -116.75 13.81 15.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 27' ' ' VAL . . . -83.21 118.53 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.083 -1.01 . . . . 0.0 109.714 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 34' ' ' LYS . 1.8 m -105.6 160.02 27.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 108.927 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.55 -26.21 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.406 2.07 . . . . 0.0 110.142 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -68.85 -51.02 44.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 109.242 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' A' ' 31' ' ' VAL . 62.6 mttm -69.81 -41.42 75.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.085 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.994 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.5 mt -65.65 -24.76 35.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.54 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 46' ' ' ARG . 27.2 tp -52.99 -38.84 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.22 -35.18 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' A' ' 25' ' ' LEU . 4.5 mt -58.09 -32.69 68.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.559 -0.713 . . . . 0.0 109.599 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.33 -43.37 67.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.469 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.84 26.98 8.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.951 . . . . 0.0 109.041 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.969 ' HB ' HD12 ' A' ' 44' ' ' LEU . 58.6 t -97.13 148.09 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.138 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.8 p-10 -84.33 148.35 26.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 76.87 -0.9 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.75 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.969 HD12 ' HB ' ' A' ' 41' ' ' VAL . 10.8 mt -100.16 110.22 22.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.132 -0.98 . . . . 0.0 109.392 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.0 p -96.21 172.14 8.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.488 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.754 ' HB3' HD22 ' A' ' 36' ' ' LEU . 4.4 ptt180 -76.64 -17.89 58.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.923 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.78 -34.5 60.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -65.4 -38.76 90.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.14 -25.68 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.062 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.33 -28.02 63.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.845 . . . . 0.0 109.349 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.5 m -70.55 -50.51 36.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.853 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.34 -32.01 68.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.07 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 6.0 tp -78.23 -24.39 47.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.25 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.02 73.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.874 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 31.9 mmtt -56.51 -33.92 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.108 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CE2' HD11 ' A' ' 60' ' ' LEU . 8.9 t80 -69.18 -45.68 69.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 108.899 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.25 -38.01 62.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.017 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.8 t -65.79 -37.14 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.85 -12.12 60.1 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.691 HD11 ' CE2' ' A' ' 56' ' ' PHE . 7.9 mt -101.96 -4.12 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.52 -0.737 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 63' ' ' VAL . 1.1 ttmt -46.63 -57.35 4.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.217 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.514 -0.741 . . . . 0.0 109.238 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 63' ' ' VAL . 7.5 p -147.56 114.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.446 179.802 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.29 63.99 0.94 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' LYS . 1.7 tt0 61.81 110.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 5' ' ' LYS . 1.6 tptt -43.95 118.19 1.39 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.367 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.554 ' HD2' HG23 ' A' ' 8' ' ' VAL . 2.1 ttpm? -39.21 99.24 0.19 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.703 -0.623 . . . . 0.0 109.642 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 7' ' ' ARG . 37.1 Cg_endo -82.44 113.8 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.57 2.18 . . . . 0.0 110.878 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER 29.77 98.48 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.084 0.468 . . . . 0.0 110.942 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.728 HG13 ' HG ' ' A' ' 14' ' ' LEU . 3.0 t -50.38 89.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 10.5 tp -116.12 -27.12 7.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 22.1 m95 -172.57 66.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.794 . . . . 0.0 109.011 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -113.69 173.27 6.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.813 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 26.4 p80 -50.59 -27.29 6.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -0.808 . . . . 0.0 109.326 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.0 -54.49 9.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.728 ' HG ' HG13 ' A' ' 8' ' ' VAL . 11.6 mt -54.59 -24.53 21.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.924 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.4 t60 -72.43 -36.83 68.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 12' ' ' HIS . 20.3 m120 -71.37 -25.14 62.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.861 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -79.55 -41.68 26.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.987 ' O ' HG23 ' A' ' 22' ' ' VAL . 63.0 t80 -70.06 -23.57 63.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.924 HD11 ' CE1' ' A' ' 15' ' ' HIS . 23.2 mt -80.32 -43.84 20.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.162 -0.962 . . . . 0.0 109.53 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -22.7 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.112 -0.993 . . . . 0.0 109.262 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.059 ' HB1' HD13 ' A' ' 38' ' ' LEU . . . -76.34 -43.94 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 0.0 108.707 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 18' ' ' PHE . 15.0 t -64.01 -47.9 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.88 . . . . 0.0 108.915 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -59.52 -44.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.608 0.718 . . . . 0.0 109.137 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -58.14 -23.34 54.78 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.654 -0.654 . . . . 0.0 109.852 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.035 HD11 HD11 ' A' ' 38' ' ' LEU . 2.9 mt -110.16 -4.9 15.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.994 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.84 109.11 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.88 -19.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -1.068 . . . . 0.0 109.798 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 -45.45 75.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.51 14.03 15.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 109.897 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -72.1 105.4 3.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 34' ' ' LYS . 5.9 m -93.17 160.46 33.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.009 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 35.0 Cg_endo -76.86 -29.2 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.426 2.084 . . . . 0.0 110.068 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 6.7 tmtt? -65.84 -49.6 67.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.208 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HB2' HG23 ' A' ' 31' ' ' VAL . 2.0 mtpt -67.36 -45.01 77.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.039 ' HA ' HD12 ' A' ' 38' ' ' LEU . 1.8 mt -62.8 -23.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.698 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 46' ' ' ARG . 55.3 tp -53.81 -36.93 63.01 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -74.79 -31.43 61.74 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.059 HD13 ' HB1' ' A' ' 21' ' ' ALA . 5.7 mt -59.74 -32.76 70.85 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 41' ' ' VAL . 42.2 mmm -84.36 -49.99 8.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.817 . . . . 0.0 109.59 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.55 23.65 1.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 108.932 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.034 ' HB ' HD12 ' A' ' 44' ' ' LEU . 8.7 t -82.05 151.93 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.708 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.78 150.03 23.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.569 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER 77.17 -2.35 2.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.661 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.034 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.9 mt -99.04 104.09 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 p -82.73 162.67 21.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HB3' HD22 ' A' ' 36' ' ' LEU . 23.2 ptt180 -69.6 -19.04 63.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.157 -0.965 . . . . 0.0 109.451 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 -26.49 38.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.36 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -41.53 71.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.24 -30.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.35 -20.01 62.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -75.79 -50.06 16.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.862 . . . . 0.0 109.227 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -57.11 -31.23 65.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.209 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.3 tp -79.31 -27.47 42.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' HG23 ' A' ' 58' ' ' VAL . 4.2 mt-30 -68.36 -25.86 65.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -71.08 -28.62 64.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 60' ' ' LEU . 8.9 t80 -81.84 -51.73 7.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.4 mtp85 -54.88 -40.02 69.3 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 54' ' ' GLN . 40.8 t -64.58 -42.67 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.58 -12.28 61.52 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.711 HD11 ' CE2' ' A' ' 56' ' ' PHE . 4.9 mt -102.77 -12.91 17.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.4 -0.813 . . . . 0.0 109.443 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -76.4 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.75 78.14 9.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.543 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 63' ' ' VAL . 12.0 p -162.36 116.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.462 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.55 175.59 5.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.443 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -79.36 105.75 10.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.917 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' LYS . 8.5 pttt -171.67 61.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.29 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 4' ' ' LYS . 15.4 mtmm 54.49 99.71 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.243 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' O ' ' CG ' ' A' ' 7' ' ' ARG . 35.7 Cg_endo -79.12 114.03 3.29 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.344 2.029 . . . . 0.0 110.59 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 38.28 54.91 1.78 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.654 -0.654 . . . . 0.0 110.293 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 8' ' ' VAL . 2.5 t -82.05 83.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.06 . . . . 0.0 109.123 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' CG ' ' A' ' 10' ' ' TRP . 13.1 tp -107.68 -29.22 9.26 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.254 -0.904 . . . . 0.0 108.774 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 9' ' ' LEU . 6.9 m95 -176.3 69.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -112.57 175.35 5.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -49.64 -22.48 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.309 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -53.67 7.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HG ' HG13 ' A' ' 8' ' ' VAL . 10.5 mt -62.76 -20.19 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 110.101 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.857 ' CD2' HD11 ' A' ' 19' ' ' LEU . 27.7 t60 -78.72 -22.57 46.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.778 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.683 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -75.29 -41.05 58.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.055 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.2 t80 -69.21 -22.2 63.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.439 -0.788 . . . . 0.0 109.723 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 15' ' ' HIS . 20.0 mt -81.05 -44.38 18.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.98 59.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.954 -1.091 . . . . 0.0 109.165 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.981 ' CB ' HD13 ' A' ' 38' ' ' LEU . . . -77.29 -43.49 33.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 0.0 109.104 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 18' ' ' PHE . 21.3 t -64.64 -43.69 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 108.969 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -57.92 -43.31 86.14 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.644 0.735 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' HIS . 14.4 t60 -62.0 -23.11 66.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.0 110.316 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 38' ' ' LEU . 2.4 mt -111.04 -2.34 15.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.98 -1.075 . . . . 0.0 110.195 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 108.59 0.31 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.27 -18.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -1.069 . . . . 0.0 109.892 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -65.87 -47.28 75.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.785 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 29' ' ' ARG . 2.6 mtp85 -117.08 13.85 14.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' CB ' HG13 ' A' ' 22' ' ' VAL . . . -63.07 119.23 9.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.0 109.984 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG23 ' H ' ' A' ' 34' ' ' LYS . 10.7 m -105.48 159.97 27.65 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 31' ' ' VAL . 34.2 Cg_endo -76.54 -24.2 10.68 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.344 2.029 . . . . 0.0 110.036 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 1.4 tmtt? -70.16 -43.84 70.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.57 -46.32 63.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.328 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.972 ' HA ' HD12 ' A' ' 38' ' ' LEU . 2.9 mt -64.69 -25.7 38.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.277 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 46' ' ' ARG . 24.5 tp -52.29 -34.57 47.31 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.1 -34.69 59.51 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.981 HD13 ' CB ' ' A' ' 21' ' ' ALA . 4.0 mt -57.92 -33.87 69.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.694 -0.629 . . . . 0.0 109.665 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 41' ' ' VAL . 26.9 mtp -86.43 -47.4 9.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.85 23.89 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 108.93 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 44' ' ' LEU . 45.2 t -77.98 157.82 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 0.0 109.543 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 p30 -84.14 143.44 29.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 75.9 4.47 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.541 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 41' ' ' VAL . 12.5 mt -111.75 100.59 9.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.505 ' C ' HD13 ' A' ' 36' ' ' LEU . 22.1 p -94.03 169.89 9.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.388 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -59.96 -23.27 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.269 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 44.3 tp10 -73.57 -32.62 64.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.339 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.25 -34.73 78.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.45 -30.35 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.888 . . . . 0.0 109.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.42 -20.12 60.16 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.361 -0.837 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -75.95 -48.48 21.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.119 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -58.6 -37.75 76.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.012 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.7 -39.43 80.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.29 -29.9 70.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.239 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -60.85 -36.55 79.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.82 -46.86 83.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 0.0 108.884 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -54.3 -36.57 63.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.59 -38.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 61' ' ' LYS . 12.8 mt -80.37 5.89 13.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.633 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 9.3 ttmm 87.67 76.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.412 0.625 . . . . 0.0 109.532 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' LYS . 7.6 tptp 42.41 59.88 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.76 . . . . 0.0 109.571 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 63' ' ' VAL . 58.6 t -120.37 56.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.356 179.897 . . . . . . . . 0 0 . 1 stop_ save_